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Abstract 
The availability of forming technologies able to mass produce porous polymeric microspheres 
with diameters ranging from 150 to 300 µm is significant for some biomedical applications 
where tissue augmentation is required. Moreover, appropriate assembly of microspheres into 
scaffold is an important challenge to enable direct usage of the scaffolds in chronic wound 
treatments.  In  this  thesis,  the  feasibility  of  the  electrohydrodynamic  (EHD)  atomization 
forming combined with thermally induced phase separation (TIPS) for production of such drug 
delivery carriers, using biodegradable polymers (poly (lactic-co-glycolic acid) and poly (ʵ-
caprolactone))  was  explored.  To  achieve  this  goal,  the  first  part  of  the  thesis  describes 
comprehensive  parametric  mode  mappings  of  the  diameter  distribution  profiles  of  the 
microspheres obtained over a broad range of key processing parameters and correlating this 
with the material parameters of five different polymer solutions of various concentrations. 
Based on the mode mapping studies, combination of poly (lactic-co-glycolic acid) (PLGA) and 
dimethyl carbonate (DMC) was found to be ideal for generating the microspheres within the 
targeted diameter range (150-300 µm). Surface porosity was achieved by electrospraying the 
PLGA/DMC solution and collecting the required size of the polymer particles in liquid nitrogen 
followed by lyophilisation. The second aim of this thesis was the in vitro release studies. In 
order to conduct this part of the study, the single needle and co-axial needle EHD/TIPS methods 
were used to generate the dye loaded microspheres of the required size. Three different dyes 
(Erythrosin B, Pyronin B and Reichardt’s) were selected as model drugs to be encapsulated 
separately in the produced microspheres. The purpose of selecting three different dyes was to 
have a prediction on the release profile of immunosuppressants with high toxicity used for 
treatment of chronic wounds such as perianal fistulae. The in vitro release studies showed that 
the dyes were released with the high initial burst release phase in 3.5-5.5 hours followed by a 
long and sustained release phase (in 30-360 hours). Systematic investigations using different 
external stimuli such as temperature, fresh media and sonication exposure was also carried out 
to observe their effects on the release rate of the encapsulated materials from the produced 
microspheres. The results acquired from the in vitro release studies showed that the temperature 
variations and the sonication with different frequencies have significant effects on the release 
rates of the incorporated materials from the polymeric microspheres. Moreover, the results 
demonstrated that the products collected by the single needle EHD/TIPS method is more 
capable of releasing the payload in  a longer period of time with  more sustained manner 
compared to their counterparts obtained from the co-axial needle method. 
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Chapter 1 
Introduction and Background 
1.1 Background 
The first procedure of microencapsulation was conducted in 1931 by Bungenburg de Jong and 
Kaas for the preparation of gelatin microspheres (Bungenburg de Jong and Kaas, 1931). Later 
on,  in  1950s,  Green  et  al.  of  National  Cash  register  Co.,  Dayton  Ochio  developed  a 
microencapsulation dye for the manufacture of carbonless copying paper which ultimately 
resulted  in  several  patents  and  made  the  microencapsulation  more  common  (Green  and 
Schleicher,  1957;  Green,  1955).  Since  then,  and  particularly  since  mid-1970’s 
microencapsulation has become more effective and popular in the pharmaceutical industry as 
well  as  for  many  other  products  and  processes  in  daily  use  such  as  food  production. 
Encapsulated  products  now  available  include  liquid  crystals,  adhesives,  perfumes  and 
fragrances, cosmetics, insecticides, algaecides, fertilizers, washing powders as well as animal 
feed  stocks,  tissue  mimicking  materials  and  medicinal  products,  and  insulation  materials 
(Arshady, 1990; Schmidt and Roessling, 2006). Such products have diameters varying between 
50 nm and 1mm with a solid, liquid or gaseous phase. The wall material can be constructed 
from surfactants, glasses, oxide ceramics, polymers, mixed oxides or even metals (Bertling et 
al., 2004; Gaponik et al., 2004). The main motivating factors for encapsulation are taste and 
odour  masking,  separation  of  incompatible  components,  protection  from  immediate 
environment, modification of impact strength, alteration of colloidal and surface properties, 
prolonged  action  or  sustained  release  of  drug/agent,  targeted  release  and  enhanced 
biocompatibility (Arshady, 1989). 
For applications in medicine and pharmaceuticals, there is a growing interest in the use of 
particles as drug delivery carriers and in the synthesis of artificial cell structures (Bertling et 
al., 2004; Botchwey et al., 2004). Both micro- and nano-particles can be used therapeutically. 
For instance, particles loaded with an entrapped therapeutic agent can transport the substance 
through blood vessels and then release their load at a target area (Panyam and Labhasetwar, 
2003).  However,  the  preparation  of  effective  and  operative  drug  delivery  systems  still 
represents an important continuing challenge in biomedicine (Mathiowitz et al., 1997). The                                                                                           Chapter 1: Introduction and Background 
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purpose in designing an ideal drug carrier is to attain sustained and controlled release which 
can decrease the fluctuation and variation of drug dosage and maintain the concentration of 
drug  to  a  constant  level  over  the  designated  treatment  period  in  order  to  optimize  the 
effectiveness of the therapeutic agent (Luan et al., 2006; Yang et al., 2001). In particular, the 
aim in designing an ideal drug delivery system is to minimize the drug degradation and loss, to 
prevent  harmful  adverse-side  effects  and  to  maximise  drug  biological  activity  and  the 
percentage  of  the  drug  accumulated  in  the  required  zone.  Therefore,  various  preparation 
methods have been investigated over the years with a view to generate drug carriers which can 
be tailored to achieve these goals (Freitas et al., 2005; Yang et al., 2001).    
Spherical particles play a crucial role in encapsulation of various materials and have been used 
for a wide range of biomedical applications (Li et al., 2004; Peng and Zhang, 2005). Polymeric 
spheres are of particular interest, since they provide characteristics such as high surface-to-
volume ratio, low density, and low coefficient of thermal expansion (Lou et al., 2008). Control 
of  the  internal  and  external  morphology  of  the  spheres  can  be  used  to  influence  their 
interactions with the encapsulated drug as well as the microenvironment after their delivery 
into the body  (Moon and Jeong, 2008). Encapsulation  of drug in  biodegradable polymer 
carriers offer the possibility of drug to be released in a controlled manner which can help to 
maintain a constant therapeutic concentration between the toxic and minimum levels in body 
fluids  over  the  period  of  treatment  following  administration  (Sinha  and  Trehan,  2003). 
Recently near monodisperse microspheres with surface porosity have received much attention 
and been classified as a new category of particles on the account of their higher effective 
diffusivity and available surface area compared to their counterparts with smooth morphology 
of  same  size  (Jeong  et  al.  2007;  Yow  and  Routh  2008;  Yin  and  Yates  2008).  Porous 
microspheres have also showed a higher rate of in vitro drug release owing to the porous 
membrane, which is more suitable for targeted delivery and chronic wound therapy (Enayati et 
al., 2010a; Setterstrom et al., 1984).  
Common  methods  able  to  generate  drug-encapsulated  polymeric  microspheres  include 
emulsion polymerization, phase separation and spray-drying. However, there are some definite 
disadvantages with these methods (Kissel et al., 1996; Konishi et al., 2003; Okubo et al., 1998; 
Zhang  et  al.,  2003).  For  example,  emulsion  polymerization  produces  polydisperse 
microspheres with a broad size distribution profile (Fujiwara et al., 2012; Kissel et al., 1996). 
Non-degradable  additives  such  as  surfactants  or  polymers  are  also  typically  required  as 
emulsifiers (Freitas et al., 2005). Residual solvent toxicity is another issue and the purifying                                                                                           Chapter 1: Introduction and Background 
3 
 
process to separate the microspheres from the solvent is slow and costly for pharmaceutical 
applications (Luan et al., 2006). Most importantly, due to exposure of drug, for instance, to 
elevated temperatures and high shear stresses in the emulsion method, the biological activity 
of the drug can be significantly reduced during processing (Kohane et al., 2006; Rasiel et al., 
2002;  Vandervoort  and  Ludwig,  2002).  Phase  separation  technique  can  also  generate 
microspheres with rigid outer surfaces and a long shelf life. However, the method requires 
time-consuming multiple processing stages, and suffers from poor control over the diameter 
distribution of the fabricated spherical particles. In addition, the particles often stick to each 
other during formation and before the completion of the processing stages, resulting in large 
aggregates  (Arshady,  1990;  Nihant  et  al.,  1995).  Spray-drying  is  another  robust  particle 
generation  method,  and  the  processing  conditions  to  control  the  generated  microsphere 
diameters are relatively straightforward. However, solvent removal is an issue in spray-drying, 
which often results in producing large aggregates. In addition, a large number of spherical 
particles are often lost during production due to sticking to the walls of the spray drier (Blanco-
Príeto et al., 2004; Burke et al., 2004; Murillo et al., 2002).  
Electrohydrodynamic (EHD) atomisation is an attractive, alternative method for the generation 
of near monodisperse micro- and nano-spheres for applications in drug delivery systems (Ding 
et  al.,  2005;  Pareta  and  Edirisinghe,  2006).  A  versatile  method  able  to  process  multiple 
solutions  and  emulsions  of  different  polymers  and/or  therapeutic  agents  under  ambient 
conditions, it is a single-stage production process for drug encapsulation with the flexibility to 
monitor the product quality at any time without delay during the production stage, without 
affecting the continuity of the process or having to wait for a multi-stage production process to 
complete before inspection (Enayati et al., 2010a; Wu and Clark, 2007; Xu et al., 2006).  
The EHD process subjects a liquid to a high electric field (potential in range of kilovolts), 
which causes  charges  to build up within the liquid.  When the applied electrostatic  force 
overcomes the surface tension of the liquid, the meniscus of the liquid held at the tip of a nozzle 
elongates into a conical shape and a fine jet generates from the apex of the cone. The jet 
subsequently breaks up and deposits on an electrically grounded collector as fine spherical 
particles (Luo et al., 2011). Stable cone-jet is the most desirable electrohydrodynamic jetting 
condition for production of near monodisperse spherical particles (Luo et al., 2011). The mean 
sphere  diameter  generated  can  be  varied  from  tens  of  nanometres  up  to  hundreds  of 
micrometres by changing the EHD processing parameters such as nozzle diameter, flow rate 
and applied voltage as well as solution properties, e.g. viscosity, surface tension and electrical                                                                                           Chapter 1: Introduction and Background 
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conductivity of polymer solution (Ahmad et al., 2008; Samarasinghe et al., 2007; Xie et al., 
2008; Yeo et al., 2005). To maintain a stable cone-jet, the rate of mass transfer to the nozzle 
exit (controlled by the liquid flow rate) should be coupled and balanced by that out of the nozzle 
(controlled by the applied voltage, which is responsible for the force causing jet formation). 
Therefore, the flow rate and the applied voltage used for each polymer liquid should be 
carefully coupled within a defined range (Xie et al., 2008).  
Biodegradability is one of the key features of drug delivery carriers (Burton et al., 2000). The 
elimination of an inactive material by a natural process is preferred over surgical removal of a 
drug delivery system which may lead to presence of non-biodegradable foreign debris inside 
the body for an indeterminate period of time. Biodegradable polymers are suggested as the 
most promising materials for drug encapsulation in developing drug delivery systems for 
sustained and controlled release of drugs. A number of polymers with different properties have 
been investigated in EHD for their potential applications in drug delivery systems. However, 
only a few of them such as poly (ʵ-caprolactone) (PCL) and poly (lactic-co-glycolic acid) 
(PLGA)  have  been  extensively  used  due  to  their  biocompatibility,  biodegradability  and 
versatile degradation kinetics (Burton et al., 2000; Körber and Bodmeier, 2008). PLGA co-
polymers  have  higher  rate  of  bio-erosion  by  hydrolysis  under  physiological  conditions 
compared with PCL as they contain more ester groups per polymer molecular chain (Chen, 
2010). The biodegradation products of these two polymers have been shown to be non-toxic, 
non-immunogenic (not causing immune response), non-teratogenic (not causing malfunction 
of foetus or embryo) and non-carcinogenic (not causing cancer) (Ravivarapu et al., 2000). 
Furthermore, the composition of these polymers can be changed in order to obtain a desirable 
release  profile  based  on  the  rate  of  hydrolytic  degradation.  For  these  reasons,  these  two 
polymers have attracted significant research in the development of drug delivery systems (Jain, 
2000) and are selected in this investigation.  
Over the past decade, the drug release characteristics of polymeric carriers encapsulating 
various drugs using different techniques have been studied (Avgoustakis, 2004). However, 
there are still relatively few attempts to modulate and manipulate the drug release profiles. 
There are two features of polymeric drug delivery systems that require particular attention. 
First is the initial burst release phase which can be both desirable and/or undesirable depending 
on biomedical applications. This phase, which mostly relies on the morphology of generated 
particles, occurs during the first 24 hours of the administration. Second is the ability to modify 
the in vitro release profile in order to achieve a stable manner of drug release. This type of                                                                                           Chapter 1: Introduction and Background 
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release profile can be achieved by controlling the drug release through external stimuli for 
example exposure to sonication, or applying different temperatures. 
Sonication  and  temperature  have  many  applications  in  medicine.  Sonication  in  form  of 
ultrasound is mostly adopted for diagnostic imaging (Moore and Promes, 2004). However, 
recently,  it  has  been  used  in  drug  delivery  systems  for  stimulating  drug  release  process 
(Mitragotri et al., 1995). In ultrasonically stimulated systems, the acoustic waves enhance the 
degradation of the loaded polymeric carrier in order to stimulate the drug release. For example, 
in the work conducted by Miyazaki et al., it was found that ultrasonic waves could cause a 
sharp drop in blood glucose level right after it was administered to an insulin loaded ethylene 
vinyl alcohol copolymer system (Miyazaki et al., 1988). Temperature is another effective factor 
in release studies and has been used for stimulating drug release processes. In the study 
conducted by Reddy et al. it was found that the drug release rate is dependent on temperature 
of the medium (Umamaheswara Reddy et al., 2007). Variations in temperature can lead to more 
controlled manner of drug release depending on the chemical properties of drug and its carriers. 
For example, in the study of Shi et al., more controlled release of the encapsulated agents (Ca-
alginate  and  poly(N-isopropylacrylamide))  in  hydrogel  beads  was  observed  at  lower 
temperature (25oC) compared to higher degrees (37oC) (Shi et al., 2006), whereas in the study 
of Lin et al., more controlled release of the drug from the ethylene vinyl acetate (EVA) was 
found at higher temperature (37oC) compared to lower temperature (24oC) (Lin et al., 2003). 
1.2 Objectives of the Project 
 
Figure 1.1: Objectives of the research presented in this thesis                                                                                           Chapter 1: Introduction and Background 
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The flow chart in Figure 1.1 displays the key objectives of this thesis. The details regarding 
each objective is briefly discussed below. 
1.2.1 Production of Polymeric Particles Using Single Needle EHD Method 
The first main objective of this project was to generate microspheres with porosity on the outer 
surface in order to develop free flowing scaffold for treatment of chronic wounds. The size 
distribution of spheres for the formation of scaffold structure was in the range between 150 µm 
and 300 µm. To meet this objective, the feasibility of the single needle EHD method for 
fabricating the required size distribution of the microspheres via a single step was investigated 
as follows: 
1.2.1.1 EHD Mode Mapping and Size Distribution Studies 
The first aim was to investigate the fundamental ability of the single needle EHD processing 
in having the control over the particle size, size distribution and shape of the products for 
preparation of polymeric carriers. It was determined how the size and size distribution of the 
particles fabricated can be systematically controlled through a range of various operating 
parameters: flow rate, applied voltage and the inherent properties of the solution such as 
viscosity, surface tension and electrical conductivity. It was demonstrated that how variations 
in  these  parameters  affect  the  jetting  mode  and  the  desired  stable  cone-jet  mode  can  be 
obtained. For this part of study, different biodegradable polymers (PLGA (33000 g/mole) and 
PCL (10000 and 45000 g/mole)) were used, and their polymer solutions were electrosprayed 
at different flow rates and the applied voltages, and the spherical particles with various size 
distributions  were  prepared.  After  these  extensive  studies,  the  ideal  set  of  processing 
parameters  for  obtaining  the  required  size  distribution  of  PLGA  polymer  particles  were 
obtained. 
1.2.1.2 Fabrication of Porous PLGA Microspheres 
Based on the results acquired from the EHD mode mapping and size distribution studies, the 
ideal set of processing parameters were determined for production of the PLGA microspheres 
with the required size distribution (150-300 µm). Then, surface porosity was generated by 
electrospraying the required size of the microspheres in liquid nitrogen followed by freeze 
drying process. The purpose of surface porosity was to obtain higher rate of drug release for                                                                                           Chapter 1: Introduction and Background 
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this particular biomedical application. Although, this has been a challenge in drug delivery 
system to control the initial burst release phase, this can have a significant application, in 
particular, in chronic wound therapy (Setterstrom et al., 1984). There is increasing evidence 
that particles with varying shape and size may play a significant role in the effectiveness of 
drug delivery and other biomedical interventions (Champion and Mitragotri, 2006; Gratton et 
al., 2007). However, in this study, the most work has focused on producing near monodisperse 
microspheres, as this type of microspheres has been considered to provide free flowing scaffold 
with large enough interstices between them for treatment of chronic wound.  
1.2.2 Production of Loaded PLGA Microspheres 
Production of particles with narrow size distribution is of particular interest in biomedical 
engineering (Kissel et al., 1996; Vonarbourg et al., 2009; Zhu et al., 2000). Research on the 
encapsulation of various therapeutic agents by efficient methods is significant for fabrication 
of advanced products with different core, targeting behaviour and release profiles (Luan et al., 
2006). Since, the EHD method has shown to be a promising technique for fabrication of drug 
delivery carriers with a required size range, the next objective of the project was to encapsulate 
therapeutic materials into the PLGA particles.  
Cyclosporine A (Cys A) and Tacrolimus are usually prescribed as antimicrobial agent for 
treatment  in  early  stage  of  chronic  wounds  such  as  Crohn’s  disease-associated  fistula 
(Ptachcinski et al., 1986; Sheng-Tanner et al., 2000). Since, this type of drugs has huge side 
effects such as neuro- and nephrotoxicity in the human body, they could not be used for in-
vitro drug release studies in the first and/or second class laboratories. Thus, in order to fulfil 
this  objective,  Reichardt’s  dye,  erythrosin  B  and  pyronin  B  were  selected  as  model 
encapsulated materials to show the feasibility of the encapsulation process. The selection 
criteria was based on covering the range of molecular weight and water solubility of the actual 
drugs, as these two properties play important role in in vitro release profile. 
The  encapsulation  process  was  carried  out  via  the  single  needle  and  the  co-axial  needle 
EHD/TIPS methods. The results obtained from both methods were then compared in order to 
find a suitable EHD process for drug encapsulation. This study successfully confirmed the 
feasibility of EHD processing (the single needle and the co-axial needle) as a technique for 
producing drug-loaded particles.                                                                                             Chapter 1: Introduction and Background 
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1.2.3 In Vitro Release Studies 
As  discussed  in  Section  1.2.1,  the  main  objective  was  the  fabrication  of  drug  loaded 
microspheres with required size and surface porosity. Single needle and co-axial needle EHD 
methods showed the ability for generation of such microspheres, and then combined with 
thermally induced phase separation (TIPS) process, the surface porosity was achieved. The 
second main objective was an in-depth study of the release profile of these carriers based on 
the effect of different parameters such as temperature and the sonication exposure on the release 
characteristics.  However,  the  overall  aim  was  to  predict  the  release  profile  of 
immunosuppressants that have high molecular weight and low water solubility.  
1.2.3.1 Temperature Stimulated Release 
The final objective was to observe the release characteristics of the model drugs at various 
temperatures. Since, initial burst release can be an advantage in drug delivery systems for 
chronic wound treatments, the effect of heat on this release phase of the model drugs was also 
investigated.  The  results  showed  that  heat  may  affect  the  release  characteristics  of  the 
incorporated materials, and depending on the chemical properties such as evaporation and 
degradation rates, it can lead to either higher or lower release rate.  
1.2.3.2 Sonication Stimulated Release  
The other final objective was to observe the release characteristics of the encapsulated dye 
upon sonication exposure. As discussed before, the initial burst release of the encapsulated 
agents in conjunction with the application of sonication was also studied. The results showed 
that sonicator responsive drug delivery has great potential in releasing the payload from their 
carriers with higher rate. Systematic investigations were carried out to determine the effect of 
sonication exposure parameters such as duty cycle and exposure time on the release rate of the 
encapsulated agents from the PLGA microspheres.  
1.3 The Structure of the Thesis 
Chapter 1 provides  the background information about  the research project  and  gives an 
overview about the basics of electrohydrodynamic atomization and other related techniques 
which are adopted for generation of micro- and nano-spheres for drug encapsulation. The                                                                                           Chapter 1: Introduction and Background 
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objectives of the research are then stated and the organization of this thesis and the scope of 
the research are outlined. 
Chapter 2 presents a detailed literature review. Since, the aim of the project is to prepare 
porous  microspheres  using  combination  of  EHD  and  thermally  induced  phase  separation 
(TIPS) method, an extensive collection of literature reviews has been surveyed to understand 
the principles of electrohydrodynamic atomization, the procedure and its usage, as well as 
materials and other methods adopted for the preparation of polymeric carriers. Furthermore, a 
literature review has been presented on micro and nano particulate drug delivery systems for 
applications in medicine and treatment of chronic wounds such as fistulae using different 
methods of product fabrication. 
Chapter  3  describes  the  experimental  setup,  modification  process,  materials  adopted, 
experiment  and  characterization  procedures  conducted,  and  a  detailed  description  of  the 
experimental tools employed.  
Chapter 4 explains the results acquired from the experimental work. This chapter contains two 
main parts: 1) the EHD mode mapping and size distribution studies, and 2) the in vitro release 
studies. The results in this chapter is discussed in detail in conjunction with the existing 
literature review. The EHD mode mapping and size distribution studies has three main sections. 
In Section 4.1, different concentrations of PCL and PLGA solutions are used to show the 
feasibility of the single needle EHD method in fabrication of polymeric microspheres with 
different size ranges. Different modes of EHD processing are also studied and classified. 
Furthermore, the effect of different parameters such as applied voltage, flow rate, viscosity and 
electrical conductivity are studied on the size, size distribution of spheres, polydispersity index 
and also the mode of cone-jet. Section 4.2 demonstrates micrographs of the produced spherical 
particles for EHD mode mapping and size distribution studies. Section 4.3 of this chapter states 
how the combination of single needle EHD and thermally induced phase separation (TIPS) 
method can be adopted for mass production of the required size distribution of microspheres 
with porosity on the outer surface for treatment of chronic wounds such as perianal fistulae. 
Chapter 4 also describes the release profiles of the dye loaded PLGA microspheres obtained 
from the single needle and the co-axial needle EHD/TIPS processes. The in vitro release studies 
has five main sections. Section 4.5 focuses on the internal and morphological structure of the 
products collected from the single needle EHD/TIPS process, and then they are compared to 
those obtained from the co-axial needle EHD/TIPS method. Sections 4.6 and 4.7 are provided                                                                                           Chapter 1: Introduction and Background 
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to show the presence of the dyes encapsulated in the microspheres produced by different 
EHD/TIPS methods. Section 4.8 focuses on the yield of the process based on the collection of 
the  products.  In  this  section,  the  percentage  yield  of  the  modified  co-axial  process  in 
comparison with the modified single needle process is briefly discussed. In the next section 
(Section 4.9) of this chapter, the in vitro release profile of loaded microspheres from the co-
axial needle technique are described and then they are compared to those obtained from the 
single needle method in order to discover the suitable process for encapsulation and drug 
delivery. This section also provides a prediction for the release profile of immunosuppressive 
agents with high molecular weight and low water solubility based on the release profiles 
obtained from using model drugs with various chemical and physical properties. The final 
section of this chapter is also dedicated to the effect of external stimuli such as temperature and 
sonication exposure on the release rate of the encapsulated materials from their polymeric shell 
for obtaining more efficient release profile. 
Chapter 5 is divided into two sections. Section 5.1 summarizes the experimental results and 
presents the conclusions of the work, whereas Section 5.2 discusses some recommendations 
for future work, employing EHD combined with TIPS processing and beyond, to continue the 
research  presented  in  this  thesis  in  new  directions.  Eventually  the  literature  referred  to 
throughout the thesis is listed in the References section.  
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Chapter 2 
Literature Review 
2.1 Introduction 
The objective underlying the research described in this thesis is to study electrohydrodynamic 
forming as a technique for preparation of micro- and nanoparticles which can satisfy the 
requirements  for  the  spheres  that  are  adopted  principally  for  applications  in  biomedical 
engineering, targeted for drug delivery and controlled release systems.    
In order to accomplish this objective, the relevant literature will be reviewed as follows: 
  Fundamental concepts of drug delivery systems, routes of drug delivery and the 
mechanism  of  drug  release:  the  aims  of  drug  delivery  systems,  variety  of  drug 
administration routes and the mechanisms which control the drug release including the 
degradation  and  erosion  of  the  polymeric  carriers  are  presented.  Furthermore,  a 
comprehensive description of various particulate drug carriers with different structures 
will be explained. 
 
  Methods  for  polymeric  microsphere  preparation:  different  techniques  for  the 
fabrication of drug loaded polymeric carriers such as emulsion-solvent evaporation 
(conventional), coacervation (aggregation of colloidal droplets) phase separation and 
spray drying are discussed, and then they are compared with the electrohydrodynamic 
forming process, which is adopted in this study, in order to find out the advantages and 
disadvantages of this forming process.  
 
  Electrohydrodynamic forming process: the theory of this processing method and the 
previous work based on using electrohydrodynamic (EHD) atomization are reviewed 
and briefly discussed. Various modes of EHD processing and all the parameters such 
as processing factors (applied voltage and flow rate) and solution properties (surface 
tension, electrical conductivity, density and viscosity) involved in this process are well 
explained. The applications of single needle and co-axial needle electrohydrodynamic 
atomization methods in preparation of various drug carriers such as microspheres,                                                                                                                Chapter 2: Literature Review 
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capsules, aerosols, porous particles and microbubbles are also reviewed in order to 
understand how this unique processing technique offers great opportunities in health 
improvement and further research. 
 
  Polymeric based drug delivery systems: numbers of different polymers have been 
extensively adopted for preparation of drug delivery carriers using EHD. In this section, 
a detailed examination of synthetic biopolymers such as poly (ʵ-caprolactone) (PCL) 
and poly (lactic-co-glycolic acid) (PLGA) will be made. 
 
  Controlling the drug release profile: The main purpose of such drug delivery system 
is to have a regulated and sustained release profile from the drug loaded carriers. In this 
part, the role of sonication and temperature in biomedical engineering, in particular, in 
drug delivery system and drug release profiles will be explained. 
 
  An  overview  of  chronic  wounds  and  the  treatments  with  application  of 
biomaterials: the aetiology of chronic wounds and how they can later on develop into 
non-healing cavities in human body tissues are reviewed. The previous work conducted 
for the treatment of perianal fistulae which are a severe type of chronic wounds is also 
revised.  Then,  the  new  approach  for  therapy  of  such  disease  by  application  of 
biomaterials using EHD method is described. 
2.2 The Drug Delivery Concept and Goal of Drug Delivery Systems 
The goal of drug therapy is to prevent, cure or control various states of a disease. To achieve 
this goal, adequate drug doses must be delivered to targeted area in the human body over the 
appropriate length of time so that therapeutic yet nontoxic levels are obtained. Pharmacological 
and toxicological actions of drugs are primarily related to the plasma concentrations of drugs 
(Finkel et al., 2009). Therefore, clinicians must be able to recognize that the speed of onset of 
drug action, the intensity of drug’s effect and the duration of drug action are controllable by 
the following four fundamental pathways of drug movement and modification in the body: 1) 
drug absorption from the site of administration which allows entry of the therapeutic agent 
either directly or indirectly into plasma; 2) drug distribution which the drug may then reversibly 
leave  the  blood  stream  and  distribute  into  the  intestinal  and  intracellular  fluids;  3)  drug 
metabolism, that the drug may be metabolised by liver, kidney, or other tissues; and 4) drug                                                                                                                Chapter 2: Literature Review 
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elimination, that the drug and its metabolites are removed from body by urine, bile or faeces 
(Finkel et al., 2009). Therefore, biocompatibility, biodegradability and pharmokinetics of the 
drug must be considered before administration. 
The concentration level of the therapeutic agent (drug), in conventional drug delivery system 
such as tablets or injections, decreases significantly after administration. It is fundamentally 
hard to keep the drug concentration in the blood stream at a therapeutic level for extended 
periods of time; therefore, multiple administrations are usually required to attain the desired 
therapeutic outcome (Cohen et al., 1991). In such drug delivery system, high concentrations of 
drugs, especially those with more side effects, may induce more adverse toxic effects, as 
delivering the therapeutic agent is only dependant on diffusion or partition from the blood 
stream to the action site. The only advantage of this system over the controlled release system 
is its low processing and administration cost. The drug level in the blood stream rises after 
administration of the drug and then decreases with time until the next administration (Fig. 
2.1a). The concentration of a therapeutic agent obtains two limits in blood stream; the toxic 
level of the therapeutic agent (upper limit) and the effective therapeutic level (lower limit). 
Thus, the key point with the traditional administrations of drug is to maintain the level of the 
drug between the two limits during the period of treatment (Park et al., 1998).  
The limitation with the traditional administration of drugs was improved by the contemporary 
drug delivery systems which can release the drug over the long periods of time with remaining 
the level of drug at the constant stage in the blood stream (Fig. 2.1b), between the toxic and 
effective level of therapeutic agent for a specific time (Brannon-peppas, 1997). For treating the 
imbalance of biological homeostasis, drug releases only when it is needed. For instance, insulin 
releases from a polymer matrix only in response to an enhanced glucose concentration of 
diabetic patients. This type of release profile is typically known as pulsatile release (Fig. 2.1c). 
Highly localised drug release which is another route of drug release, can be attained by various 
targeting strategies (Fig. 2.1d). In this drug delivery system, release is restricted to a target site 
at a high local concentration for an extended time, and multiple drug components are planned 
to be sequentially released only when they are needed. For instance, ischemic brain leads to 
numerous cellular events including provocation of excitatory amino acids and reactive oxygen 
species  within  an  hour,  formation  of  polymorphononuclear  leukocytes  within  a  day,  and 
macrophages activation within a week. Therefore, a temporally programmed drug release 
system is an outstanding solution to supply multiple drugs. Therapeutic efficiency in these two                                                                                                                Chapter 2: Literature Review 
14 
 
introduced systems is very high while the side effects are significantly reduced compared with 
the traditional administrations (Kim et al., 2009). 
 
Figure 2.1: Different types of controlled release systems: (a) Drug delivery based on simple 
diffusion and partition; (b) Sustained release to prolong the therapeutic period; (c) Pulsatile 
release to tightly maintain homeostasis; (d) On-site release to maximize therapeutic efficiency 
and to minimize the side effect (Kim et al., 2009). 
2.3 Routes of Drug Delivery Using Micro and Nano Spheres 
There are number of potential routes for administration of drug loaded micro- and nano-
particles, ranging from parenteral, i.e. intramuscular and subcutaneous, to nasal, pulmonary, 
oral, ophthalmic, transdermal, etc. In this part, a short description of the most popular drug 
delivery routes is provided. 
Oral drug delivery: this is the most common method of drug delivery as it is convenient, easy 
to use and can be controlled by patient. However, there are some drawbacks associated with 
this method. For instance, the oral course is very variable, so that there is a noticeable potential 
for bio-inequivalence between orally administrated drugs (Zhang et al., 2002). 
Parenteral drug delivery: this technique is used if drugs cannot be given by the oral route due 
to two reasons, firstly poor absorption properties of drug, secondly, propensity to degrade in 
the gastrointestinal tract. In this technique, drugs are delivered by injection to the target sites                                                                                                                Chapter 2: Literature Review 
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in the body. The aim of using this method is to deliver the drug to specific body tissues. The 
most common ways of administrating drug to the targeted area in this method are intramuscular 
(IM), intravenous (IV) and subcutaneous (SC) (Sinha and Trehan, 2005). 
Pulmonary drug delivery: inhalation is another effective route of drug delivery for some of 
the  therapeutic  agents.  In  this  route  of  drug  delivery,  the  therapeutic  agents  are  directly 
delivered to lungs (Clark, 1995). The physical characteristics of the drug carriers are crucial 
for successful pulmonary drug delivery. The desired range of spheres for transporting the drug 
to the lungs must be within 1-5 µm (Grossman, 1994; Schreier et al., 1993). In this route of 
drug delivery, biodegradable polymeric carriers can help the inhalation treatment to have a 
sustained release of the drug (Kawashima et al., 1998). Gradual release from inhaled drug 
loaded microspheres can increase the residence of the drug in the airway, and therefore can 
reduce the percentage of the therapeutic agent in the blood stream. This method would also be 
more convenient for patients compared with the oral administrations due to reduction in the 
dosage frequency (Schreier et al., 1993). 
Transdermal drug delivery: this technique utilises an adhesive patch containing drug, which 
passively diffuses through the dermal system (skin). The skin is formed to act as a potent barrier 
against external  damage;  therefore, transdermal  delivery systems  have been developed to 
overcome  this  resistance,  and  by  far  number  of  different  drugs  have  been  delivered 
transdermally such as contraceptives, nicotine and oestrogen (Prausnitz et al., 2004; Singh and 
Roberts, 1989). 
2.4 Particulate Drug Carriers 
The development of drug delivery in the form of polymeric carriers is a relatively new area of 
scientific research, as the technology to work at atomic, molecular and supramolecular levels 
have  only  become  extensively  available  in  recent  years.  Particulate  drug  carriers  include 
different types of structures such as micro/nano spheres (micro/nano particles), liposomes, 
vesicles, micelles and dendrimers (Fig. 2.2). Microspheres are small spherical units, composed 
of various combinations of natural and synthetic materials with diameters in the micrometre 
range. The therapeutic agents can be dispersed or dissolved in the matrix of spheres. However, 
nanospheres are spherical nano-sized unit, where active compounds can be firmly adsorbed at 
their surface, entrapped or dissolved in the matrix. Nanocapsules are the nano-scale capsules                                                                                                                Chapter 2: Literature Review 
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with a polymeric shell and an inner core. In this case, the active substances are dissolved in the 
core (Mainardes et al., 2006). 
 
Figure2.2: Pharmaceutical carriers (Kaparissides et al., 2006)  
Liposomes contains a lipid biolayer surrounding an aqueous core, which can be produced in 
sub-micron size. They are capable of carrying drugs either in their lipid biolayer or aqueous 
core (Bangham et al., 1965). Micelles are another type of drug carriers which are a collection 
of amphiphilic surfactant molecules that spontaneously aggregate to form a spherical vesicle 
in water. The core of each micelle is hydrophilic which can sequester hydrophobic drugs until 
they are released by some drug delivery mechanisms. Micelles are usually formed from small 
molecules, which have a hydrophilic or polar head group and hydrophobic tail, and are often 
composed  of  the  hydrocarbon  portion  of  long  fatty  acids.  Geometrical  features  such  as 
molecular size of the surfactants determine the micelle size (Nishiyama and Kataoka, 2003; 
Savic  et  al.,  2003).  A  dendrimer  is  commonly  described  as  macromolecule  which  is 
characterised by its highly branched 3D structure, and has the ability to provide a high degree 
of  surface  functionality  and  versatility.  Dendrimers  have  been  often  referred  to  as  the 
“Polymers of the 21st century” (Lee et al., 2005; Pushkar et al., 2006). The unique architectural 
design  of  this  type  of  macromolecules  provides  high  degree  of  branching,  multivalency, 
globular  architecture  and  well-defined  molecular  weight  that  clearly  distinguishes  their 
structures from other types of drug carriers in medical applications such as gene transfection, 
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architecture with characteristics amenable to modifications of size, polarity, morphology as 
well as internal structure (Boas and Heegaard, 2004).  
2.5 Mechanisms of Drug Release 
Mechanism of drug release from synthetic degradable polymeric carriers involves a series of 
steps: diffusion, chemical reaction and solvent activation. The classification of controlled 
release systems is based on the means which controls the drug release that requires dissolution 
of the drug followed by diffusion through the structure of polymeric particles in order to reach 
the release medium. So far, two different types of diffusion-controlled mechanisms have been 
developed: the first is the reservoir system, and the second is the matrix system (Huang and 
Brazel, 2001). 
In the reservoir system, the drug is physically captured inside a polymeric device that can be 
then injected or implanted in the body. In this mechanism, the drug diffuses through the 
polymer membrane which entraps and protects the drug from the outer environment (Fig. 2.3a). 
Early forms of this mechanism involved using non-degradable polymers such as silicone 
rubber, that could release drugs with low lipophilic molecular mass over extremely long time 
periods (Folkman and Long, 1964). This approach led to the development of small silicone 
capsules such as Norplant containing contraceptives that can be slowly released by diffusion 
through the polymeric shell for 5 years. The process of diffusion is described by a series of 
equations managed by Fick’s first low of diffusion: 
J = -D 
𝜕𝑐
𝜕𝑋                                                                                                             (2.1) 
Where J, known as flux density, is the amount of drug crossing the membrane per unit time 
and is typically expressed in units such as moles of particles per m2 per second. D is the 
diffusion coefficient of the drug in the membrane that reflects a drug molecule ability to diffuse 
through the polymeric matrix. This coefficient is also dependent on factors such as molecular 
size and charge. 
𝜕𝑐
𝜕𝑋 represents the rate of change in concentration where c is relative to distance 
x in the membrane. 
In the matrix mechanism, drug is physically embedded and distributed in a polymeric carrier 
(Fig. 2.3b) through which the entrapped drug consequently diffuses out (Langer and Folkman, 
1976; Langer, 1990). The matrix systems are the most common mechanisms for controlling                                                                                                                Chapter 2: Literature Review 
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the release rate of drugs. This is due to relatively easy fabrication of devices compared with 
reservoir  systems,  and  less  risk  of  an  accidental  high  dosage  that  could  result  from  the 
membrane rupture of reservoir device.   
Mechanism of drug release in some of other drug delivery systems is based on a combination 
of  diffusion  and  polymeric  degradation  processes.  In  those  systems,  biodegradable  (or 
bioerodible) polymers are adopted for fabrication of the drug carriers. The concept behind 
using biodegradable polymers is that they can be finally absorbed by the body due to their 
biocompatibility, and hence there is no need for surgical removal.   
Bioerosion of a polymer can be defined as the conversion of a material that is insoluble in water 
into  one  of  the  form  which  is  water-soluble.  In  a  mechanism  of  bioerosion,  the  drug  is 
preferably distributed uniformly throughout a polymer matrix in the same way as in monolithic 
systems. In this form, the drug releases as the polymer surrounding the drug is eroded (Fig. 
2.3c). 
 
Figure 2.3: Schematic representation of (a) Reservoir diffusion controlled, (b) Matrix diffusion 
controlled and (c) Biodegradable drug delivery devices (Salamone, 1996) 
2.6 Polymer Degradation and Erosion 
Although classification of the biopolymers adopted in drug delivery systems is difficult due to 
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common properties within groups of polymers. There are number of different descriptions for 
degradation and erosion in the literature review (Vert et al., 1992). However, the following 
definitions  are  adopted  in  this  study:  Degradation  is  based  on  a  chemical  process  and 
exclusively refers to bond cleavage and the chain scission process during which polymer chains 
are sliced to form oligomers and monomers, whereas, erosion is fundamentally a physical 
phenomenon dependent on dissolution and diffusion processes leading to reduction of material 
(Tamada and Langer, 1993).  
Polymer Degradations: degradation is one of the important procedures that leads to drug 
release  in  drug  delivery  system.  Polymeric  biomaterials,  depending  on  the  mode  of 
degradations can be classified further into two categories of hydrolytically degradable and 
enzymatically degradable polymers.  
Hydrolytical degradation is the main type of degradation for synthetic polymers. There are 
number of different variables influencing this process, such as the type of chemical bond, 
copolymer composition, water uptake and pH. During the process of degradation, one or some 
of these factors can occur to have a significant effect on the degradation of polymer. One of 
the most crucial parameters for monitoring degradation is molecular weight. Apart from loss 
of molecular weight, other factors have been proposed as a measure of degradation including: 
loss of mechanical strength and complete degradation into monomers or monomer release 
(Huang and Brazel, 2001). 
Enzymatic degradation of polymer is another type of degradations, and mainly occurs in natural 
biopolymers such as proteins (gelatine and collagen), polysaccharides and poly (β-hydroxy 
acids), where appropriate enzymes are obtainable (Huang and Brazel, 2001). 
Polymer Erosion: this mechanism basically has two different types: first; surface erosion and 
second,  bulk  erosion  (Göpferich,  1996).  When  the  surface  erosion  occurs,  polymers  lose 
material from the surface; therefore, they become smaller in terms of size but keep their original 
geometric shape (Fig. 2.4b). With surface eroding polymers, the rate of erosion exceeds the 
rate of water permeation into the bulk of the polymer. Due to kinetics of erosion, the mechanism 
of surface erosion is often considered to be desirable in drug delivery systems, and hence the 
rate of drug release is highly reproducible and predictable. Also, the magnitude of the erosion 
rate may change by simply altering the surface area of the drug delivery carrier. The slow rate 
of  water  permeation  into  surface  eroding  polymers  has  further  beneficial  influence  on 
protecting water labile drugs from quick release up to the time of drug release (Göpferich,                                                                                                                Chapter 2: Literature Review 
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1996). Poly (anhydrides) and poly (orthoesters) are the examples of surface eroding polymers, 
which in both classes, the biodegradable polymers possess highly labile groups that ensure 
rapid hydrolysis of polymer chains encountering water molecules. Permeation of water is 
retarded by designing the polymer chains with hydrophobic monomer units. Alternatively, 
hydrophobic excipients can be added to stabilise the polymer bulk (Lee et al., 2004; Modi et 
al., 2005).  The ideal surface erosion can occur when the erosion rate is directly proportional 
to external surface area. This can result in zero-order drug release (a steady amount of drug 
release over time) provided that diffusional release is restricted and the overall shape remains 
constant. 
 
Figure 2.4: Schematic illustration of the biodegradation of a polymeric drug delivery system: 
(a) Bulk erosion and (b) Surface erosion 
In the case of bulk eroding polymers, erosion is not limited to the surface of the polymer or the 
device. Therefore, the size of device may remain constant for a substantial period of time during 
its application (Fig. 2.4a). Bulk erosion occurs when the rate of water permeation into the bulk 
of the polymer exceeds the rate of erosion. As a result, polymer molecules in the bulk are 
hydrolysed. The kinetics of polymer bulk erosion is more complicated than for surface eroding 
polymers and the majority of biodegradable polymers adopted in controlled drug delivery for 
release of drug undergo bulk erosion rather than surface erosion (Lee et al., 2004). 
Surface  and  bulk  erosion  mechanisms  occur  for  most  biodegradable  polymers;  however, 
relative extent of the mechanisms varies completely with chemical structure of the polymer                                                                                                                Chapter 2: Literature Review 
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backbone. Polymer erosion is more complex compared with degradation, as it depends on many 
factors including swelling, the dissolution and diffusion of oligomers and monomers, and also 
morphological changes (Kwon et al., 1991). 
2.7 Methods for Preparation of Micro and Nano Polymeric Spheres 
A number of different methods are available for fabrications of micro- and nano-spheres and 
also  encapsulation  of  therapeutic  agents  in  the  polymeric  carriers:  emulsion  solvent 
evaporation/extraction,  spray  drying,  phase  separation,  suspension  cross-linking  and 
electrohydrodynamic atomization. Each technique has its own advantages and disadvantages, 
depending on the polymer and the solvent used, the drug and the site of its action and also the 
duration of therapy (Fukushima et al., 2000; Jain, 2000; Okada and Toguchi, 1995). Generally, 
there  are  few  requirements  needed  for  successful  and  effective  preparation  of  polymeric 
spheres: 
  The  chemical  stability  and  biological  activity  of  the  therapeutic  agent  should  be 
preserved during the whole process of drug delivery. 
  The encapsulation efficiency and the yield of the process should be high enough for 
mass production of micro- and/or nano-spheres. 
  Spheres  should  be  within  certain  range  of  size  and  they  should  also  be  almost 
monodisperse (uniform size). 
  Spheres should also have a controlled release profile without high initial burst release. 
2.7.1 Emulsion-Solvent Evaporation/Extraction Methods 
2.7.1.1 Single Emulsion Method 
This technique is adopted for loading the hydrophobic drugs in carriers via oil-in-water (o/w) 
emulsification method. In the first step for the preparation of the drug-loaded spheres, the 
polymer is dissolved in a water-immiscible solvent and then the drug is dissolved into the 
polymer solution. The resulting solution is emulsified in water using an emulsifier (Hombreiro 
Pérez et al., 2000; Jain, 2000). In this technique, the amount of solvent in the emulsion is 
usually reduced by increasing the temperature for evaporation of the residual solvent (Arshady, 
1991). Although with this technique, the drug loaded spheres can be simply fabricated, it is 
only suitable for hydrophobic drugs. The encapsulation efficiencies for hydrophilic drug are                                                                                                                Chapter 2: Literature Review 
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very low since drug may diffuse out from the dispersed oil phase into the aqueous phase 
(Arshady, 1991; Hombreiro Pérez et al., 2000). 
2.7.1.2 Double Emulsion Method 
Most water-soluble drugs are encapsulated by the water-in-oil-in-water (w/o/w) mechanism 
(Crotts and Park, 1998; Okochi and Nakano, 2000). In this technique, first, the polymer is 
dissolved in an organic solvent and then the aqueous solution of the drug is emulsified to form 
a water-in-oil (w/o) emulsion. Subsequently a w/o/w emulsion is formed by enhancing the w/o 
emulsion into an excess amount of water containing an emulsifier under strong stirring (Fig. 
2.5). Finally, the residual solvent from the solution is removed by evaporation or another 
extraction method. Advantage of this method compared to the single emulsion technique is the 
high  encapsulation  efficiency  for  hydrophilic  drugs  (Crotts  and  Park,  1998;  Okochi  and 
Nakano, 2000). 
 
Figure  2.5:  Processing  scheme  for  microsphere  preparation  by  double  emulsion  system 
(Chiellini et al., 2008) 
2.7.2 Coacervation and Thermally Induced Phase Separation (TIPS) Methods 
The term, coacervation is derived from the Latin word “acervus”, meaning aggregation and the 
prefix co indicates union of colloidal particles. This process, which is illustrated in Figure 2.6,                                                                                                                Chapter 2: Literature Review 
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has three steps and is carried out under continuous agitation. The first step is the formation of 
three immiscible chemical phases. The second stage is the deposition of the coating and the 
final step is the rigidization of the coating (Carrasquillo et al., 2001; Mallardé et al., 2003). 
Formation of three immiscible chemical phases: the three phases include one liquid vehicle 
phase, one core material and one coating material phase. These three phases are formed by 
dispersing the core material in a solution of coating polymer. The vehicle phase is adopted as 
a solvent for the polymer. For the coating material phase, an immiscible polymer in liquid state 
is formed by (i) altering the temperature of polymer solution, (ii) addition of salt, (iii) addition 
of non-solvent or (iv) addition of incompatible polymer to the polymer solution (Madan, 1978). 
Deposition of the coating phase: this phase includes the deposition of the liquid polymer 
coating upon the core material. This occurs when the polymer is adsorbed at the interface 
formed between the core material and the liquid vehicle phase. This adsorption phenomenon 
is a required condition for an effective coating. 
Rigidization of the coating phase: the rigidization of the polymer coating is generated when 
the continued deposition of the coating material is promoted by a reduction in the total free 
interfacial energy of the system. This phase can be carried out using thermal cross linking or 
desolvation techniques. 
 
Figure  2.6:  Schematic  representation  of the coacervation process: (a)  Dispersion of core 
material in a shell polymer solution, (b) Separation of coacervation from solution, (c) Coating 
of the core material by coacervation microdroplets, (d) Coalescence of coacervation to form 
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The processing setup for this technique is fairly simple. It contains jacketed tanks with variable 
speed agitators. However, the significant disadvantage of this method is that when the spheres 
are formed, they stick to each other prior to the completion of the process and produce large 
aggregates.  
Thermally induced phase separation (TIPS) is a supplementary fabrication method which has 
been used lately in polymer particle formation to produce porous surface microspheres for 
applications in wound therapy, drug delivery and also tissue engineering (Blaker et al., 2008a, 
2008b; Keshaw et al., 2010; Martínez-Pérez et al., 2011). This technique requires the use of 
solvent such as dimethyl carbonate with a low melting point that is easy to sublime. Then, by 
collecting the products in an immiscible liquid to the polymer solution with a melting point of 
lower than the solvent, such as liquid nitrogen, a polymer-rich and a polymer-poor phases are 
formed. Following cooling below the solvent melting point, using a vacuum-drying to sublime 
the solvent, a porous structure of the products is obtained. 
2.7.3 Suspension Cross-Linking 
Suspension cross-linking process prepares the polymeric microspheres by forming a stable 
droplet suspension of the polymer solution in an immiscible liquid, gradual hardening of the 
droplets by covalent cross-linking, and finally, recovery of the resulting cross-linked polymeric 
spheres. For the preparation of polymeric products, the core material remains entirely within 
droplets. This is because the core material has significantly a higher affinity for droplet phase 
than suspension medium. In this technique, the average size of the droplets must be around one 
order magnitude larger than that of the core spheres to ensure entire encapsulation (Arshady, 
1989). 
2.7.4 Spray Drying 
In this technique, dried spherical particles are produced from liquid polymer solution by rapidly 
drying the processing solution with a hot gas.  This method offers number of advantages 
compared with the other methods described above. It has improved the reproducibility of 
microspheres, and the processing conditions are relatively easy which facilitates to control the 
sphere size. However, this technique (Fig. 2.7) has two main disadvantages: first, loss of a large 
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large aggregates prior to the complete removal of the solvent (Blanco-Príeto et al., 2004; Burke 
et al., 2004; Murillo et al., 2002).    
 
Figure 2.7: Schematic process for preparation of microspheres by spray drying  
    (Zbicinski et al., 2000) 
2.7.5 Electrohydrodynamic (EHD) Atomization 
Over the past decade, electrohydrodynamic (EHD) atomization  is recognised and appreciated 
as an attractive and alternative method for the generation of micro- and nano-spheres suitable 
for application in drug delivery systems (Ding et al., 2005; Pareta and Edirisinghe, 2006). As 
discussed earlier, emulsion polymerization, phase separation and spray-drying are the common 
fabrication methods for generating a variety of drug-loaded hollow polymeric structures (Yang 
et al., 2001; Zhang et al., 2008; Zhu et al., 2000). However, there are some certain drawbacks 
with these approaches. For instance, emulsion method results in a broad size distribution of 
sphere (Kissel et al., 1996). Moreover, non-degradable additives such as polymers or surfactant 
are generally adopted in this method as emulsifiers (Freitas et al., 2005) and the separation of 
products from solvent can be expensive and time-consuming but requires to be conducted in 
order to decrease the volume of residual solvent to a safe level for application in medicine and 
pharmaceuticals. Most importantly, due to exposure of drug to elevated temperatures and high 
shear stresses in the emulsion method, the biological activity of drugs can be greatly reduced 
during processing (Kohane et al., 2006; Rasiel et al., 2002). 
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Figure 2.8: Schematic representation of the single-needle EHD setup adopted for fabrication 
of polymeric carriers (Enayati et al., 2010b) 
In the EHD method (Fig. 2.8), spheres are fabricated at ambient temperature and pressure. 
Therefore,  this  method  simply  overcomes  the  complications  associated  with 
defunctionalisation of drugs under extreme processing conditions in the emulsion method. 
Furthermore, this method is cable of producing spheres with a narrow size distribution and a 
mean diameter which can be varied from tens of nanometres to hundreds of micrometres by 
controlling the processing parameters such as flow rate(s), needle diameter(s) and applied 
voltage. Besides, with the application of voltage in production of microspheres, the problems 
with the large aggregates of products in the phase separation and spray-drying techniques have 
been easily overcome (Ahmad et al., 2008; Samarasinghe et al., 2007; Xie et al., 2008). 
The single needle EHD (Fig. 2.8) describes a method in which a liquid is passed at a controlled 
flow rate through a silicone tube to the nozzle maintained at several kilovolts relative to a 
ground electrode a few centimetres away. 
2.8 Principles and Theoretical Aspects of EHD Process 
The effect of an applied electrical field on a liquid with certain conductivity was described in 
1600, when William Gilbert stated that electrostatically charged amber could produce a jet of 
liquid from a droplet (Gilbert, 1600). Electrohydrodynamic research was initially presented in 
the technical literature by Lord Rayleigh, who also studied the influence of an electric field on 
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is dependent upon a balance of forces such as the electrical stresses, owing to the presence of 
an electric field and the surface tension forces (Rayleigh, 1882). He also observed a conical 
shape of the deformed liquid and a thin jet evolving from the tip of a cone. Later, Theoretical 
discussions of a mathematical model for the conical shape of the droplet under the influence of 
an electric field were supplied by Taylor, showing that a conducting fluid could exist in 
equilibrium in the form of a cone under the action of an electric field but only when the 
semivertical angle was close to 49.3, which is a material-dependent value (Taylor, 1969, 
1964). The critical voltage Vk in kilovolts applied to transform a spherical droplet to a cone-
shape at the end of a cylindrical capillary connected to one of the electrodes can be predicted 
based on the semivertical angle of 49.3 (Taylor, 1969): 
                                                                                                                                              (2.2) 
Where H is distance between the electrodes, L is the length between the end of the cylindrical 
capillary and the contacting point of the electrode on the capillary, R is the inner radius of the 
capillary, T is the surface tension, and  is the semivertical angle. Because this semivertical 
angle has been found to vary with different polymer solutions and melts (Rangkupan and 
Reneker,  2003),  the  critical  voltage  to  generate  a  cone-shape  from  a  droplet  varies  with 
different electrosprayed materials. 
The cone jet mode is the most desirable and the used mode for producing fine spheres for 
application in drug delivery. In this EHD jetting mode, the liquid derives from the capillary in 
the form of a regular, symmetric cone with a thin jet at its apex (Fig. 2.9a), stretching along 
the capillary axis and breaking up into fine particles. To achieve this mode, the liquid is pumped 
through a nozzle at a known flow rate and a droplet is formed at the tip of this nozzle. Then, 
an electric field (potential) is introduced which in turn induces a surface charge to the droplets. 
As a result of this electric stress, the droplet is transformed into a conical shape. The liquid 
acceleration and the conical shape of the liquid results from the balance of several forces 
applied to the surface of droplets formed on the tip of the nozzle. These forces consist of liquid 
pressure, liquid surface tension, gravity and electric strength in the liquid surface. The conical 
shape is sometimes referred to as Taylor cone that forms when the outward stress owing to an 
electric field is equal to the inward stress due to the liquid surface tension. The forces involved 
in the formation of cone jet are illustrated in Figure 2.9b (Hartman et al., 1999). Further 
investigation shows, when the applied voltage accelerates the surface charge towards the cone 
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apex, the jet breaks up into a number of primary or main droplets and a number of secondary 
droplets and satellites (Jaworek and Krupa, 1999a, 1999b). 
 
Figure 2.9: (a) A stable cone-jet (Taylor, 1969). (b) A geometric diagram of an axisymmetric 
liquid cone with a thin jet at its apex depicting forces acting on a cone-jet (Hartman et al., 1999) 
V is the volume of the conical frustum and V1 is the jet volume, V2 is the space in which the 
jet is not occupying in the conical frustum. Upon the establishment of a conical shape of the 
droplet at the capillary end, at a sufficiently high-applied voltage, additional surface area needs 
to be created by some means to accommodate the charge build-up on the conical surface (Fig 
2.9) (Hartman et al., 1999).  The electrostatic force and viscous drag force are the two main 
forces acting on an ion moving in horizontal under the application of electric field. The sum of 
electric field related forces is:  
                                                                                                                                              (2.3)  
Where   and   are respectively the electrostatic force and the viscous drag force acting 
on a positive ion;   and   are respectively the electrostatic and the viscous drag force 
acting  on  a  negative  ion.  Electrostatic  force  and  viscous  drag  force  can  be  respectively 
expressed as qE and 6πηrμE, where q is the amount of charge on the ion, E is the electric field 
strength, η is the solution viscosity, r is the hydrodynamic radius of the ion and μ is the ion 
mobility. Hence, equation (2) can also be expressed as the following: 
 Felectrostatic= (n1qE)-(n16πƞrpiµpiE)-[n1 (1-y)qE]+[n1(1-y)6πƞrniµniE]               (2.4) 
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Where n1 is the number of ions in a solution of mass m, μpi and μni are the ion mobility of 
positive and negative ions. When the solution becomes charged at the electrode, a fraction of 
the negative ions, y, is neutralized due to limited contact between the solution and the charged 
electrode. The solution thus still contains n1(1-y) negative ions and n1 positive ions. 
Zeleny  (1917)  was  the  first  person  who  studied  this  mode  of  interest.  Later  on,  Taylor 
successfully examined the cone-jet profile and the angle based on the liquid in the cone-jet. 
Based on the assumption that the jet is thinner than the capillary tube for a liquid with relatively 
high conductivity, Mora and Loscertales (1994) stated the scaling laws of droplet size and spray 
current (the two ratios below) related to the flow rate and liquid properties (De La Mora and 
Loscertales, 1994; Zeleny, 1917): 
r*~(ʵʵ0 Q/K)1/3                                                                                                                     (2.5) 
I ~ f(ʵ)(rQK/ʵ)1/2                                                                                                                                                                                 (2.6) 
Where r* is the radius of the scaled jet, ʵ0 is the permittivity of vacuum, ʵ is the permittivity of 
liquid, Q is the flow rate, K is the conductivity of the liquid, I is the spray current and f(ʵ) is 
the dimensionless function of ʵ. 
However, according to the experimental work, the use of scaling laws for the prediction of 
resultant relics (particles with different shapes and sizes) is still controversial. This is because 
experimental errors in the reported measurements do not allow adequate distinction between 
various types of relics (Gañán-Calvo, 1997; Gañán-Calvo et al., 1997). In addition, there is a 
range of different combinations (processing parameters and physical properties of the injected 
liquid) that affects the stability of EHD and the size of produced particles. For instance, Mei 
and Chen (2007) demonstrated that enhancement in flow rate of the flowing liquid results in 
an increase in particle size for certain value of liquid flow rate (Mei and Chen, 2007). However, 
over a certain range of material combinations and processing parameters, size of particles 
decreases with an increase in the magnitude of the following parameters: voltage, electrical 
conductivity, and surface tension of the electrosprayed solution. In contrast, an increase in 
particle size can also be obtained by means of increasing the flow rate, density and also 
viscosity of the sprayed solution (Zhang et al., 2006). 
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2.8.1 Modes of EHD Process 
There are various modes in which the jet can form from nozzle tip in electrospraying. These 
modes are typically defined by geometrical features of the liquid at the apex of the nozzle and 
the behaviour and disintegration of the jet into droplets (Fig. 2.10). The various spraying modes 
are all of interest, because each of them has different stability and provides different size, size 
distribution  and  shape  (Cloupeau  and  Prunet-Foch,  1990).  Different  parameters  such  as 
physical properties of the liquid (e.g. surface tension, electrical conductivity and viscosity) and 
processing parameters (e.g.  flow  rate and  applied voltage) have significant  influences  on 
generating different modes of EHD (Paine et al., 2007). The spraying modes can be basically 
divided into two major groups; those in which small fragments of the liquid are ejected from 
the nozzle, and those which produce a long continuous jet that disintegrates further downstream 
of the jet (Jaworek and Krupa, 1999a, 1999b). The first set includes dripping, micro-dripping, 
spindles  and  ramified  meniscus  modes,  whereas  the  latter  includes  cone-jet,  multi-jet, 
oscillating jet, ramified-jet and precession modes (Fig. 2.10). Electrospraying at low voltage 
creates the modes such as dripping, microdripping, rapid dripping and spindle. However, at 
high applied voltage, the modes of a sustained and continuous jet can be formed such as stable 
cone-jet, multi-jet, ramified-jet and precession. In the modes under the application of high 
voltage, the jet usually breaks up into droplets a few millimetres away from the nozzle exit. 
The meniscus and the jet can be either stable or spin around the needle axis or rotate irregularly 
(Cloupeau and Prunet-Foch, 1994; Hayati et al., 1987a, 1987b). 
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2.8.2 Effect of Liquid Flow Rate on the Cone-Jet Mode 
The size distribution of spherical particles generated by the EHD process in the mode of the 
cone-jet is varying and depending on the diameter of the jet flowing out of the nozzle, and on 
the break-up of this jet into droplets. Every liquid has a minimum flow rate below which a 
stable cone-jet mode cannot be produced for a given voltage. At this minimum flow rate, the 
jet breaks up with the application of applied voltage due to asymmetric instabilities. These 
instabilities are also known as varicose instabilities (Hartman et al., 2000). At higher flow rate, 
when the current  through the liquid cone increases, the surface charge  on the jet  grows. 
Therefore, above a certain surface charge the jet break-up will also be influenced by lateral or 
azimuthal instabilities of the jet mode. These instabilities are also called kink. When the 
influence of these kink instabilities enhances, the size distribution of main droplets also swells 
(Hartman et al., 2000). 
2.8.3 Effect of Applied Voltage on the Cone-Jet Mode 
Electric field strength between the capillary and the ground electrode is a crucial factor in 
controlling the mode of jet in the EHD process. This is determined largely by tuning the applied 
voltage and the configuration of the ground electrode. Within a well-defined range of voltage, 
the meniscus of liquid gives the shape of cone and becomes stationary. However, below this 
range, the spray always operates in pulsating mode (Gañán-Calvo, 1997; Gañán-Calvo et al., 
1997). With a given inter-electrode spacing, various modes of atomization can be observed 
from dripping to the multi-jet if the voltage is gradually increased from low to high values. 
Applied voltage is a key parameter in generating the cone-jet mode and this mode can be 
successfully achieved within a specific range of applied voltage (Tang and Gomez, 1994). 
Within  this  range,  particle  size  reduces  with  increasing  applied  voltage.  Therefore,  it  is 
necessary to select the appropriate flow rate and voltage to obtain the stable cone-jet mode for 
fabrication of the required size of spherical particles (Jayasinghe and Edirisinghe, 2004).  
2.8.4 Liquid Properties 
Different modes of EHD are also influenced by the liquid properties such as viscosity, electrical 
conductivity, surface tension, relative permittivity and density (Gañán-Calvo, 1997; Gañán-
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2.8.4.1 Viscosity 
Viscosity is a property of liquid which plays a crucial role in the process of jet break-up and 
influences the size of the generated products (López-Herrera et al., 2003). Increase in viscosity 
will lead to an enhancement of particle size in EHD processing (Weber, 1931). Jayasinghe and 
Edirisinghe (2002) conducted a study to show the effect of viscosity on the size of relics 
produced by EHD forming. They found that an enhancement in viscosity over three orders of 
magnitude  had  a  significant  influence  on  the  size  of  generated  particles  (Jayasinghe  and 
Edirisinghe, 2002). 
2.8.4.2 Electrical Conductivity 
Electrical conductivity is another most crucial property affecting the mode of cone-jet for 
electrospraying.  Sufficient  electrical  conductivity  is  needed  for  the  liquid  droplet  at  the 
capillary exit to be transformed into a conical shape. However, if the electrical conductivity is 
extremely high, EHD forming will be impossible owing to corona discharge occurring before 
the required applied voltage for the stable cone-jet mode is obtained. On the other hand, liquids 
with low electrical conductivity such as olive oil cannot be subjected to EHD processing; 
however,  they  can  be  electrosprayed  in  the  cone-jet  mode  by  artificially  enhancing  their 
conductivity  with  additives  such  as  ethanol  (López-Herrera  et  al.,  2003).  The  electrical 
conductivity for different liquids influences the morphology of the liquid issued in the stable 
cone-jet mode. Based on experimental research, by increasing the conductivity, the filament 
width, length, flow rate for the cone-jet mode and particle size will all decrease (Gañán-Calvo, 
1997; Gañán-Calvo et al., 1997). 
2.8.4.3 Surface Tension 
For the formation of the stable cone jet in producing spherical particles, the surface tension has 
to be overcome by the applied electric stresses. The higher the surface tension, the greater is 
the electric field  (potential) required for break  up. According to  the experimental results 
obtained by Smith in 1986, the threshold voltage for the stable cone-jet will increase with the 
liquid surface tension (Smith, 1986). However, if the liquid surface tension is extremely large, 
the  stable  cone-jet  may  not  be  established,  because  the  required  electric  field  (potential) 
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Gomes adopted gases with higher electrical breakdown strength as a surrounding fluid instead 
of air to achieve the stable cone-jet mode for water (Tang and Gomez, 1995). 
2.8.4.4 Relative Permittivity 
Dielectric constant, known as relative permittivity, is a measure of the polarizability of material 
in an electric field, which is related to the ability of solutions in formation of the cone-jet and 
production of particles. Polarisation leads to reduction in the magnitude of the electric field 
(potential) inside the liquid. The three parameters of dielectric constant, vacuum permittivity 
and conductivity determine the electrical relaxation time: 
te= βʵ0/K                                                                                                                                   (2.7) 
Electrical relaxation time is the time required to smooth a perturbation in the electric charge, 
where  β  is  the  relative  permittivity, ʵ0 and  K  are  the  vacuum  permittivity  and  electrical 
conductivity respectively (Gañán-Calvo, 1997; Gañán-Calvo et al., 1997). 
2.8.4.5 Density 
Density is another parameter that plays an important role in determining the jet characteristics 
in the cone-jet mode. When the viscosity and the conductivity of a liquid are large enough, the 
electrical charge is efficiently transmitted across the jet section by viscous forces. However, 
these viscous forces depend on the density of the liquid (Gañán-Calvo, 1997; Gañán-Calvo et 
al., 1997). Furthermore, the liquid density is of some importance, owing to the influence of 
gravity on the cone shape. For large capillaries with diameter greater than 1mm, gravity affects 
the shape of the cone strongly (Hartman et al., 1998). 
2.8.4.6 Nozzle Size and Electrode Configuration 
There are still some differences of opinion among researchers with regard to needle size. In 
1990, Cloupeau and Prunet-Foch illustrated that for a given liquid, the flow rate changes with 
respect to the change of needle size (Cloupeau and Prunet-Foch, 1990). However, later on in 
1996, Tang and Gomez found that the particle size is independent of the nozzle size. They 
showed  that  the  needle  size  significantly  influenced  the  stable  cone-jet  mode  domain  of 
electrospraying. As the needle size increases, the maximum liquid flow rate needed for the 
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graph, the stable cone-jet domain of the electrospray becomes narrower as the needle size 
increases (Tang and Gomez, 1996). 
In 2002, the study conducted by Jayasinghe showed that the droplet trajectories depend on the 
configuration of the  ground electrode.  For  a point like ground electrode, the smaller the 
diameter of the point, the higher configuration of the droplets generated in the spraying pattern. 
They pioneered the use of a point-like ground electrode, and this configuration of the ground 
electrode was the key to their innovation of electrostatic atomization printing (Jayasinghe et 
al., 2002). 
2.9 Co-axial Electrohydrodynamic Atomization 
Further development of the EHD process led to the co-axial electrohydrodynamic atomization. 
In this technique, electrohydrodynamic forces generate co-axial jets for immiscible liquids or 
suspensions. A schematic of the basic experimental setup for the co-axial EHD process is 
provided in Figure 2.11, where the two immiscible liquids or suspensions (yellow for outer 
liquid and blue for inner liquid) are passed through the two concentrically arranged capillaries. 
The outer and inner needles in the co-axial arrangement are coupled to the same electrical 
potential of several kilovolts relative to an earthed ring electrode. 
 
Figure 2.11: Schematic representation of the co-axial EHD setup (Enayati et al., 2010a)                                                                                                                Chapter 2: Literature Review 
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2.9.1 Co-axial Electrohydrodynamic Atomization Mechanism 
For a certain range of flow rates and applied voltages which depends on the physical properties 
of suspensions, a cone-jet is formed at the exit of needles with an outer meniscus surrounding 
the inner one (Fig. 2.12b). A liquid thread is distributed from the vortex of each one of the two 
menisci, leading to a compound jet of the two co-flowing suspensions (Fig. 2.12c) (Loscertales 
et al., 2002). 
 
Figure 2.12: The co-axial EHD process: a) Needle, b) Dripping mode and c) Formation of a 
compound cone-jet 
2.9.2 The Driving Liquid Concept 
For obtaining a structured and stable cone-jet, the electrohydrodynamic forces in terms of 
voltage supply must act on at least one liquid, although they may act on both. In the co-axial 
EHD process, the liquid/suspension which the electrohydrodynamic forces act predominantly 
to  form  a  cone-jet  is  called  the  driving  liquid.  The  driving  liquid  can  be  determined  by 
comparing the electrical relaxation time of the two liquids. The electrical relaxation which was 
introduced  in  Section  2.8.4.4  on  relative  permittivity,  is  the  time  required  to  smooth  a 
perturbation in the electric charge. The driving character of one of the liquids can be neglected 
in favour of the other one if the electrical conductivity is sufficiently enhanced by adding a 
suitable additive to it (López-Herrera et al., 2003). By applying voltage as an electrical force, 
when charges are located at the outer surface, the tangential electrical stresses which point 
towards the vortex of the conical interface must be efficiently transmitted throughout the liquid 
bulk by viscous diffusion. This requires the viscosity of the outer liquid to be high enough to 
play a crucial role in the liquid motion. Furthermore, the use of low viscous liquid in the outer 
needle would lead to intense re-circulation in the electrified meniscus and these re-circulatory 
motions are incompatible with the stable compound jets. However, when the liquids with lower 
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oil can be used in the outer needle. This is one way of electrospraying non-conductive liquids 
such as insulators (Loscertales et al., 2002).  
2.10 Applications of EHD Methods in Preparation of Various Drug Carriers 
2.10.1 Single Needle EHD Method 
In the single needle EHD processing, a therapeutic agent is encapsulated in the particles, e.g. 
dispersed in a polymeric matrix (Ciach, 2007). The processing parameters and the inherent 
physical  properties  of  the  solutions  adopted  perform  a  crucial  role  in  determining  the 
characteristics of the drug carriers. It has been demonstrated that the parameters such as needle 
size, collection distance, flow rate and the applied voltage enables carriers to be generated with 
different size, shape and morphology for various applications (Berkland et al., 2004; Xie et al., 
2006a, 2006b). The first part of the experimental work in this thesis concentrates on controlling 
the size of the fabricated spheres via processing parameters. Then, a detailed description of 
various structures such as spherical particles with smooth and porous surface made by the 
single needle EHD is given. Furthermore, the single needle EHD setup followed by TIPS 
process was then applied for fabrication of the polymeric microspheres loaded with the model 
drugs.   
2.10.1.1 Spherical Particles 
One of the most essential challenges in the current pharmaceutical and medical research is the 
generation of drug loaded carriers with high encapsulation efficiency and a well-defined and 
controllable size distribution (Langer, 1998). In 2009, Wu adopted the EHD technique for 
production  of  spherical  nanoparticles  with  mean  size  ranging  300-400  nm  which  were 
composed of genetically engineered elastin-like polypeptides (ELPs), a biodegradable and 
bioresponsive polymer. In this study, doxorubicin was successfully loaded into the particles 
and the loading of the drug at 20 wt% did not influence the product morphology. However, the 
particle  size,  polydispersity  and  morphology  were  significantly  affected  by  solvent 
concentration, spraying voltage and the polymer molecular weight. The release rate of the drug 
was also influenced by the pH and solubility of ELPs (Yiquan Wu et al., 2009). Xu and Hana 
Similarly prepared bovine serum albumin (BSA)-loaded tripolyphosphate (TPP) cross-linked 
chitosan particles with size which was found to be hugely influenced by flow rate (Xu and 
Hanna,  2007).  In  another  study,  BSA  loaded  spherical  particles  was  fabricated  by                                                                                                                Chapter 2: Literature Review 
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electrospraying an emulsion of BSA in polylactide (PLA) solutions. The spherical particles 
ranging from 0.8-4 μm were produced with smooth surface (Xu et al., 2006). The encapsulation 
efficiency and the yield of the process were varied 22-80% and 64-80% respectively. However, 
the in vitro release profile of the loaded material did not show a steady state during the time of 
observation owing to quick PLA erosion (Xu et al., 2006). 
It has been illustrated that EHD processing can be adopted for preparation of polymeric micro- 
and nano-spheres encapsulating both hydrophilic and hydrophobic drugs (Pareta et al., 2005; 
Valo et al., 2009), which the biofunctionality of the drug is unaffected and also the high 
encapsulation efficiencies can be obtained. For example, Xie et al. generated spheres by EHD 
processing for sustained delivery of the anticancer drug paclitaxel to treat C6 glicoma with an 
encapsulation efficiency up to 80% (Xie et al., 2006b). Same values were stated for the case of 
ampicillin loaded chitosan micro/nano-spheres with a mean size of 520 nm (Arya et al., 2009), 
and by Ding et al. for taxol-loaded poly (ʵ-caprolactone) (PCL) which showed great sustained 
release profiles for a month (Ding et al., 2005). 
Furthermore, varying the properties of the solvents and solutions employed in EHD forming 
also provided a means of tailoring the morphology and different structures of the spherical 
particles (Farook et al., 2009a). In 2004, Berkland presented that specific structural types such 
as  tapered  shapes,  porous  surface,  and  blood  cell-shaped  particles  could  be  obtained  by 
changing the properties of the polymer and solvent adopted (Berkland et al., 2004). Decrease 
in the size of the generated particles was demonstrated by increasing the conductivity of the 
polymer solutions. Also, the morphology of the fabricated particles can be considerably varied 
by adopting different combinations of polymers such as poly caprolactone, poly lactic-co-
glycolic acid and poly-L-lactic acid and solvents (Yao et al., 2008). 
2.10.1.2 Porous Particles 
Recently, near monodisperse (uniform size) microspheres with surface porosity have received 
much attention and been classified as a new category of particles on the account of their higher 
effective diffusivity and available surface area compared to their counterparts with smooth 
morphology of same size (Jeong et al., 2007; Yow and Routh, 2008; Yin and Yates, 2008). The 
bioactive agents can be arranged in a specific order to make this structure have a unique 
architecture for particular applications in pharmaceutical and biomedical research (Jiang et al., 
1999). In 2007, Wu and Clark collected porous particles by electrospraying the PCL different                                                                                                                Chapter 2: Literature Review 
38 
 
solutions into water bath. They had the different concentrations of PCL solutions dissolved in 
chloroform. Solvent evaporation and phase separation are the two main mechanisms for the 
formation of pores on the surface of particles. They demonstrated that solvents with low boiling 
points generate pores with irregular morphologies and large dimensions. Moreover, Wu and 
Clark illustrated that solvents with internal property of high evaporation rate has key role in 
the formation of porous particles via EHD processing (Wu and Clark, 2007). Also, in 2009, 
Enayati et al. conducted a study using EHD process for evaluating the release profile of 
oestradiol from the polymeric particles. The results illustrated that the porous membrane in the 
PLGA particles which was induced by sonication could lead to a higher rate of drug release 
with more controllable release manner compared to their counterparts with the smooth surfaces 
(Enayati et al., 2010a). Moreover, the porous morphological particles can lead to a higher initial 
burst release due to the surface porosities which can be more suitable for targeted delivery and 
chronic wound therapy (Setterstrom et al., 1984).  
2.10.1.3 Aerosol 
Aerosol is another type of pharmaceutical carrier which can be generated using the single 
needle EHD process. In 1990, the first aerosol carriers were produced for pulmonary disease 
therapy. The aerosols which are adopted in an inhaled drug delivery system for pulmonary 
disease therapy must have some critical characteristics. For example, for an effective drug 
delivery of the aerosol to the lower airway, the aerodynamic size distribution of the particles 
should be varied between 2-5 µm with near monodisperse (uniform size) property (Ijsebaert et 
al., 2001). Based on the final aerosols collected in this study, EHD processing was shown to 
meet these requirements for fabrication of the required products. The resulting microspheres 
were nearly monodisperse, and the size distribution of particles could be simply varied by 
controlling the processing parameters such as the applied voltage and flow rate. In another 
study in 2000, Zimlich et al. developed a hand-held prototype of pulmonary drug delivery 
nebulizer using the single needle EHD process. In this study, 78% of the aerosols with a size 
of 1-6 µm were found in the respiratory tract, which were approximately four times greater 
than that attained using some other commercially tested devices (Zimlich et al., 2000).  
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2.10.2 Co-axial EHD Method 
The co-axial EHD processing is a powerful technique for the fabrication of capsules in the 
range of micrometre and nanometre size. It facilitates encapsulation of sensitive materials such 
as cells, enzymes, dye and/or drug in the core of a protective shell. A range of different 
polymeric  materials  including  polyurethanes,  polysiloxanes,  polylactides,  polyglycolides, 
poly(lactic-co-glycolic) acid are employed as shell materials of the capsule/bubble production. 
The polymers mentioned above are the most desirable materials for encapsulations, owing to 
their physical properties, such as elasticity, insulating ability, physical strength, toughness and 
freedom from leachable impurities. Many of these polymers in particular, polylactide (PLA), 
polyglycolide (PGA) and poly(lactide-co-glycolide) (PLGA) are designed to degrade within 
the body environment (Brannon-peppas, 1997; Langer, 1998). These biodegradable polymers 
have been widely adopted in research and pharmaceutical applications as they have shown no 
adverse tissue reaction when carrying bio-active agents. They can be hydrolysed in human 
body to form products which can be easily eliminated without the need to remove the implants 
by surgery. Also, the co-axial EHD method has the ability for microbubble productions in 
which  they  have  shown  great  potential  in  therapeutic  applications  such  as  targeted  drug 
delivery, diagnostic imaging, focused ultrasound surgery, and also gene therapy (Mizushige et 
al., 1999; Poliachik et al., 1999; Schmidt and Roessling, 2006; Unger et al., 2001). In this study, 
the co-axial EHD combined with TIPS process was also used for fabrication of the loaded 
microspheres and comparison of the data obtained from the single needle EHD/TIPS method. 
2.10.2.1 Capsules 
Using the co-axial EHD method for micro/nano encapsulation is of particular interest in drug 
delivery (Barisci et al., 2000; Xie et al., 2008), food industry (Yoshii et al., 2001), and specific 
material processing (Burlak et al., 2001; Lee et al., 2001). Loscertales et al. conducted a study 
in 2002 in order to demonstrate the fabrication and control of near monodisperse capsules in 
varying size ranges from 0.15 to 10 micrometres. This study showed that the capsule diameters 
were affected by experimental parameters including applied voltage and the flow rates, the 
physical properties of the solution and also the interaction between inner and outer solutions 
during the electrospray (Loscertales et al., 2002). A year later, an investigation was conducted 
by Lopez-Herrera et al. to study the electrified co-axial jets of two solutions progressed from 
a structured cone-jet. This group presented the concept of driving liquid and also studied the 
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work did not involve the specification of criteria that determines the structure of the capsules 
(López-Herrera et al., 2003). Chen et al. conducted another study to investigate the co-axial jet 
electrospraying using an ethanol/glycol/TWEEN mixture and cooking oil as two solutions. In 
this study, they discovered that the physical properties of the outer liquid with higher viscosity 
and more electrical conductivity play important role in controlling the process (Chen et al., 
2005).   
Number of studies have been conducted in this category for encapsulation of bioactive agents. 
Paclitaxel as a hydrophobic anticancer drug was encapsulated in biodegradable polymer via 
the co-axial EHD process (Ding et al., 2005). The size distribution of the capsules in this study 
was between 1 and 15 µm. Another study related to microencapsulation was conducted by 
Pareta and Edirisinghe to demonstrate the ability of the co-axial EHD setup for preparation of 
polymer-coated starch/bovine serum (BSA) capsules. The mean diameter of the products was 
found to be 5-6 µm and more than 75% of the BSA in the in-vitro studies was released over a 
7  days  period  (Pareta  and  Edirisinghe,  2006).  In  2009,  Wu  et  al.  produced 
oligodeoxynucleotide encapsulated lipoplex nanocapsules via co-axial jetting (Yun Wu et al., 
2009). In this study, the products diameter was about 190 nm which they provided an efficient 
medium for gene therapy. In another study in 2010, Enayati et al. used the co-axial needle EHD 
method to produce oestradiol encapsulated in the biodegradable poly (lactide-co-glycolide) 
shells ranging from 120 nm to a few micrometres (Enayati et al., 2010a). The in vitro studies 
of this investigation showed a sustained release of the drug for a period of over 20 days with 
entrapment  efficiency  of  70%.  Capsules  with  micro-  and/or  nano-scale  anisotropy  have 
received additional attention owing to their ability to instantaneously show different physical 
and chemical properties. In Lim et al. study, gold nanocrystals (NC) was encapsulated into one 
compartment of anisotropic polymeric particles via EHD co-jetting of aqueous nanoparticles 
suspensions followed by thermal cross-linking (Lim et al., 2010). Biocompartmental capsules 
with varying nanocrystal densities were acquired by changing the NC concentration in the 
jetting  suspension.  This  investigation  demonstrated  a  new  approach  for  preparing 
organic/inorganic composite products with precisely engineered, anisotropic micro- and/or 
nanocapsules, and may contribute to advanced progress in developing scientific areas such as 
smart materials or particle-based diagnostics.    
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2.10.2.2 Microbubbles 
Another versatile application of the co-axial EHD principle is to produce microbubbles with 
near monodisperse size distribution (Ekemen et al., 2013; Farook et al., 2007). Since EHD 
method can provide distinctive advantages compared with e.g. microfluidic devices and simple 
agitation (Pancholi et al., 2008), preparation of microbubbles via co-jetting has opened a new 
window  in  a  range  of  different  biomedical  applications  from  use  as  contrast  agents  for 
ultrasound imaging to drug delivery. In 2007, Farook et al. was pioneered to show that the co-
axial EHD system could be used for preparation of microbubbles less than 10 µm. In this 
investigation,  glycerol  was  pumped  through  the  outer  needle  of  the  co-axial  needle 
arrangement, while air was simultaneously flown through the inner needle (Farook et al., 2007). 
This procedure was then adopted to fabricate phospholipid-coated microbubbles with a high 
yield of 109 bubbles per minute (Farook et al., 2009b). In this study, phospholipid-coated 
microbubbles were found to be highly stable at ambient temperature with size distribution of 
6.6 ± 2.5 µm. However, at biological temperature (37oC), the mean diameter of the bubbles 
rapidly decreased to 1-2 µm within 20 minutes (Farook et al., 2009a). Farook et al. also 
demonstrated that the stability of the microbubbles prepared by the co-jetting can be further 
improved and the polydispersity index controlled by adding a dispersant such as Tween to the 
phospholipid solution (Farook et al., 2009a). Producing bubbles by the co-axial EHD process 
demonstrates  three  characteristic  spray  modes:  bubble  dripping,  coning  and  continuous 
bubbling  as  the  latter  mode  is  the  most  suitable  mode  for  microbubble  preparations  for 
applications in biomedicine. In another study, Ekemen et al. used silk fibroin (SF) to produce 
hallow spherical structure of SF in single step by utilizing the co-axial EHD process. The 
produced bubbles had size distribution of 240-1000 µm and their characteristics could be easily 
controlled through simple adjustments of the processing parameters (Ekemen et al., 2013). 
FTIR characterizations of the samples confirmed that the rate of air infused into the SF bubbles 
during the processing was enhanced at higher flow rates. Ekemen et al. also showed that the 
resultant bubbles can serve as pore generator when dehydrated (Ekemen et al., 2013). The 
results  acquired  from  tensile  strength  test  presented  that  the  electrohydrodynamically 
fabricated SF and their composite bubbles can be used as new tools for generating porous 
structures in a controlled manner with a range of potential applications in biocoatings and tissue 
engineering scaffolds. 
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2.10.2.3 Hollow Spheres 
Many studies have recently focused on the versatility of co-jetting in production of hollow 
micro- and nano-spheres. Chang et al. (2009) conducted a study using volatile liquid such as 
perfluorohexane (PFH) instead of air at inner needle to produce hollow spheres. In this study, 
polymethylsilsesquioxane (PMSQ) capsules were generated using the co-axial EHD process 
with  an  even  higher  degree  of  control  over  their  characteristics.  It  provided  a  mean  of 
controlling the content of the capsules by heating the suspension to the boiling point of the 
PFH.  Experimental  results  showed  that  using  more  volatile  liquid  leads  to  higher  near 
monodisperse products at the cone-jet mode, compared to those with less volatile solvent (Fig. 
2.13) (Chang et al., 2009). This is due to the inherent properties such as high evaporation rate, 
moderate conductivity and low surface tension of the solvent used during the EHD process. 
 
Figure 2.13: SEM image of the one-hole microspheres (flow rates for PFH at 300 μl min-1 and 
for PMSQ at 600 μl min-1) (Chang et al., 2010). 
Unlike traditional methods such as emulsification, fabrication of core-shell capsules via the co-
axial EHD forming was obtained in a single step, which is clearly more preferable. In this 
study, dye encapsulation was obtained by PFH core evaporation to enable inward diffusion of 
the  liquid  (Chang  et  al.,  2009).  This  procedure  was  further  developed  for  fabrication  of 
monoporous hollow spheres (Chang et al., 2010) which in turn could provide higher effective 
diffusivity (Guan et al., 2007). Chang et al. (2009) also showed that the geometry and the 
porosity of these nanocapsules with and without a single surface pore could be controlled by 
changing the processing parameters of the co-axial EHD setup. Experimental observations 
demonstrated that flow rate plays the most important factor in the final morphology which 
could be varied to control the pore size of the hollow nanospheres. The size distribution of the 
fabricated monoporous hollow spheres is between 275 and 860 nm with the pore size of 35-
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PFH  solvent  during  the  electrospraying  process.  This  method  overcomes  some  of  the 
challenges related to the existing techniques of producing this type of structure, for instance, 
requirement  for  highly  specialised  equipment,  presence  of  highly  controlled  processing 
environment and the use of surfactants and other additives (Guan et al., 2007). Ability for 
tuning the pore size of the hollow spheres via the co-jetting system is of interest for specific 
applications in drug/gene delivery vehicles, targeting and catalysis. 
2.10.3 Application of Multi-Capillary EHD Processing 
2.10.3.1 Three Needles EHD System 
Versatile capability of EHD system in encapsulation led to different combination of needles 
arrangement. The concept of electrified co-jetting was further extended by Roh et al. (2006), 
and triphasic nanocolloids with three different compartments were obtained by simultaneous 
injection of three separate liquid flows (Roh et al., 2006). Later on in 2008, Ahmed et al. 
exhibited the ability of employing three co-axially arranged needles to form a variety of novel 
morphological structures (Fig. 2.14) (Ahmad et al., 2008). 
 
Figure  2.14:  Schematic  representation  of  the  three  needles  experimental  set  up  of  (a) 
Concentric arrangement and (b) Co-planar arrangement (Ahmad et al., 2008; Roh et al., 2006) 
The resulting documents from Ahmad et al. study showed the ability of electrohydrodynamic 
flow for preparing double layered bubbles, porous encapsulated threads and nanocapsules 
containing three layers (Ahmad et al., 2008). This capability of EHD system in processing 
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in situ encapsulation of nanoparticles, liquid and/or gases (Ahmad et al., 2008; Kalra et al., 
2009).  In  multi-capillary  EHD  system,  it  is  not  imperative  to  have  the  needles  arranged 
concentrically (Fig. 2.15). 
 
Figure 2.15: Droplet, nanocapsule and thread formation: (a) The co-axial two needles with 
olive oil and glycerol; (b) Non-concentric co-axial two needle encapsulation; (c) Co-axial tri-
needle encapsulation with air, glycerol and olive oil; (d) High magnification scanning electron 
micrograph of nanocapsules showing different regions (densities); (e) Transmission electron 
micrograph of nanocapsule with non-concentric multiple layers; (f) Transmission electron 
micrograph of nanocapsule with concentric multiple layers; (g) Air encapsulation in twin-
layered thread with olive oil and PEO solution; (h) Instabilities during thread formation; and 
(i) Two-needles (third needle switched off) co-axial non-concentric thread encapsulation using 
olive oil and PEO solution (Ahmad et al., 2008)  
Three  needles  system  can  also  be  used  as  anisotropic  imaging  probes  with  short-term 
biocompatibility by reducing the co-polar distance of two needles (Yoshida et al., 2007). 
2.10.3.2 Four Needles EHD System 
Great flexibility of the EHD system in microencapsulation of different materials led to more 
sophisticated  arrangement  of  co-axial  four  needles.  Labbaf  et  al.  (2014)  pioneered  to 
demonstrate the feasibility of using four co-axially arranged needles in production of nano-
particles and fibres with four distinct layers (Labbaf et al., 2014).                                                                                                                Chapter 2: Literature Review 
45 
 
 
Figure 2.16: Schematic diagram of four needle experimental setup (Labbaf et al., 2014) 
Four different polymers, polyethylene glycol (PEG), poly (lactic-co-glycolic acid) (PLGA), 
poly (ʵ-caprolactone) (PCL) and polymethylsilsesquioxane (PMSQ) were used for generating 
the multi-layered polymeric carriers (Fig. 2.17). This study showed the great feasibility of EHD 
forming process in successfully producing the four layered drug delivery vehicles in a single 
step, which can be hugely beneficial to provide multi-stage controlled release of active agents 
for particular applications in pharmaceutical and biomedicine (Labbaf et al., 2014).  
 
Figure 2.17: Formation of products produced by the four needle EHD process: a) Fibres, b) 
Fibre cross section, c) Nanoparticles, d) Nanoparticle cross section (Labbaf et al., 2014) 
Transmission (TEM) and scanning electron microscopy (SEM) followed by focused ion beams 
showed that the produced fibres were quite uniform (Fig. 2.17a) and possesses four different                                                                                                                Chapter 2: Literature Review 
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layers of 2, 0.07, 0.12 and 1 µm in thickness from outer to inner (Fig. 2.17b). The acquired 
results also presented the four layered spherical nanoparticles with average size distribution of 
620 nm ± 150 nm (Figs. 2.17c and 2.17d). Furthermore, in vitro release studies were conducted 
in support of the four layered nanoparticles. Four different dyes were separately loaded in each 
layer during electrospraying to show the multi-stage controlled release manner of the produced 
nanoparticles over time (Labbaf et al., 2014).      
2.11 Polymers and Drug Delivery Systems 
Polymers, as the most versatile class of materials, have been widely adopted for application in 
drug  delivery  systems  (Li  and  Vert,  1999).  Polymers  can  be  either  degradable  or  non-
degradable. Over the past two decades, the use of biodegradable and biocompatible polymers 
for the administration of therapeutic agents has been rapidly enhanced. This type of polymers 
can be either natural or synthetic. In general, synthetic polymers have several advantages over 
the natural ones  as  their properties  can be tailored  and have lower level  of toxicity.  An 
important key point to consider when selecting a drug carrier is to match the degradation rate 
to the needs of the application (Uhrich et al., 1999). 
Synthetic polymers are broadly used for drug delivery and they often include esters such as 
poly lactic acid (PLA), poly glycolic acid (PGA), the copolymer poly lactic-co-glycolic acid 
(PLGA) and poly ʵ-caprolactone (PCL). These cited polymers are considered as the aliphatic 
polyesters which have attracted much interest as drug carriers due to their biodegradability and 
biocompatibility. This class of polymers degrades via the hydrolytic cleavage of the ester bonds 
in their backbone (Fu et al., 2000; Sinha and Trehan, 2003). More details about the PLGA and 
PCL, the two polymers adopted in this study, are provided below. 
2.11.1 Poly (Lactic Acid-Co-Glycolic Acid) (PLGA) 
This type of polymer is amphiphilic. However, the lactic acid is more hydrophobic than the 
glycolic acid, and hence lactic-rich PLGA copolymers are less hydrophilic. It absorbs less 
water, and subsequently degrades more slowly (Witschi and Doelker, 1998). The physical 
properties such as the polydispersity index and the molecular weight influence the mechanical 
strength of the polymer and its ability to be formulated as a drug delivery vehicle. Furthermore, 
these properties may control the biodegradation rate and hydrolysis of the polymer. PLGA is 
basically synthesised by means of random ring-opening co-polymerization of glycolic acid and                                                                                                                Chapter 2: Literature Review 
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lactic acid monomers. During the process of polymerization, successive monomeric units of 
glycolic and lactic acid are linked together in PLGA by ester linkages; therefore, yielding 
linear, aliphatic polyesters as products (Fig. 2.18). The commercial PLGA polymers are usually 
characterized in terms of intrinsic viscosity, which is directly related to their molecular weight. 
The  other  properties  of  the  copolymer  such  as  mechanical  strength,  swelling  behaviour, 
capacity to undergo hydrolysis and subsequently the biodegradation rate are directly influenced 
by the PLGA polymer crystallinity. The resultant crystallinity of PLGA copolymers depends 
on the type and the molar ratio of the individual monomer components of lactide and glycolide 
in the copolymer chain (Jalil and Nixon, 1990). The PLGA polymers containing 50:50 ratio of 
lactic and glycolic acids are hydrolysed much faster than those obtaining higher proportion of 
either of the two monomers (Sinha and Trehan, 2005). 
The  glass  transition  temperature  of  the  PLGA  copolymers  is  above  the  physiological 
temperature of 37oC, and hence they are glassy in ambient temperature. Therefore, they obtain 
a fairly rigid chain structure that provides them with sufficient mechanical strength to be 
utilized in drug delivery vehicles. In 1988, Jamshidi et al. reported that this glass transition 
temperature  of  PLGA  decreases  by  decreasing  the  content  of  lactide  in  the  copolymer 
composition and  reducing the molecular weight (Jamshidi et al., 1988). 
A three phase mechanism for the biodegradation of PLGA copolymer has been reported (Cai 
et al., 2000) as follows: 
1.  Random chain scission process, which the molecular weight of the polymer reduces 
extensively. However, there is no considerable weight loss and no soluble monomer 
products made. 
2.  A decrease of molecular weight in the middle phase is accompanied by rapid loss of 
mass, and soluble oligomeric and monomer products are formed 
3.  The products of soluble monomer are formed by soluble oligomeric fragments which 
corresponds to the complete polymer solubilisation 
 
Figure 2.18: Synthesis of poly (lactic-co-glycolic acid) (PLGA)                                                                                                                Chapter 2: Literature Review 
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2.11.2 Poly (ε-Caprolactone) (PCL) 
PCL  is  another  type  of  aliphatic  polyester  which  is  synthesised  by  the  ring-opening 
polymerization of the cyclic monomer ʵ-caprolactone (Fig. 2.19) (Benoit et al., 1999). 
 
Figure 2.19: Synthesis of poly (ʵ-caprolactone) (PCL) 
There are distinct mechanisms that influence the PCL polymerization and they are categorised 
as anionic, cationic, co-ordination and radial. Each one influences the molecular weight (Mw), 
molecular weight distribution, end group of composition and chemical structure of the polymer. 
PCL with semi-crystalline structure has a glass transition temperature of -60oC and a melting 
point ranging between 59-64oC, depending on the crystalline structure of the polymer. The 
average molecular weight of PCL samples varies from 10,000 to 45,000, and it is graded 
according to the molecular weight (Mw). PCL is soluble in hydrophobic solvents such as 
chloroform, dichloromethane, carbon tetrachloride, benzene, toluene and cyclohexanone in 
ambient temperature. However, it has low solubility in acetone, 2-butanone, ethyl acetate, 
dimethyl formamide and acetonitrile and is insoluble in alcohol, petroleum, ether and diethyl 
ether. PCL can be combined with other polymers in order to improve stress crack resistance, 
dye ability and adhesion. PCL polymer is adopted in combination with other polymers such as 
cellulose propionate, cellulose acetate burytate, poly lactic acid and poly lactic-co-glycolic acid 
for manipulation of the drug release rate from micro- and nanoparticles (Chang et al., 1986). 
2.12 Controlling and Regulating Drug Release Profiles 
Controlled release systems based on using polymers as a carrier have been widely adopted to 
decrease the amount of drug required to achieve a given therapeutic effect in patients. The key 
purpose of these systems is to deliver the pharmaceutical agents to the target site and to release 
them at specified rate over a defined period of time. There are two strategies to achieve this 
aim: 1) increase the efficiency of such system in order to modulate the initial burst release 
phase, which is the period of high release rate in 24 hours following administration; 2) use of                                                                                                                Chapter 2: Literature Review 
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external stimuli such as sonication to non-invasively promote the release from the polymeric 
carriers. This type of release profile regulation is applicable in pulsatile drug delivery systems. 
In this project, both strategies are investigated in order to find an ideal pattern in release profile 
of agents with optimum control in various therapeutic applications. The existing literature 
relevant to both strategies are discussed in the following sections. 
2.12.1 Importance of the Burst Release in Drug Delivery Systems 
As discussed earlier in Section 2.2, biodegradable polymer particles with loaded drug have 
been widely investigated in pharmaceutical applications for their potential to release bioactive 
agents in a sustained pattern. However, these products still suffer from a crucial technical issue 
which is known as the burst release (Fig. 2.20). The burst release usually occurs over a short 
period of time during the first 24 hours of administration (Huang and Brazel, 2001; O’Donnell 
and McGinity, 1997; Wang et al., 2002; Zhang et al., 2005). 
 
Figure 2.20: The burst release effect in drug delivery systems with a zero-order release pattern 
(Huang and Brazel, 2001) 
Burst release is often regarded as an undesirable and negative phenomenon in drug delivery 
systems. Because it can be associated with toxicity and decreases the lifetime of the therapeutic 
systems,  making  it  a  major  obstacle  in  the  utilization  of  these  types  of  delivery  system. 
However,  there  are  certain  situations  which  this  phenomenon  can  be  desirable.  In  many 
pulsatile delivery systems, for example, repeated burst release is one of the purposes for rapid 
delivery of the active agents at specific time (Table 2.1); whereas in some other applications, 
therapeutic agents need to be administered at different rates. For example, the drugs adopted at 
the first stage of wound therapy need to have high initial release rates to provide instant pain                                                                                                                Chapter 2: Literature Review 
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relief followed by a sustained and prolong release to help gradual wound healing (Setterstrom 
et al., 1984).  
Table 2.1: Desirable application with positive and negative effects of burst release 
Positive burst release situations  Negative burst release effects 
Wound therapy (burst release followed by a 
diminishing need for drug) 
Local  or  systemic  toxicity  (from  high  drug 
concentrations) and short half-life of drugs  
Targeted delivery (triggered burst release)  Economically and therapeutically wasteful of 
drug 
Pulsatile release  Shortened  release  proﬁle;  requires  more 
frequent dosing 
 
A few studies have been conducted to investigate the initial burst release mechanism and the 
control of this phenomenon. Burst release is usually attributed to two main reasons: 1) The 
heterogeneous distribution of the drug in the polymeric carriers, and 2) morphology of the drug 
loaded carriers as the drug can escape from their polymeric shell through porous structure 
which is formed during the fabrication process (Huang and Brazel, 2001; Yang et al., 2001). 
In most previous investigations, surface-associated drugs have been identified as the main 
factor determining the burst release phase (Cohen et al., 1991). This mostly arises due to quick 
water intake of particle matrix which consequently leads to swelling of polymer chains near 
the  surface.  This  in  turn  vastly  increases  the  diffusion  process  of  the  therapeutic  agent 
molecules dispersed in this region. Another reason associated with initial burst release could 
be due to the fact that some drugs become entrapped on the surface of the polymer shell during 
the fabrication process  (Batycky et al., 1997). This usually  arises when drug loading for 
encapsulation  process  is  too  high  (Brazel  and  Peppas,  1999).  Moreover,  diffusion  and 
migration of loaded agents during drying and storage  stages may lead to a heterogeneous 
distribution of drugs. For example, as water moves to the particles’ surface, it starts to evaporate 
and drug may diffuse by convection with water, leading to an uneven drug distribution across 
the particles, with higher concentration towards the surface (Fig. 2.21) (Kishida et al., 1998; 
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Figure 2.21: Drug redistribution at the surface due to convection during the drying process 
(Kishida et al., 1998) 
2.12.1.1 Controlling the Burst Release Phase 
Several  strategies  can  be  applied  for  controlling  the  burst  release  in  application  of  drug 
delivery: 
Preventing of drug on the surface of polymeric carriers 
Decreasing the rate of water intake which can be achieved by enhancing the hydrophobicity 
of the drug carrier 
Enhancing the diffusional resistance to the drug by increasing the length of the diffusion 
pathways to the drug molecules 
The three strategies mentioned above can be effectively performed by enhancing the polymer 
concentration  in  fabricating  solution,  manipulating  carrier  size  and  surface  modification 
(Huang and Brazel, 2001; Ravivarapu et al., 2000; Yamaguchi et al., 2002). There are a variety 
of surface modification techniques such as: 
Surface extraction method, which is effective in decreasing the initial burst release, removes 
the applied drug from the outer layers of drug loaded carriers. However, the main problem with 
this technique is the extraction cost and the reduction in the effective use (frequently expensive) 
of active agents (drugs).  
Surface modification via chemical couplings method, a complex procedure that involves 
two stages: 1) surface activation, 2) coupling reaction 
Surface  modification  via  co-incorporation  of surface  modifying  agents  into  carriers’ 
method, a process that requires surface modifying agents for co-incorporating into the carrier 
matrix  during  the  fabrication  protocol.  This  method  requires  overnight  stirring, 
ultracentrifugation  and  in  some  cases  elevated  temperature  which  may  lead  to 
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Surface modification via additional coating method, is another method of controlling the 
burst release phase, by providing an outer drug free layer. In this strategy, the amount of drug 
release is regulated by the dissolution or erosion of the outer coating which is applied to the 
loaded polymeric carriers (Fig. 2.22). Optimising the thickness of the outer shell coating can 
result  in  a  more  controlled,  time  dependent  release  of  the  active  agents.  Also,  the  other 
processing parameters such as the type of the coating materials, their coating concentration as 
well as the coating techniques should be considered carefully in this strategy. 
 
Figure 2.22: Schematic illustration of surface modification with erodible coating layer for drug 
release system (Rasve et al., 2011) 
Although the suggested methods introduced above can be used to prevent burst release, they 
contain some additional costly phases which can lead to reductions in drug loading percentage 
and efficiency in such drug delivery systems. The final part of the thesis is allocated to the 
initial  burst  release  phase,  and  the  positive  effect  of  this  phenomenon  for  the  particular 
biomedical application in chronic wound therapy. 
2.12.2 Application of Sonication in Drug Release 
Sonication  is  a  subsection  of  acoustics  that  relates  to  sound  pressure  or  stress  waves  at 
frequencies greater than the upper limit of the human hearing range i.e., >20kHz (Wu and 
Nyborg, 2008). Sonication has been adopted for over 30 years in diagnostic imaging of the 
human body. Also, it has been employed for other therapeutic applications, such as collagen 
repair promotion (Demir et al., 2004), nerve regeneration (Lazar et al., 2001; Paik et al., 2002), 
thrombolysis and fracture healing enhancement (Dalecki, 2004; Warden, 2003). In recent 
years, it has been applied for drug delivery enhancement including facilitating the delivery of 
drug across the skin and transferring chemotherapeutic drugs into tumours.  
In sonication simulated pulsatile systems, the acoustic waves promotes the erosion of the 
polymer  matrix,  thereby  increasing  the  drug  release.  An  investigation  was  conducted  by 
Miyazaki et al. to study the influence of sonication at a frequency of 1MHz on the release rate 
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release rate was improved with exposure of sonicator, which in turn led to a dramatic reduction 
in blood glucose level (Miyazaki et al., 1988). In another study, kost et al. also investigated the 
application  of  sonication  on  the  degradation  of  biodegradable  polymers  such  as 
polyanhydrides, polyglycolides as well as the release rate of the molecules integrated into those 
polymers. In the final outcomes, they observed the feasibility of ultrasonically augmenting of 
polymer degradation and up to 20-fold increase in the release rate of the incorporated materials 
(Kost et al., 1989).  
Table 2.2: Application of pulsatile drug delivery system with the respective diseases (Rajput 
et al., 2012) 
Disease  Chronological behaviour  Drugs used 
Peptic ulcer   High secretion of acid in the afternoon and  night  H2 blockers 
Asthma  Precipitation of attacks during night or at early morning 
hour 
β2 agonist, 
Antihistaminics 
Cardiovascular 
diseases 
Blood pressure is at its lowest during the sleep cycle and 
rises steeply during the early morning awakening period 
Nitroglycerin, Calcium 
channel blocker 
Arthritis  Pain in the morning and more pain at night  NSAIDs, 
Glucocorticoids 
Diabetes mellitus  Increase in the blood sugar level after meal  Sulfonylurea, Insulin 
Attention deficit 
syndrome 
Increase in DOPA level in afternoon  Methylphenidate 
Hypercholesterol
emia 
Cholesterol synthesis is generally higher during night 
than during day time 
HMG CoA reductase 
inhibitors 
 
Further application of sonication is the simulation of drug release in pulsatile systems. Table 
2.2 enumerates the various diseases that requires pulsatile drug delivery system as a more 
improved way of transferring the active agents within human body. This system has attracted 
the attention of many researchers for the treatment of various diseases in which the drug 
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It is essential to have a good understanding of the disease physiology before designing the 
pulsatile drug delivery system. Diseases  where the circadian rhythm plays a crucial part, 
pharmacokinetics of the drug cannot be constant within 24 hours. Asthma, for example, is one 
of the diseases where the pulsatile drug delivery system can be usefully applied. This is because 
the circadian changes in normal lung function reaches a low point in the early morning hours 
and the pulsatile drug delivery system can be applied to enhance the dosage of the prescribed 
drug such as antihistamines at low points of the day. 
2.12.2.1 The Physiological Effects of Sonication 
There are two main types of physiological effects upon tissue with the application of sonication. 
Occurrence of its thermal effects is usually accompanied with the non-thermal effects; however 
by variation of exposure parameters, only non-thermal effects can be obtained.  
Thermal bioeffects of sonication where thermal effects occur in tissue with an increased 
temperature  to  40-45oC  for  more  than  5  minutes.  These  effects  can  produce  number  of 
biological responses including blood flow enhancement, muscle spasm reduction and also 
improved extensibility of collagen fibres (Barnett et al., 1994). Higher temperature can also 
result in protein denaturation and tissue ablation.  
Non-thermal bioeffects of sonication which are predominantly based on two processes: 1) 
cavitation  and  2)  acoustic  streaming.  Cavitation  in  particular  plays  a  significant  role  in 
delivering therapeutic agents to the targeted tissue. 
Cavitation is the formation and successive oscillation of gas and/or vapour filled bubbles which 
expand and compress due to ultrasonically induced pressure variations in a medium exposed 
to the sonicator (Barnett et al., 1994). Based on ongoing researches, there are two distinct types 
of cavitation: stable (non-inertial) and transient (inertial). In the former cavitation, the induced 
pressure in the medium generates a fairly stable oscillation in bubble size. This oscillation 
produces a circulating fluid flow (known as acoustic microstreaming) around the bubbles 
which,  in  other  word,  is  a  unidirectional  movement  of  fluid  along  the  cell  membrane 
(Marmottant and Hilgenfeldt, 2003).  The amplitude of the oscillation controls the velocities 
and shear rates of microstreaming. The investigations show that microstreaming is capable of 
shearing open red blood cells (Rooney, 1970) as well as drug carriers such as liposomes 
(Marmottant  and  Hilgenfeldt,  2003)  at  high  amplitudes.  However,  when  the  shear  stress 
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Transient cavitation which is also known as collapse cavitation, occurs as a results of increase 
in the intensity of the sonication. For a given bubble size and sonicator frequency, there is a 
critical pressure above which the inertia of surrounding fluid cannot be supported by the 
pressure of the gas inside the bubble during compression. Therefore, the bubbles collapse and 
produce shock waves as well as high temperature and pressure inside the bubbles. This collapse 
can have a significant damage upon both cells and drug carriers and may also lead to production 
of smaller bubbles by fragmentation of the original bubbles. This action can have a further 
cavitation nucleus growing by more gas absorption from the surrounding area, then the process 
is repeated (Brennen, 1995). Asymmetrical collapse can also occur in the case of bubbles 
collapsing near a solid surface. This can produce a high speed fluid jet towards the solid surface 
(Jenne, 2001) and may be strong enough to penetrate the surface of relatively rigid drug carriers 
leading to release of additional drug and also damaging the tissue membrane (Fig. 2.23). 
 
Figure 2.23: Asymmetric collapse of a bubble near a surface, producing a jet of liquid towards 
the solid surface (Pitt et al., 2004) 
The acoustic shock waves caused by collapsed cavitation can also lead to enhancement of drug 
release rate by damaging the carrier surface. Recently, sonication has been used to efficiently 
regulate the drug release from the liposomes, micelles and particles by inducing both thermal 
and non-thermal influences. For instance, the presence of cavitation near the carriers’ surface 
was found to significantly increase drug release rate and gene delivery  (Enayati et al., 2010a; 
Ferrara, 2008; Suzuki et al., 2007; Unger et al., 2001).  
Due to increased temperature and decreased pressure upon exposure of particles to sonicator, 
microbubbles will be formed. These microbubbles will undergo cavitation, causing pores 
formation on the particles surface, leading to the drug release in the surrounding medium. This 
action results in the enhanced permeability of the cellular membrane, most likely as a result of 
microstreaming, leading to enhanced penetration of the drug into the cells (Lentacker et al., 
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In this study, the application of sonication in drug release system has two purposes: first to 
provide a higher release rate of the adopted agents encapsulated in the polymeric particles, and 
second to evaluate the accuracy for the entrapment efficiency of the loaded ingredient which 
was calculated with respect to the yield of the process. 
2.12.3 Application of Temperature in Drug Release 
Temperature can have either positive or negative effects on the polymeric carriers as well as 
the  encapsulated  drug.  These  positive  and  negative  effects  on  the  polymeric  carriers  are 
dependent on the critical temperature of the polymer (Jones, 2004). For example, the critical 
temperature of 50%:50% (lactide:glycolide) PLGA is 37°C; thus the polymer will start to 
shrink and collapse as the temperature is raised above this point. However below the critical 
temperature, the polymer is formed crystalline. Since, the PLGA is a biodegradable polymer, 
in  an  aqueous  solutions,  it  will  shrink  and  biodegrade  at  faster  rate  above  the  critical 
temperature compared to that of below the critical temperature. Therefore, the drug release 
from the PLGA carriers occurs at faster rate due to quicker bulk erosion of the polymer above 
the critical point compared to that of below the critical point (Jamshidi et al., 1988).  
In the study conducted by Reddy et al., it was found that the drug release rate is dependent on 
temperature  of  the  release  medium  (Umamaheswara  Reddy  et  al.,  2007).  Variations  in 
temperature can lead to more controlled manner of drug release depending on the chemical 
properties such as evaporation or degradation rate of the encapsulated active agents (Deng et 
al., 2010). Deng et al. also demonstrated that more control of the initial burst release phase can 
be obtained by variations in the temperature of the release medium. However, the changes in 
temperature for obtaining a more controllable release profile is completely dependent on the 
chemical structure and degradation rate of active agent in the release medium. For example, in 
Shi et al. study, more controlled release of the encapsulated agents (Ca-alginate and poly(N-
isopropylacrylamide)) in hydrogel beads was observed at lower temperature (25oC) compared 
to higher degrees (37oC) (Shi et al., 2006), whereas in Lin et al. study more controlled release 
of the drug from the ethylene vinyl acetate (EVA) was found at higher temperature (37oC) 
compared to lower temperature (24oC) (Lin et al., 2003). Thus, the release rate of drug at 
different  temperatures  not  only  depends  on  the  critical  temperature  of  the  biodegradable 
polymer in aqueous solution, it is also dependent on the chemical properties of the incorporated 
materials.  In  this  Study,  temperature  as  another  external  stimuli  has  been  also  used  to                                                                                                                Chapter 2: Literature Review 
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investigate its influence on the release rate of the encapsulated materials from the polymer 
carriers. 
2.13 Application of Biomaterials in Biomedical Research 
Although biomaterials have great potential to positively improve the quality of life, at the same 
time  they  may  be  associated  with  health  risk;  particularly  the  inhalation  toxicology  and 
pathology of particles have become the important features which affect their wide applications 
in pharmaceutical and biomedical fields (Williams, 2008). Bio-safety is one of the most crucial 
requisites for medical devices, including every medically applied particles. Thus, it is essential 
to  develop  bio-safe  micro-  and/or  nano-spheres.  Different  morphological  spheres  were 
fabricated earlier and applied in biomedical fields; however, the potential bio-safety problems 
still exist, since most of them had been generated by metals (Asiyanbola and Soboyejo, 2008; 
Chen et al., 2006; Gupta et al., 2006), metallic oxides (Liu et al., 2008), inorganic materials 
(Hilder and Hill, 2008) and non-biodegradable polymers (Bhargava et al., 2006; Hou et al., 
2003; Luo and Eisenberg, 2001; Zhang and Eisenberg, 1996). Therefore, these potentially 
harmful particles may be deposited permanently in the tissues of the body, with possible 
translocation to major organs, and hence limiting the medical usage of such materials. 
Producing the appropriate size of microspheres is one of the main and important features of 
such drug delivery systems. The appropriate size distribution of spheres will determine their 
ability to penetrate the structure of tissue in vivo (intercellular trafficking), which may become 
both desirable and/or undesirable in various applications (Sinha et al., 2006). Morphology of 
spheres is another crucial factor in determining physical and chemical properties which also 
influences their in-vivo applications. Spherical particles with different morphologies and sizes 
will have distinct surface area to volume ratio, anisotropy and so on, endowing them additional 
promising advantages for medical and pharmaceutical applications (Chen et al., 2006; Hilder 
and Hill, 2008; Liu et al., 2008). 
 2.13.1 Chronic Wound Therapy 
Chronic wounds barely heal itself in an orderly set of steps and in an expected time the most 
wounds do (Mustoe, 2005). The wounds which do not heal within three months are generally 
considered chronic. In acute wounds, there is a precise stability between production (tissue 
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and degradation plays an excessive role (Edwards et al., 2004). These wounds cause patients 
severe emotional and physical stress which creates significant burden on the entire healthcare 
system (Augustin and Maier, 2003). Chronic wounds may only influence the epidermis and 
dermis or the tissues where is it appeared all the way to the fascia (Crovetti et al., 2004). 
Chronic wounds are often accompanied with pain, and bleeding to some extent. Lack of 
treatment  of  a  chronic  wound  will  lead  to  more  pain  and  possible  blood  infection,  and 
consequently will induce cancer depending on the location and the severity of the wound in the 
affected tissue (Reddy et al., 2012). 
Perianal fistulae are a severe type of chronic disease with an abnormal connection in the form 
of hollow track between the anal canal and the perianal skin. The aetiology of perianal fistulae 
contains anorectal abscess initiated by bacterial infection, Crohn’s disease, trauma and anal 
fissure (Blaker et al., 2008a, 2008b). Although the pathogenesis remains undetermined, there 
are two key hypotheses: 1) fistulae can initiate in the anus or rectum as deep penetrating ulcers 
which spread over time as a consequence of faeces being pushed into the ulcer with the 
defecation forces (Hughes, 1978), 2) fistulae can occur due to infection or frank abscess of the 
anal glands located at the anal crypts (Hawley, 1975; Parks, 1961; Schuppan and Freitag, 
2004). Based on the both hypotheses, fistulae appear when there is no quick compensatory 
fibrogenic response to fill the caused defect (Kirkegaard et al., 2004; Schuppan and Freitag, 
2004). Perianal fistulae are then extended due to bacterial colonization by the commensals of 
the lower gastrointestinal tract and/or skin (de San Ildefonso Pereira et al., 2002; Nicholls et 
al., 1990; Seow-Choen et al., 1992; West et al., 2005). 
The treatment options are continuing to develop, since perianal fistulae do not heal itself 
without the need to surgery. For example, in the case of crohn’s disease-associated fistulae, 
there  is  proven  efficacy  from  the  thiopurines,  the  Infliximab  and  possible  benefits  from 
antibiotics,  Cyclosporine  A  and  Tacrolimus  (Schwartz  and  Herdman,  2004).  These 
antimicrobial agents are effective with clinical improvements that are usually observed after 6-
8 weeks. However, it results in early deterioration on withdrawal. For full treatment of Crohn’s 
disease-associated fistulae, surgery is very successful; however it can involve several operative 
procedures and lead to consequence of provoking faecal incontinence (Schwartz and Herdman, 
2004). 
Lately, for treatment of tissue cavities such as fistulae, biomaterials such as fibrin glue was 
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mucosal advancement flap repair of the complex study (Buchanan et al., 2003). Failure of this 
study was due to semi-liquid consistency and the disadvantage of the materials to fill in the 
cavities for promoting the healing process. In another approach, fistulae plugs were fabricated 
from porcine small intestine submucosa with the aim of plugging the fistulae track (Johnson et 
al., 2006). The failure of this study was also due to nature of the device to completely fill in the 
cavities caused by fistulae. Moreover, it was unclear whether the collagen materials employed 
for  preparation  of  the  devices  were  entirely  compatible  in  fistulae  matrix.  Still,  there  is 
evidently an ongoing need for novel treatment strategies of perianal fistulae, but with more 
suitable filling biomaterials. It is suggested that the physical properties of filler materials 
combined with bioactive phases could improve the rate and the speed of the heeling process. 
Blaker et al. (2008) developed a study to produce porous PLGA microspheres containing either 
antibacterial phosphate glass or metronidazole for use as a potential alternative filler strategy 
in fistulae treatment (Blaker et al., 2008a, 2008b). Although, the fabricated microspheres had 
such a good interconnected porous structure and implanted as a cluster, the nature of the wound 
packet resulted in movement of them subsequent to the implantation site. Failure was due to 
the large size distribution of microspheres (~1.5 mm), where most of them were destroyed at 
the event of in vivo injection (Blaker et al., 2008b). Besides, due to large polydispersity of the 
produced particles, no cell migration was occurred into the free flowing microsphere-scaffold 
for tissue regeneration (Blaker et al., 2008a).  
Microspheres have been widely used in medical and pharmaceutical applications as effective 
carriers of encapsulated drugs (Foy et al., 2004; Li et al., 2004; Peng and Zhang, 2005); 
therefore, they are considered for in vitro studies of the perianal fistulae treatment in this 
investigation. This type of polymeric particles provide special characteristics such as high 
surface-to-volume ratio, low density, and low coefficient of thermal expansion (Lou et al., 
2008). These characteristics facilitate the manipulation of the surface properties of the interior 
or exterior of the microspheres to control interactions with various species (Moon and Jeong, 
2008). Encapsulation of drug in biodegradable polymer enables the drug to be released in a 
more controlled manner which in turn helps to sustain a constant therapeutic concentration 
between the toxic and minimum levels in body fluids over the period of treatment following 
administration (Sinha and Trehan, 2003).  
Based on the literature review conducted on perianal fistulae as a type of chronic wounds, 
microspheres with surface porosity are considered for two main reasons: 1) porosity on surface 
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of such disease (Table 2.1) and 2) a more sustained period of drug release will be obtained due 
to lower water uptake of the biodegradable polymeric carriers (Enayati et al., 2010a). 
Failure of the previous research in treatment of such disease was due to the incomplete filling 
of the fistulae cavitation with the application of biomaterials. This issue could be simply 
resolved  by  introducing  the  EHD  method  combined  with  TIPS  process  to  fabricate  near 
monodisperse microspheres in a form of free flowing scaffold. Based on the literature review 
and research conducted on the perianal fistulae, microspheres in a form of free flowing scaffold 
with surface porosity and size distribution of 150-300 µm would be more suitable for filling 
the fistulae cavitation.  Furthermore, this range of microspheres would have large enough 
interstices between them to allow cell migration for wound healing and tissue regeneration 
(Fig. 2.24). The reason behind selecting this range is that the microspheres less than 100 µm 
may start moving to other parts of the human body by absorption into blood system and result 
in further complication such as embolism and/or deposition in another organ, and also the 
microspheres over 350 µm cause blockage of the needle at the events of in vitro and/or in vivo 
injection tests. 
 
Figure 2.24: Schematic diagram of perianal fistulae with the arrangement of microsphere-
scaffold for treatment 
The main purpose of this study is to fabricate microsphere-scaffold with the single needle 
EHD/TIPS process. To ensure robust EHD production, this work mapped EHD parameters 
using  a  variety  of  polymer  solutions  for  controlled  generation  of  near  monodisperse 
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profile of the spherical particles obtained over a broad range of flow rates and applied voltages 
are presented. 
The in vitro release studies are the second purpose of this project. It was aimed to predict the 
in vitro release profile of immunosuppressive drugs such Cyclosporine A and Tacrolimus with 
high  molecular  weight  and  very  low  water  solubility.  Since,  these  drugs  have  several 
drawbacks such as marked nephron- and neurotoxicity, three fluorescent dyes (erythrosin B, 
pyronin and Reichardt’s dye) as surrogate drug entity were selected. Selection of these dyes 
was based on covering the range of molecular weight and water solubility of the actual drugs 
as these two properties play crucial role in release rate of incorporated materials. The single 
needle EHD/TIPS process was conducted for encapsulation of each dye into the required size 
of the microspheres, and then the results were compared with those produced by the co-axial 
EHD/TIPS technique in order to discover a more suitable method in fabrication of the required 
drug delivery carriers for the chronic wound therapy.  
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Chapter 3 
Experimental Details 
3.1 Introduction 
This chapter of the report reviews in details the procedures adopted for the experiments in this 
thesis. The materials used, the corresponding suppliers and the product details are given. The 
methods used to characterise the materials and the solutions are also described. A detailed 
description of the equipment adopted in the single needle EHD and the co-axial needle EHD 
processes for mode mapping studies and the in situ development of scaffold with dye loaded 
microspheres is also given. Finally, the experiments for the in vitro characterization of the dye 
loaded microsphere-scaffolds are also discussed. 
3.2 Materials 
The main materials used in the experimental work were as follows: 
3.2.1 Poly (Lactic-Co-Glycolic Acid) (PLGA) 
PLGA is a copolymer of glycolic and lactic acid which has been approved by the Food and 
Drug Administration (FDA) for usage in therapeutic devices due to its biocompatibility and 
biodegradability. Various forms of PLGA can be acquired depending on the ratio of lactide and 
glycolide monomers and they are usually identified in terms of the monomer ratio adopted. In 
this research work, the PLGA copolymer 50:50 Resomer RG503H (Boehringer Ingelheim, 
Germany) was used with the molecular weight of 33000 g/mole composed of 50% lactic and 
50% glycolic acid. 
3.2.2 Poly (ε-Caprolactone) (PCL) 
PCL is  another important  polymer in  the drug  delivery systems  owing to  its  mechanical 
properties, miscibility with a large range of other polymers and biodegradability. This polymer 
has a high melting point of approximately 60oC with a glass transition temperature of -60oC. 
The two different molecular weights of PCL used in this work were PCL10,000 (Mw = 10000 
g/mole) and PCL45,000 (Mw = 45000 g/mole) and they were both purchased from Sigma 
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63 
 
3.2.3 Dimethylacetomide (DMAc) 
DMAc (C4H9NO) is a colourless, water miscible, high boiling point liquid compound. This 
solvent has a molecular weight of 87.12 g/mole with density of 0.94 g/cm3 and melting point 
of -20oC. DMAc was procured from Sigma Aldrich (Poole, UK) and used as a solvent in this 
study. 
3.2.4 Dimethylformamide (DMF) 
DMF is an organic compound with formula (CH3)2NC(O)H. This solvent is colourless with 
miscibility in water and high boiling point around 154oC. The molecular weight of DMF is 
73.09 g/mole with density of 0.95 g/cm3 and very low melting point of -60oC. DMF was 
purchased from Sigma Aldrich (Poole, UK) and used as a solvent in this study for dissolution 
of polymer. 
3.2.5 Toluene  
Toluene is a clear, water-insoluble liquid with characteristic smell of paint thinner. This liquid 
with formula C7H8 has a molecular weight of 92.138 g/mole and density of 0.90 g/cm3. Toluene 
has a high boiling point (110oC) and the melting point of nearly -95oC. This solvent with high 
level of evaporation rate was purchased from Sigma Aldrich (Poole. UK) and used as a solvent 
in this study. 
3.2.6 Dimethyl Carbonate (DMC) 
DMC is an organic compound which is a colourless, flammable liquid with solubility in water 
and high boiling point of 90oC. This liquid has a molecular mass of 90.08 g/mole and density 
of 1.07 g/cm3. This solvent has a melting point of between 2-4oC, and due to low level of 
toxicity it is often considered as a green reagent. This liquid is used as a solvent for dissolution 
of polymer and was purchased from Sigma Aldrich (Poole, UK). 
3.2.7 Distilled Water 
Distilled water is water that has many of its impurities removed through distillation. Distillation 
involves boiling the water and then condensing the steam into a clean container. It has an 
electrical conductivity of less than 10 µS/cm and total dissolved solids of less than 10 mg/L. It                                                                                                          Chapter 3: Experimental Details 
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was used as a collection media in the particle production and provided by the Biomaterial Lab 
in Mechanical Engineering Department at UCL (London, UK). 
3.2.8 Ethanol 
General purpose research grade ethanol with molecular weight of 46 g/mole (C2H5OH 99%), 
density of 0.79 g/cm3 and viscosity of 1.3 mPa s, was used in this investigation. As described 
in Section 3.9.2.3, ethanol was used as a supplementary liquid in the SBF media for release 
studies of some packs of loaded microspheres. In addition, ethanol was also used for the 
calibration of the characterisation apparatus and for cleaning the capillary of the needles which 
were the essential components of the experimental set-up. This material was purchased from 
Sigma Aldrich (Poole, UK). 
3.2.9 Liquid Nitrogen 
Liquid nitrogen is nitrogen in liquid state at an extremely low temperature that is produced 
industrially by fractional distillation of liquid air. It is a clear liquid with density of 0.81 g/ml, 
boiling point of -196oC and freezing point of -210oC at atmospheric pressure. Due to its very 
low melting point, it is used in thermally induced phase separation procedure for removal of 
solvent or unnecessary materials from systems. Liquid nitrogen combined with freeze drying 
is widely used to produce solid form of a liquid solution that has high melting point. This liquid 
was provided by BOC (London, UK). 
3.2.10 Erythrosin B 
Erythrosin B (C20H6I4Na2O5) with molecular weight of 839.85 g/mole was used as a model 
drug in in vitro release studies to predict the release profiles of Cyclosporine A (1202.61 
g/mole) and Tacrolimus (804.018 g/mole). This fluorescent dye has very low water solubility 
(1 g/mole) and is widely used for applications in food colouring and printing ink (Lin and 
Brusick,  1986;  Lyday,  2005).  Also,  due  to  its  biocompatibility  and  biodegradability  in 
physiological environments, it has been used as a biological stain for detection of viable cells 
in  tissue  engineering  and  a  dental  plaque  disclosing  in  dentistry  (Krause  et  al.,  1984). 
Nowadays, erythrosin B can be found in sweets such as some candies and popsicles, and even 
more widely used in cake-decorating gels and colouring of pistachio shells (Cantor, 1997; 
Diamond Foods, 2007). This dye was purchased from Sigma Aldrich (Poole, UK).                                                                                                           Chapter 3: Experimental Details 
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3.2.11 Pyronin B 
Pyronin B (C42H56Cl8Fe2N4O5) with molecular weight of 1042.28 g/mole was also used as a 
model drug in in vitro release studies for prediction of Cyclosporine A and Tacrolimus release 
profiles. This dye has low water solubility (20 g/mole) with particular application in cell 
biology and haematology for detection of the required cells under investigation. The major 
application of this dye as a stain is identification and analysis of the heamatopoietic stem cells 
in histology, due to its biocompatibility, biodegradability and non-toxicity in physiological 
environments (Challen et al., 2009). This agent was procured from Sigma Aldrich (Poole, UK).  
3.2.12 Reichardt’s Dye 
Reichardt’s dye (C41H29NO, Mw = 551.68 g/mole) was also used as a model drug in in vitro 
release studies to forecast the release profiles of Cyclosporine A and Tacrolimus from the 
porous microspheres. Unlike the other two fluorescent agents, Reichardt’s is a completely 
hydrophobic dye and has a lower molecular weight. Since, it has both positive and negative 
charge sides, it is used in characterizing the polarity of certain microenvironments such as cell 
membrane.  Moreover,  it  is  been  used  for  determining  the  water  content  of  a  solvent  by 
changing the colour (Reichardt, 1994). This dye was also procured from Sigma Aldrich (Poole, 
UK). 
3.2.13 Simulated Body Fluid (SBF) 
SBF  is  a  mixture  of  several  different  chemicals  that  when  combined  produce  similar 
composition to human blood plasma (Oyane et al., 2003; Swain and Pattanayak, 2008). The 
existing  chemicals  for  SBF  preparation  includes  NaCl,  KCl,  CaCl2.2H2O,  MgCl2.6H2O, 
NaHCO3, K2HPO4, NaSO4.10H2O, tris  buffer such as  Tris-hydroxymethyl-aminomethane, 
H2NC(CH2OH)3 and 1 mole of HCl. The concentration of total ions for SBF preparation is 
presented in Table 3.1 (Kokubo et al., 1990). All of these reagents were purchased from Sigma 
Aldrich (Poole, UK) with analytical grade.  
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Table 3.1: comparison between ion concentration of SBF and human blood plasma (Kokubo 
et al., 1990; Ohtsuki et al., 1995)  
Ion  SBF (g)  Blood plasma (g) 
 
Na+  142.0  142.0 
K+  5.0  5.0 
Mg2+  1.5  1.5 
Ca2+  2.5  2.5 
Cl-  148.8  103.0 
HCO3-  4.2  27.0 
HPO4
2-  1.0  1.0 
SO4
2-  0.5  0.5 
 
For preparation of SBF, 500 mL deionised water was added into 1 L of polyethylene bottle and 
covered with a transparent glass lid. The reagents were then dissolved one by one in order 
according to  Table 3.2 with constant stirring. During preparation, the temperature of the 
solution was maintained at 36.5oC by being placed in a water bath and the pH of the solution 
was adjusted to 7.4 by titration with 1 mole of HCl. The total volume of the solution was then 
made up to 1 L by adding deionised water. The SBF solution is usable for a maximum period 
of four months. Afterwards, the reagents start to degrade that results in pH changes in the 
solution (Kokubo et al., 1990; Ohtsuki et al., 1995). 
Table 3.2: Chemicals used for SBF preparation (Kokubo et al., 1990; Ohtsuki et al., 1995)  
Order 
 
Reagent 
 
Amount 
 
1  NaCl  7.996 g 
2  NaHCO3  0.350 g 
3  KCl  0.224 g 
4  K2HPO4･3H2O  0.228 g 
5  MgCl2･6H2O  0.305 g 
6  1M-HCl  40 mL 
7  CaCl2  0.278 g 
8  Na2SO4  0.071 g 
9  (CH2OH)3CNH2  6.057 g 
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3.3 Characterisation of the Solutions 
3.3.1Viscosity 
Dynamic viscosities of the solutions prepared for this study were determined using a U-tube 
viscometer (BS/U type, Schott Instrument GmbH, Germany). The calibrated U-tube adopted 
for measurements was size C with nominal constant of 0.03. The time measured for a standard 
volume of solution to pass through the capillary of the U-tube was noted for five passes, and 
the mean value and standard deviation were calculated. Then, the total kinematic viscosity (v) 
was computed by having the nominal constant multiplied with the time (t): 
v = Ct       (m2/s)                                                                                                                                (3.1) 
The dynamic viscosity (η) was then calculated by having the value of density (ρ) of solution 
multiplied by the kinematic viscosity: 
η = vρ                                                                                                                                      (3.2) 
By combining the two equations, (3.1) and (3.2), the dynamic viscosity is calculated: 
η = Ctρ     (Pa s) or (kg/(m.s))                                                                                                                                 (3.3) 
Water was adopted for calibration of the U-tube viscometer. The mean value of five readings 
was taken as the dynamic viscosity of each sample. It is essential to calibrate the U-tube 
viscometers, which are not calibrated by manufacturers, by a liquid with known properties and 
then comparing the values in order to validate the results.  
3.3.2 Density 
Density of the liquids or the solutions prepared for this study was measured using a 25 ml 
standard bottle (VWR International, Lutterworth, UK). The mass of the empty bottle (W1) and 
the mass of the bottle filled with liquid or the solution (W2) were measured using an electronic 
balance device (AND HF-1200G A&D Instruments Ltd, Japan). Density was then calculated 
as follows: 
The density of the liquid or the solution = (W2-W1)/25    (kg m-3)  (3.4)                                                                                                          Chapter 3: Experimental Details 
68 
 
The mean value and standard deviation of the five successive calculations were then taken as 
the density of liquid or the solution. The characterizations of all the solutions used in this study 
were carried out at the ambient temperature (~24oC) and pressure. 
3.3.3 Surface Tension 
The  surface  tension  of  the  solutions/liquids  was  calculated  using  Kruss  Tensiometer  K9 
(Standard Wilhelmy’s plate method). The plate was suspended from a hook and a 25 ml beaker 
containing sample was placed on the platform. The plate was thoroughly immersed into a 
sample whose surface tension was to be measured. The plate was then gradually lifted and the 
surface tension value was presented on the reading monitor when the plate was about to detach 
from the liquid surface. For minimising the errors, the plate was cleaned completely with 
ethanol and dried before each set of measurement. This procedure was conducted five times 
for each sample, and the mean value along with the standard deviation were then recorded as 
the surface tension of the relevant sample. 
3.3.4 Electrical Conductivity 
Electrical conductivity was measured using pHenomenal PC 5000 H (VWR International, 
Lutterworth, UK) conductivity probe. The electrode on the conductivity probe was always 
cleaned with ethanol or distilled water and dried before each set of measurements. The standard 
conductivity probe was kept immersed in a 20 ml beaker of solution up to the point marked on 
the electrode for 60 s and then the reading of the meter was recorded. The mean value and 
standard deviation of the five successive readings were taken as the final value for the electrical 
conductivity of the sample. 
3.3.5 pH 
The pH of solution was also measured dipping a standard pH probe (pHenomenal CO11, VWR 
International, Lutterworth, UK) in solution. The pH probe was held in the solution for 60 s and 
then the reading shown on the meter was recorded. For accuracy in measurement, the pH probe 
was needed to be thoroughly cleansed with distilled water or ethanol and then dried before any 
measurement.  The  five  consecutive  measurements  were  taken  and  the  mean  value  was 
calculated as the final value for the pH of the solution.                                                                                                          Chapter 3: Experimental Details 
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3.4 Solution Preparation 
3.4.1 PLGA Solutions for EHD Mode Mapping and Size Distribution Studies 
Clear solution of PLGA with varying concentrations (5%, 10% and 20% w/w) were prepared 
by having the appropriate amount of the polymer combined with DMAc under mechanical 
stirring until complete dissolution of PLGA (~2700 s). The same procedure with the similar 
concentrations was carried out for preparation of the PLGA solutions mixing with DMF. 
Another PLGA solutions with different concentrations (5%, 10% and 15% w/w) were also 
prepared by dissolving this copolymer in DMC under mechanical stirring until full dissolution 
of polymer in the solution (~2700 s). 
3.4.2 PCL Solutions for EHD Mode Mapping and Size Distribution Studies 
PCL solutions of different concentrations (15%, 20% and 25% w/w for PCL10,000, and 5%, 
7% and 10% w/w for PCL45,000) were also prepared by mixing the proper amount of polymer 
and toluene under mechanical stirring at ambient temperature until clear solution for the total 
PCL dissolution was obtained (~3600 s). Lower concentrations were used for PCL45,000 to 
ensure the solutions remain in the dilute concentration regime for the higher molecular weight 
PCL polymer to be able to generate spheres instead of fibres (Luo et al., 2012) during EHD 
processing. 
3.4.3 Dye Loaded Solutions for In Vitro Release Studies 
3.4.3.1 Single Needle EHD/TIPS Process 
Three separate batches of 17.5% w/w PLGA solutions were prepared by having appropriate 
amount  of  the  polymer  fully  dissolved  in  dimethyl  carbonate  for  2700  s  under  ambient 
conditions. After complete dissolution of PLGA in DMC, 0.16 g of each dye was added to each 
solution to give a final concentration of 0.6% w/v. Full dissolution of the dyes in the solutions 
was performed with vortexing. One extra batch of PLGA solution with same concentration 
(17.5% w/w) was also prepared and used as the control sample during the experimental process. 
3.4.3.2 Co-axial Needle EHD/TIPS Process 
Three separate batches of same concentration (17.5% w/w) of PLGA solutions were prepared 
by having appropriate amount of the polymer fully dissolved in dimethyl carbonate for 2700 s 
under ambient conditions. Also, 0.3 g of each dye with total concentration of 3% w/v was                                                                                                          Chapter 3: Experimental Details 
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dissolved  in  dimethyl  carbonate  for  the  encapsulation  of  agent  by  the  co-axial  needle 
EHD/TIPS process.  
3.5 Particle Formation for EHD Mode Mapping and Size Distribution Studies 
3.5.1 Single Needle EHD Setup 
Needle setup: in the single needle EHD processing, a stainless steel needle (Stainless tube & 
Needle Co. Ltd, Staffordshire, UK) was coupled to a high power voltage supply in order to 
provide the electric field on the apex of the needle. The external and internal diameters of the 
nozzle were 1.34 mm and 1.18 mm respectively.   
Syringe pump: the single needle was connected by silicone tubing to a 5 ml plastic syringe 
(BD PlasticTM, VWR International, Lutterworth, UK) containing the polymer solution. The 
flow rates of solution through the needle were controlled by high precision syringe pump 
(Infuse/Withdraw  PHD  4400  Hpsi  programmable  syringe  pump,  Harvard  Apparatus  Ltd, 
Edenbridge,  UK). The  pump  was  calibrated with ethanol before each  set  of  experiments 
conducted. The range of flow rates for PLGA/DMF and PLGA/DMAc solutions was varied 
from 30 to 200 µl min-1, whereas this range for the solutions of PLGA dissolved in DMC was 
between 75 and 450 µl min-1, and for both PCL types in toluene varied from 20 to 50 µl min-1. 
High voltage power supply: the needle and the ground electrode were coupled to a high 
voltage DC power supply unit (FC30 P4 12w, Glassman Europe Limited, Bramley, UK) via a 
high voltage power cable. At each flow rate, when the solution was pumped through the needle, 
the appropriate range of voltage was used in order to obtain stable cone-jet on the tip of the 
needle. Therefore, collection of spherical particles from each sample was conducted at specific 
range of voltage when the stable cone-jet mode was achieved. 
Ground electrode: An electrode was connected from the voltage power supply unit to the 
ground as shown in Figure 3.1. The electrical stress is determined by the strength of the electric 
field between the needle and the ground electrode.  
Data recording unit: different modes of jet and particle formation process were monitored 
using LEICA S6D JVC-colour video camera attached to a zoom lens and a data DVD video 
recorder  MP-600  using  CDV  Recorder/Editor  DN-100  with  a  video  screen  for  real  time 
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In the process of single needle, the spherical particles were collected at a working distance of 
80 mm below the nozzle exit directly into 10 ml glass vials containing 5 ml distilled water. 
Each sample was collected for 600 s and then dispersed on a glass slide by a pipette in order to 
be dried for analysis under optical microscopy. 
3.6 Particulate Scaffold Fabrication 
3.6.1 Conventional Single Needle EHD Setup 
The single needle EHD setup was used for development of free flowing and non-free flowing 
scaffold structures (Fig. 3.1). The same procedure as explained in Section 3.5.1 was carried 
out; however, the collection medium was changed from glass vial filled with water to a beaker 
contained liquid nitrogen. 15 wt% concentration of the PLGA/DMC combination was selected 
for  the  preparation  of  the  particulate  scaffold  structure,  as  this  concentration  of  polymer 
solution from the EHD mode mapping and size distribution studies (Section 3.5) provided the 
required size range of particles. This combination in 20 ml plastic syringe was electrosprayed 
for 1800 s in a metallic collection vessel filled with liquid nitrogen.  
 
Figure 3.1: Experimental setup of single needle EHD/TIPS for the production of microspheres 
Free flowing scaffold structure: for development of the free flowing scaffold, metallic beaker 
was filled with liquid nitrogen to the top and every 2 minutes it was topped up in order to keep 
the level of liquid nitrogen constant in the beaker. In this form of scaffold development, when 
the spherical particles reached the liquid nitrogen, they became solidified and started flowing 
around due to the lower density of the polymeric microspheres compared to the liquid nitrogen.                                                                                                          Chapter 3: Experimental Details 
72 
 
Non-free flowing structure: for the formation of rigid (non-free flowing) scaffold structure, 
only a small amount of liquid nitrogen was poured to the bottom of the metallic beaker to 
provide a freezing medium for the collection of solid spherical particles. In this arrangement, 
as soon as the particles entered the beaker started to solidify and aggregate to form a rigid non-
free flowing scaffold. 
Collection  of  particles  in  cold  medium  using  liquid  nitrogen  led  to  generation  of  solid 
microspheres. For production of the spherical particles, flow rate was set at 225 µl min-1, and 
in order to obtain the stable cone-jet mode, the applied voltage range varied between 6-7 kV. 
During the collection of particles, the beaker was placed 80 mm below the tip of the needle 
with the ground electrode connected to it. The direct grounding of the electric field to the 
collector resulted in attraction of the charged microspheres and their deposition at the bottom 
of the metallic container. 
3.6.2 Freeze Drying 
These spherical particles after collection in the metallic beaker containing liquid nitrogen were 
immediately placed in freeze dryer until the complete extraction of the solvent (DMC) was 
obtained (~20 hours). The frozen spherical particles after removal from the freeze dryer were 
completely solidified. These prepared microspheres after freeze drying were subjected to SEM 
and optical microscopy studies for further analysis. 
3.7 Agent Loaded Microspheres Fabrication for In Vitro Release Studies 
3.7.1 Conventional Single Needle EHD/TIPS Process 
The experimental setup for producing the PLGA microspheres with the entrapped dye was the 
same as presented in Figure 3.1. For mass production of the dye loaded microspheres by 
EHD/TIPS method, a 20 ml volume syringe (BD PlasticTM, VWR International, Lutterworth, 
UK) was fully loaded with the prepared PLGA solution containing dye. Since, the main aim of 
this study was to produce microspheres with size distribution of 150-300 µm, the polymer 
concentration for producing the required size range of dye loaded carriers was increased from 
15 wt% to 17.5 wt% in the solution. This change was highly related to the environmental 
variations such as higher humidity, higher ambient temperature and atmospheric pressure.                                                                                                           Chapter 3: Experimental Details 
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For transferring the polymer-dye solution to the needle, the flow rate was set at 400 µl/min and 
the voltage was varied between 6.5 and 8.5 kV depending on the polymer-dye solution. To 
develop the near monodisperse microspheres, the single-needle EHD process for the PLGA 
solution containing each dye was carried out at the stable cone-jet mode into the metallic beaker 
that contained liquid nitrogen. The collection vessel was placed 80 mm below the exit of the 
nozzle with the ground electrode directly connected to it for attraction and deposition of the 
charged microspheres at the bottom of the metallic container. After 2700 s of collection in the 
container filled with liquid nitrogen, the samples were immediately placed in a freeze dryer 
(LTE Scientific Ltd, Oldham, UK) and lyophilized for 20 hours. After freeze drying, the free 
flowing lyophilized microspheres were collected into vials and stored for morphological and 
in-vitro release studies. 
3.7.2 Modified Single Needle EHD/TIPS Process  
In our initial experiments during the process of single needle electrospray, the products were 
scattered to the peripheral environment, due to the cloud of nitrogen gas that formed at ambient 
temperature  above  the  collection  beaker.  Therefore,  a  smaller  quantity  of  products  was 
collected in the metallic beaker and consequently the percentage yield of the process and the 
drug entrapment efficiency could not be accurately calculated. Figure 3.2 shows how this issue 
was overcome with the modifications applied to the single needle EHD/TIPS method for 
enhancing the efficiency of the process. 
 
Figure 3.2: Schematic diagram of the modified single needle EHD/TIPS process                                                                                                          Chapter 3: Experimental Details 
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A funnel shaped compartment, a metallic beaker with wider opening and a second ground 
electrode (a ring with inner diameter 15 mm and outer diameter 20 mm) were adopted for 
optimization. The second ground electrode, which was placed between the tip of the nozzle 
and the metallic beaker, provided further stability of the cone-jet mode and also directing the 
products to the metallic beaker. The funnel shaped compartment made of non-conductive 
material created an area to prevent the particles from scattering to the peripheral environment. 
The funnel was 120 mm high and it was placed at 5 mm below the second ground electrode 
and 10 mm gap above the beaker (Fig. 3.2). It was necessary to have the gap between the 
metallic beaker and the funnel in order to allow the nitrogen gas to escape and facilitate the 
direction  of  the  formed  microspheres  towards  the  collection  vessel.  A  metallic  beaker 
connected to a ground electrode with a wider opening that the funnel also provided a broader 
area  for  more  attraction  of  oppositely  charged  particles  to  the  collection  vessel.  The 
electrospraying of the polymer-dye solutions was also carried out by the modified single needle 
process with the similar processing parameters and the same duration (2700 s) as described in 
Section 3.7.1. The frozen products were then lyophilized for 20 hours. 
3.7.3 Modified Co-axial Needle EHD/TIPS Process 
In order to obtain the higher percentage yield of the process and the entrapment efficiency, the 
co-axial needle was also modified according to the modifications of the single needle process 
by a second ground electrode, a funnel shaped non-conductive compartment and a metallic 
collector with wider opening than the funnel (Fig. 3.3).  
 
Figure 3.3: Schematic diagram of the modified co-axial needle EHD/TIPS process                                                                                                          Chapter 3: Experimental Details 
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The experimental setup for the co-axial needle EHD/TIPS process was similar to the single 
needle setup, but a two needles stainless steel co-axial device (Stainless tube & Needle Co. Ltd, 
Staffordshire, UK) was coupled to a high-power voltage supply. The central needle with 0.65 
mm inner diameter was used to carry the agent-loaded solution, whereas the outer needle with 
1.18 mm orifice (inner diameter) perfused with the prepared 17.5 wt% PLGA solution to 
produce the spherical polymeric shell. The flow rate for the inner needle was set at 80 µl/min 
while for the outer needle it was 400 µl/min. The applied voltage to provide the stable cone-jet 
for the microspheres fabrication was set at 6.8–7.4 kV over the period of collection depending 
on the physical properties (such as conductivity, surface tension and viscosity) of the two 
flowing solutions. The strategic method of microspheres collection, the collection distance and 
the  period  of  products  collection  were  similar  to  the  modified  single  needle  setup.  The 
lyophilisation of the products collected from the co-axial EHD/TIPS process was also carried 
out as before.  
3.8 Characterization of Generated Particles 
3.8.1 Optical Microscopy 
Five drops of each sample after collection in 10 ml glass vials were dispersed on a glass slide 
by a pipette and then placed in a desiccator for 12 hours (apart from microspheres collected in 
liquid nitrogen and lyophilized by freeze dryer) in order to dry and become ready for optical 
microscopy. An optical microscope (Nikon Eclipse ME 600, Nikon, Japan) was extensively 
used for all the investigations described in particle formation for EHD mode mapping and size 
distribution studies. The diameter measurements of the produced microspheres were carried 
out by means of Image Pro-Insight software (Media Cybernetics, UK). 
3.8.2 Scanning Electron Microscopy 
The morphology and detailed structure of the fabricated spherical particles were investigated 
using scanning electron microscopy (JEOL, JSM-630 field emission SEM). It was equipped 
with an emitter which can have a resolution up to 1.5 nm. The accelerating voltage was set at 
5kV and the working distance between the emitter and the sample was fixed at 20 mm. The 
SEM  studies  were  used  extensively  for  all  the  investigations  described  in  agent  loaded 
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The produced microspheres collected from both the single needle and the co-axial needle 
EHD/TIPS processes were completely dry due to collection in liquid nitrogen and long hours 
of freeze drying. Therefore, they could be taken for SEM studies immediately.  
Since the polymers adopted for the preparation of spherical particles are non-conductive, the 
dried samples for the SEM studies were initially glued onto aluminium stud via adhesive 
carbon tabs, and then sputtered coated (Edwards sputter coater S 1 50B) with gold for 180 s 
prior to placing in SEM chamber for further analysis. This enables the samples to be more 
visual in SEM chamber and avoid charging which can cause damage to the samples. For 
determining the size distribution of particles, 100 spheres were randomly selected and analysed 
from each sample. The diameter of the microspheres from SEM studies was also measured by 
Image Pro-Insight software (Media Cybernetics, UK). 
Since the fabricated microspheres were quite large with an internal solid structure, focused ion 
beams (FIB) could not be adopted for investigation of the internal structure. Therefore, for 
analysis by SEM machine (Hitachi S-3400N), they were randomly sectioned with a surgical 
blade after sputter gold coating.   
SEM was also applied for further morphological analysis of the produced microspheres used 
in the release studies. A small quantity from each pack of loaded microspheres in the relevant 
release media at ambient (22 ± 2 oC) and physiological (37 ± 1oC) temperatures after 2 and 12 
days were prepared on glass slides, and placed in desiccator for 24 hours for complete drying 
under ambient conditions before SEM examination. This part of SEM studies was conducted 
in order to observe the effect of release medium on the degradation process of the loaded PLGA 
microspheres during the early and later stages of release studies. SEM preparation of these 
samples was similar as explained above. 
3.8.3 Energy-Dispersive X-Ray Spectroscopy 
Energy-dispersive X-ray (EDX) spectroscopy was used to confirm the presence of the dye in 
the PLGA microsphere-scaffolds. This study was performed for the modified single needle 
samples containing the PLGA microspheres with each of the entrapped dyes. For this study, a 
batch of the lyophilized microspheres (~0.01g) was gold-coated at argon atmosphere and then 
placed in the system comprised of a field emission SEM column (Gemini SEM), with an 
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XRF) for the analysis. The applied voltage was set at 20 kV. Sample preparation for EDX 
studies was similar to the SEM studies.  
3.8.4 Fourier Transform Infrared (FTIR) Spectroscopy 
Fourier transform infrared (FTIR) was adopted to illustrate the presence of different functional 
groups of the agents encapsulated in the polymeric particles. A Perkin-Elmer Spectrum 2000 
spectrophotometer (Cambridge, UK) was adopted for this investigation. A resolution of 4 cm-
1 and 32 scans were selected. FTIR spectra window was obtained by the Potassium bromide 
(KBr) disk method. In this method, 200 mg of the dried spectrophotometric-grade KBr powder 
was completely mixed with 10 mg of the dye loaded microspheres, and then fused into a 
transparent disk using a hydraulic press. The prepared KBr disk contained the sample was then 
placed in FTIR spectroscopy for analysis. 
3.9 In Vitro Release Measurement 
3.9.1 UV Spectroscopy 
Release of the encapsulated materials (dyes) from their polymeric shell (microsphere) was 
determined by UV spectroscopy. In this section, a brief description is provided on how the UV 
absorption  spectra  can  be  used  to  identify  the  compounds  as  well  as  measuring  the 
concentrations of the encapsulated dye in a solution. In UV spectroscopy, light in the ultra-
violet rays is transmitted through a sample containing the encapsulated materials. Different 
components in the sample may absorb certain wavelength of the transmitted light. The intensity 
of the light which is absorbed at a given wavelength will then be related to the concentration 
of the component in the measured sample. At appropriately low concentration of the absorbing 
component detected in sample, a linear relationship exists between the absorbance and the 
concentration of materials. This linear relationship is expressed by the beer-lambert law in 
physics (Calloway, 1997; Mitschele, 1996) as follows: 
𝐴 = log10
𝐼𝑜
𝐼                                                                                                                              (3.5) 
log10
𝐼𝑜
𝐼 = ԑ 𝑙 𝑐                                                                                                                      (3.6) 
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Where A is the absorbance, Io is the incident intensity, I is the transmitted light intensity (dB), 
ԑ is the coefficient of the material in the sample (L mole-1 cm-1), 𝑙 is the path length through 
the sample (cm) and C is the concentration of the species under investigation (mole L-1).  
Release profiles of the encapsulated dyes were measured by using Perkin Elmer Lambda 35-
vis spectrophotometer (Cambridge, UK). This system has the following specifications: optical 
system with double beam, spectral bandwidth of 0.1, 0.2, 0.5, 1, 2 and 5nm, wavelength ranging 
from 190 to 900 nm, accuracy of ± 0.3 nm, repeatability of ± 0.1 nm, and photometric readout 
for absorbance % and transmittance % reflectance. In in vitro release studies, the first step for 
drug release calculation and entrapment efficiency is to determine the calibration curve and the 
second step is finding the linear relationship between the concentration of the encapsulated 
materials and the corresponding absorbance. These steps will be descried in the next sections. 
Calibration curve, which is based on the quantity of light absorbed by a solution against the 
solution concentration, must be prepared for finding the concentration of an unknown solution. 
For  plotting  a  calibration  curve,  a  number  of  standard  solutions  with  various  known 
concentrations of the agent compound need to be measured by the UV spectrophotometer 
(Barreiro-Iglesias et al., 2003; Cavrini et al., 1989; Thompson et al., 2005). A sample of an UV 
calibration curve is given in Figure 3.4.  
 
Figure 3.4: A sample of an UV calibration curve with the indicated error (R2=0.9998) 
3.9.2 Measuring Dye Encapsulation 
3.9.2.1 Erythrosin B and Pyronin B 
Erythrosin B absorbs light at three different wavelengths, 309 nm, 351 nm and another one 
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due to much stronger and clearer absorbance signal (Fig. 3.5). Pyronin B has light absorption 
at four various wavelengths of 261 nm, 348 nm, 398 nm and another one within the range of 
450-550 nm, but only wavelength 348 was selected as a reference owing to much stronger light 
absorption and easily detection by UV spectroscopy (Fig. 3.6). Different samples with known 
concentrations of each dye in SBF was prepared, and the absorbance of the sample was then 
measured using UV spectrophotometer. Calibration curves of erythrosin B and pyronin B were 
respectively prepared for the different known concentrations ranging 0.001-0.5 mg/ml (1-500 
ppm) and 0.001-0.35 mg/ml (1-350 ppm) dissolved in SBF (Fig. 3.8). All measurements were 
repeated in triplicate. 
 
Figure 3.5: UV spectra of SBF media with different known concentrations of erythrosin B 
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3.9.2.2 Reichardt’s Dye  
Wavelength 308 nm was selected as a reference for Reichardt’s as it absorbs signal only at this 
wavelength. Different samples with known concentrations of this dye were dissolved in 80:20 
SBF:ethanol (v/v) and the absorbance of each sample was measured with UV spectroscopy. 
The calibration curve was then prepared for the different known concentrations ranging 0.001-
0.05 mg/ml (1-50 ppm) (Fig. 3.8). Since, Reichardt’s is a hydrophobic material with no water 
solubility, ethanol in minimum volume was added to the SBF release medium for release rate 
studies. UV spectra of Reichardt’s dye are shown in Figure 3.7. All measurements were 
repeated in triplicate. 
 
Figure 3.7: UV spectra of SBF:ethanol (80:20 v/v) media with different known concentrations 
of Reichardt’s dye 
The linear relationship between the concentration of each dye and the absorbance is shown in 
Figure 3.8. The correlation coefficient (R2) of each dye, which is related to either experimental 
or calculation errors, and the equation between the concentration of the dye and the absorbance 
were also determined from this graph.                                                                                                           Chapter 3: Experimental Details 
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Figure  3.8:  Linear  relation  between  concentration  of  each  dye  and  their  absorbance  at 
wavelength: 308 nm for Reichardt’s, 348 nm for pyronin B and 351 nm for erythrosin B 
3.9.2.3 Sample Preparation for Release Studies 
In vitro release studies were carried out on all the samples collected from both the modified 
single needle and the modified co-axial needle EHD/TIPS processes. For erythrosin B and 
Pyronin B release studies, 0.1 g of the microspheres with dye encapsulated after freeze drying 
were collected in glass vials and then 10 ml of SBF was added. For Reichardt’s release profile, 
0.05 g of the fabricated microspheres were prepared in a glass vial with addition of 50 ml 
SBF:ethanol (80:20 v/v). 
The release studies for each dye were carried out on at five different conditions including: 
ambient condition (22 ± 2oC), physiological temperature (37 ± 1oC), physiological temperature 
with fresh SBF and physiological temperature with sonication at 20 kHz for 30 s and also 40 
kHz for 20 s. In total 5 batches of the loaded microspheres for the release studies of each dye 
were  prepared  in  the  explained  media  for  the  five  different  conditions.  This  part  of  the 
investigation using  various  external  stimuli, such as  sonication exposure and temperature 
variations, was to determine their effects on the release rate of the dyes from the microspheres. 
The main purpose was to obtain more suitable release rate of the incorporated agents. At 
discrete time intervals, 2 ml of each sample was extracted to measure the absorbance of the 
entrapped dye using the UV spectrophotometer and subsequently returned to the same vial after 
measurement. The in vitro release studies were conducted up to the time when the release had 
plateaued. In order to eliminate contamination and excessive unwanted PLGA in the measuring                                                                                                          Chapter 3: Experimental Details 
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solution, a 0.5 µm cellulose acetate membrane was adopted to filter the solution before each 
UV measurement was taken. For the samples in physiological temperature with fresh media, 2 
ml of the solution extracted from each sample was replaced with a 2 ml new release media after 
each  UV  measurement.  The  amount  of  dye  released  in  each  media  from  the  pack  of 
microspheres was determined by interpolation of absorbance value from the calibration curve 
(Fig. 3.8). This study was performed for both the modified single needle and the modified co-
axial needle EHD/TIPS methods in triplicate for each dye and the average values and standard 
deviations were calculated. 
In  order  to  normalize  the  results  for  the  control  at  all  time,  8  batches  of  only  PLGA 
microspheres with no dye loaded were prepared. 2 of them were used for normalization of the 
samples at ambient temperature, whereas the other 6 were for normalization of the samples 
kept in the incubator at physiological temperature. 2 of them were used for the normalization 
of the samples replaced with fresh media by having 2 ml of them substituted with a new fresh 
media every time when measuring the relevant samples, whereas the other 2 was used for 
normalization of the samples in physiological temperature without the fresh SBF replacement. 
The last 2 control samples were adopted for normalization of the samples in physiological 
temperature with the application of sonication at different frequencies. Throughout the process 
of  dye  release  studies,  the  controlled  samples  were  also  measured  accordingly  at  pre-
determined time intervals by UV spectrophotometer. 
3.9.2.4 Dye Entrapment 
To  determine  the  concentration  of  pyronin  B  and  erythrosin  B  entrapped  in  packs  of 
microspheres, 0.1 g of the products after freeze drying was added to glass vial which was first 
filled with 5 ml DMC to dissolve the polymeric microspheres and release the dye, and then 
addition of 5 ml SBF to dissolve the dye. For determination of Reichardt’s dye concentration, 
0.05 g of the relevant microspheres was added to a solution containing 5 ml DMC and 45 ml 
SBF:ethanol (80:20 v/v). The solutions were stirred for 120 s and then 2 ml from the vials was 
filtered with 0.5 µm cellulose acetate membrane before the UV measurements. According to 
the absorbance measured with UV spectroscopy for each sample, the dye entrapment efficiency 
was then calculated based on the yield of the process. In fact, the entrapment efficiency is the 
ratio between the weight of the agent incorporated into the microspheres and that which was 
used in the electrosprayed solutions (Equation 3.9).                                                                                                           Chapter 3: Experimental Details 
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Based on the assumption that the solvent is all evaporated during the freeze drying process, the 
percentage yield of the process can be determined by measuring the weight of the materials 
collected in the metallic beaker (Equation 3.8). The dye entrapment efficiency, the dye loading 
percentage and the actual percentage of dye loaded in the process were calculated using the 
following equations: 
Yield (%) =[
Weight of the products after freeze drying
weight of of PLGA+weight of dye ] × 100                                            (3.8) 
Dye entrapment efficiency (%) = [
Weight of dye in the microspheres
Yield of the process ×weight of drug in the solution] × 100    (3.9) 
Dye loading (%) = [
Weight of dye in the microspheres
weight of the microspheres loaded with dye] × 100                               (3.10) 
Actual dye loaded in the process (%) = [
Weight of dye in the total microspheres
weight of dye in the electrosprayed solution ] × 100  (3.11) 
The actual percentage of dye loaded in the process (Equation 3.11) is the ratio between the 
weight of dye encapsulated in the total microspheres collected from each process and the 
weight of dye used in the electrosprayed solution. This equation is really important for mass 
production by the EHD/TIPS methods as it shows the capability of the process in preserving 
the amount of the dye encapsulated based on the collection of the total microspheres.  
3.10 Sonication Exposure Setup 
The effect of sonication on the release profile of the encapsulated materials was discussed in 
Section 2.12.2. This part of the investigation incorporating sonication was to determine the 
influence of different parameters such as duty cycle and exposure time on the release rate of 
the dyes from the microspheres. For this part of experimental work, a preliminary study was 
carried out on the release profile of PLGA particles fabricated via the modified single needle 
and co-axial needle EHD/TIPS processes. As explained in Section 3.9.2.3, two samples from 
each dye encapsulated in the produced microspheres were exposed to sonication using an 
ultrasonic cell disruptor (XL2000 Misonix Inc. Farmingdale, NY, USA; probe diameter 3mm) 
with operating frequencies of 20 kHz for 30 seconds and 40 kHz for 20 seconds. To avoid any 
damage or local heating to the dye loaded microspheres, they were gently poured into a water 
proof elastic latex tube which was relatively transparent to sonicator (Fatemi and Greenleaf, 
1998). The tube and the sonicator probe were immersed in a beaker contained water with an                                                                                                          Chapter 3: Experimental Details 
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estimated 40 mm distance between them. The probe was kept with an angle of approximately 
45o respect to the vertical line so that the microspheres were not directly in line with the probe 
axis and thus introduced to relatively small intensity of sonication1. Ultrasonic wavelengths 
with 20 kHz and 40 kHz were applied for 30 s and 20 s respectively, and the sample was 
returned to the vial for the UV spectroscopy measurements. As described e arlier, control 
measurements were also conducted to confirm that there was no change in the UV spectroscopy 
readings due to transfer of the microspheres between vial and the tube. 
 
Figure 3.9: Schematic diagram of the sonicator exposure to a prepared sample 
3.11 In Situ Deposition 
The in situ deposition study was carried out in conjunction with the discussion in Section 2.13.1 
to empirically investigate the ability of the prepared microspheres for transferring through the 
syringe needle and their formation into scaffold after injection. For this purpose, a pack of 
microspheres  with  0.3  g  weight  and  10  ml  SBF  were  prepared  (Fig.  3.10b).  For  this 
investigation, a piece of pig meat (150 mm, 50 mm and 12 mm) with the skin cover was also 
prepared and placed on a worktop (Fig. 3.10a). To find out how microspheres would form into 
scaffold within an infected tissue, an irregular-shaped cavity was created with 5 mm depth from 
the surface of the meat. Afterwards, 0.3 g of the microspheres was added to the 10 ml SBF and 
shaken for 60 s on the vortex machine to form a suspension. The suspended solution was then 
injected by a syringe and a needle through the cavity created in the meat (Figs. 3.10c, 3.10d 
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and 3.10e). After 600 s interval, waiting for the injected materials to dehydrate, the area around 
the cavity was sectioned with a surgical blade (Figs. 3.10f and 3.10g).  
 
Figure  3.10:  In-situ  deposition  protocol:  a)  Piece  of  meat,  b)  SBF  solution  and  the 
microspheres,  c)  Microspheres  suspended  in  SBF,  d)  Syringe  filled  with  SBF  and  the 
suspended microspheres, e) Injection process of the suspended solution, f) Dehydration of the 
injected materials and g) Incision by surgical blade 
As  shown  in  Figure  3.10g,  the  pack  of  free  flowing  microspheres  after  injection  and 
dehydration formed into a scaffold structure that deposited inside the created cavity within the 
tissue.                                                                                                     Chapter 4: Results and Discussion 
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Chapter 4 
Results and Discussion 
Overview 
This chapter of the thesis has two main parts: 1) the EHD mode mapping and size distribution 
studies, and 2) the in vitro release studies. In the first part of this chapter, the single needle 
EHD method was used to explore its ability for preparing polymeric drug spheres with different 
size ranges. The aim was to optimise the combination of several key processing parameters in 
order to achieve the stable cone-jet and subsequently producing spherical polymeric carriers 
with narrow size distribution. Then, according to the EHD mode mapping and size distribution 
studies, further experiments were conducted to investigate the capability of single needle EHD 
processing for fabricating the porous microspheres with the required size distribution (150-300 
µm) and assembly of them into scaffold by TIPS and freeze-dryer for the purpose of chronic 
wounds therapy. 
In the second part of this chapter, the results of process modifications and the improvements 
on the yield for obtaining more accurate entrapment efficiency of the incorporated materials 
were discussed. The morphological studies were also carried out investigating the differences 
between the loaded products of the single needle and the co-axial needle EHD/TIPS methods. 
Moreover, the results of in vitro release studies were investigated to show the capability of the 
loaded PLGA microspheres in providing controlled release of the active agents in a sustainable 
dosage over the release period. The advanced treatment of chronic wound requires the porous 
surface microspheres with great ability of delivering their payload with a high initial burst 
release followed by a sustained period. Therefore, in the in vitro release studies, the effects of 
different temperatures, addition of fresh media and sonication exposure upon the dye release 
were investigated, aiming to modify the release rate of the incorporated materials by external 
stimuli for an optimum control release. Finally, it was attempted to predict the release profile 
of immunosuppressive agents such as cyclosporine A and Tacrolimus based on the in vitro 
release profiles of the dyes adopted. In this second part of this chapter, the results of further 
investigations such as FTIR and EDX studies were also discussed in order to provide more 
information on the presence of the encapsulated dyes in the produced microspheres and the 
effect of the procedures on the biofunctionality of the processing materials.                                                                                                      Chapter 4: Results and Discussion 
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4.1 EHD Mode Mapping and Size Distribution Studies for Controlling the Size of Spheres 
via Systematic Processing Parameter Variations 
One of the most important characteristics of drug delivery systems is, selecting the appropriate 
size of the constituent particles (Panyam and Labhasetwar, 2003). This factor has a substantial 
influence  on  different  in  vivo  functions  of  drug  carriers  such  as  circulation  time, 
immunogenicity,  internalization,  extravasation,  targeting,  intercellular  trafficking  and 
degradation as well as flow properties, clearance and uptake mechanisms (Mitragotri and 
Lahann, 2009). For example, particles with micrometre size are important in passive drug 
targeting such as in pulmonary drug delivery and chronic wound therapy, whereas nano-sized 
particles have the ability to penetrate small capillaries, allowing enhanced accumulation of 
nano-particles at target sites (Lanza et al., 2002). 
4.1.1 Characteristics of PCL and PLGA Solutions with Various Concentrations 
The EHD process by which the spherical particles are generated is governed by the physical 
properties of solutions such as surface tension, viscosity, density and electrical conductivity as 
well  as  the  processing  parameters  (the  flow  rate  and  the  applied  voltage).  Different 
combinations of these variables lead to generation of various jetting modes (Cloupeau and 
Prunet-Foch, 1990). Therefore, to reach the ideal jetting mode for production of the required 
microspheres, the first step was to characterise the properties of the solutions adopted in this 
investigation (Table 4.1). 
Increasing the polymer concentration of the solutions enhances the surface tension, density and 
viscosity, but decreases the electrical conductivity (Table 4.1). These changes in the solution 
properties due to changes in the polymer concentration lead to different EHD jetting modes, 
and hence the ranges of flow rate and the applied voltage to achieve the stable cone-jets change 
for each polymer solution. 
An increase in the polymer concentration of the solution which was corresponded to an increase 
in the viscosity and the surface tension (Table 4.1) meant that a stronger electrostatic force (the 
applied  voltage)  was  required  to  form  a  cone-jet  for  a  solution  of  a  higher  polymer 
concentration. For example, PLGA/DMF and PLGA/DMAc solutions had higher viscosity and 
surface tension compared with PCL/toluene and PLGA/DMC solutions. Thus, higher applied 
voltages  were  found  to  be  necessary  to  obtain  the  cone-jet  during  the  EHD  processing. 
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conductivity and dielectric constant of the toluene, a much higher applied voltage was required 
to facilitate the stable cone-jet formation for generating spherical particles (Fig. 4.3). 
Table 4.1: Properties of the polymer solutions adopted in the microspheres formation 
Solution  Viscosity  
(mPa s) 
Surface Tension  
 (mN m-1) 
Conductivity 
(µS m-1) 
pH  Density 
(kg m-3) 
5% PLGA in 
DMAc 
4.5 ± 0.2  37.5 ± 0.9  2.8 ± 0.3  7.5  950 ± 10 
10% PLGA in 
DMAc 
6.1 ± 0.3   39.1 ± 0.7  1.5 ± 0.3  7.5  960 ± 10 
20% PLGA in 
DMAc 
12.9 ± 0.5  54.17 ± 1.2  0.90 ± 0.2  7.5  1000 ± 10 
5% PLGA in 
DMF 
4.0 ± 0.2  36.9 ± 0.7  2.5 ± 0.3  7.5  960 ± 10 
10% PLGA in 
DMF 
4.15 ± 0.3  40.9 ± 1.0  1.3 ± 0.2  7.5  980 ± 10 
20% PLGA in 
DMF 
11.5 ± 0.5  49.1 ± 0.8  1.0 ± 0.2  7.5  1050 ± 10 
5% PLGA in   
DMC 
3.7 ± 0.3  28.5 ± 0.5  0.20 ± 0.1  6.5  1100 ± 10 
10% PLGA in 
DMC 
4.18 ± 0.5  32.8 ± 0.6  0.10 ± 0.1  6.5  1110 ± 10 
15% PLGA in 
DMC 
12 ± 0.3  34.4 ± 0.9  0.10 ± 0.1  6.5  1110 ± 10 
5% PCL45000 in 
toluene 
3.0 ± 0.4  26.5 ± 0.6  -2  7.0  900 ± 10 
7% PCL45000 in 
toluene 
6.7 ± 0.4  28.0 ± 0.6  -  7.0  1000 ± 10 
10% PCL45000 
in toluene 
11 ± 0.6  29.5 ± 0.7  -  7.0  1100 ± 10 
15% PCL10000 
in toluene 
6.0 ± 0.5  28.4 ± 0.5  -  7.0  900 ± 10 
                                                           
2 Electrical conductivity of the PCL solutions were out of the measurement range of the conductivity meter. 
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Solution  Viscosity  
(mPa s) 
Surface Tension  
 (mN m-1) 
Conductivity 
(µS m-1) 
pH  Density 
(kg m-3) 
20% PCL10000 
in toluene 
16 ± 0.7  29.6 ± 0.8  -  7.0  940 ± 10 
25% PCL10000 
in toluene 
25 ± 0.8  32.8 ± 0.6   -  7.0  960 ± 10 
Solution  Viscosity 
(mPa s) 
Surface 
Tension 
(mN m-1) 
Conductivity 
(µS m-1) 
pH  Density 
(kg m-3) 
Dielectric 
Constant 
DMF  1.0 ± 0.2  37.1 ± 0.8  4 ± 0.3  7.5  944 ± 10  37.8 
(Smallwood, 
1996) 
DMAc  2.1 ± 0.3  36.1 ± 0.6  4.6 ± 0.3  6.0  940 ± 10  36.7 
(Smallwood, 
1996) 
DMC  0.60 ± 0.2  30.7 ± 0.4  0.20 ± 0.1  6.0  1070 ± 10  3.1 (Tundo and 
Selva, 2002)  
Toluene  0.60 ± 0.1  28.5 ± 0.5  8.0x10-8  (Luo et 
al., 2012) 
7.0  867 ± 10  2.38 
(Smallwood, 
1996) 
 
Unlike the electrical conductivity that directly influences the EHD cone-jet mode, dielectric 
constant (relative permittivity) is a parameter that has very less effect on the cone-jet formation; 
however, it has a direct influence on the size distribution of particles. Experimentally, it has 
been demonstrated that the liquids with greater value of dielectric constant produce relatively 
small size of particles under cone-jet mode compared with those obtained lower value of 
dielectric constant (Luo et al., 2012).  
4.1.2 Classifications of EHD Jetting Modes of the Polymer Solutions 
Geometrical features of the jet and the various types encountered in this study as a function of 
the operating parameters for the generation of the spherical particles have been classified in 
Figure 4.1. According to Jaworek & Krupa, they include dripping, unstable cone-jet, stable 
cone-jet, multi-jet and irregular instabilities modes (Jaworek and Krupa, 1999b).                                                                                                      Chapter 4: Results and Discussion 
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In the EHD technique, the cone-jet is the most stable and used atomization mode, as it generates 
a nearly uniform and near monodisperse spherical particles. In this study, dripping mode 
occurred when there was no voltage applied or either the applied voltage was not high enough 
to break the surface tension of the solution. In this mode, the drops form the shape of regular 
droplet detaching from the needle capillary as the gravitational force overcomes the surface 
tension (Fig. 4.1b). An increase in the applied voltage led to either unstable or the stable cone-
jet mode. This rise in the voltage stabilised and shaped the cone-jet which results in a balance 
of liquid pressure, liquid surface tension, gravity, electric stresses at the liquid surface, the 
liquid inertia and the liquid viscosity (Hartman et al., 2000). When a balance between all these 
applied forces occurred, stable cone-jet was obtained (Fig. 4.1d); otherwise unstable cone-jet 
was generated (Fig. 4.1c). 
 
Figure 4.1: Geometrical  features  of different  jet  modes:  a) No dripping,  b) Dripping, c) 
Unstable cone-jet, d) Stable cone-jet, e) Multi-jet and f) Irregular instabilities 
Further increase of the applied voltage caused multi-jet mode to evolve. This mode of jet 
occurred at applied voltage well above the range of applied voltage obtained for the stable 
cone-jet (Fig. 4.1e). Irregular instabilities mode which is another possible form of EHD jetting, 
encountered when intermittent droplet formation occurs (Fig. 4.1f). 
4.1.3 Effect of Flow Rate and Applied Voltage on the Size Distribution 
In this section, the effect of applied voltage and flow rate on the size and size distribution of 
spherical particles was studied. These two variables (flow rate and applied voltage) along with                                                                                                      Chapter 4: Results and Discussion 
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different concentrations of polymer solutions were the significant parameters in determining 
the size distribution of the spherical particles collected at the stable cone-jet mode. The size of 
the  spherical  particles  was  increased  by  enhancement  of  the  flow  rates  and  polymeric 
concentration of the solutions (Figs. 4.2-4.6). This phenomenon occurred for all the polymer 
solutions with various concentrations. However, increase in the applied voltage led to reduction 
in size of particles collected at the stable cone-jet. Since, all the particles were tried to be 
collected at the stable con-jet mode, voltage was applied in a range to keep the cone-jet mode 
stable for the period of collection. However, sometimes due to the physical properties of the 
solutions and their interactions with the applied electric field, the cone-jet mode could not be 
very stable at varying flow rates (Fig. 4.3).   
4.1.3.1 Parametric Mode Mapping of PCL Solutions 
Different concentrations of the PCL solutions dissolved in toluene were electrosprayed at 
different flow rates and the ranges of applied voltage, and the size distribution of the spherical 
particles produced were plotted against these two variables. Figure 4.2 shows the results 
acquired from the electrospray of PCL10,000 solutions, whereas Figure 4.3 is related to the 
findings collected from different concentrations of PCL45,000 solutions. 
The solution with 15 wt% concentration of PCL10,000 dissolved in toluene provided a range 
of particle size varied from 100 µm up to 380 µm (Fig. 4.2a) depending on the flow rates and 
the range of applied voltage, whereas this range (size distribution of particles) with 20 wt% 
concentration of PCL10,000 were broadened changing from 200-600 µm (Fig. 4.2b). By 
increasing the concentration of this PCL type to 25 wt%, the particle size distribution extended 
slightly wider between 180-600 µm (Fig. 4.2c). This shows the direct effect of polymeric 
concentration and the flow rate on the size and size distribution of the spherical particles. 
Electrospray of PCL10,000 solutions with 20 and 25 wt% concentrations in general provided 
narrower  size  distribution  of  particles  at  each  flow  rate  compared  with  the  15  wt% 
concentration. This was attributed to the higher viscosity of the more concentrated polymer 
solutions (Table 4.1) that provided more charges on the surface to break the surface tension 
upon the application of voltage. Therefore, it led to more stability of the cone-jet mode in 
production of the spherical particles.                                                                                                       Chapter 4: Results and Discussion 
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Figure 4.2: Parametric mode mapping of particles obtained from PCL10,000/toluene solution: 
a) 15 wt% concentration, (b) 20 wt% concentration and (c) 25 wt% concentration                                                                                                       Chapter 4: Results and Discussion 
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Figure 4.3: Parametric mode mapping of particles obtained from PCL45,000/toluene solution: 
(a) 5 wt% concentration, (b) 7 wt% concentration and (c) 10 wt% concentration                                                                                                       Chapter 4: Results and Discussion 
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The solution with 5 wt% concentration of PCL45,000 in toluene provided a range of particle 
size varied from 20 µm up to 150 µm (Fig. 4.3a), depending on varying flow rates and the 
ranges of applied voltage. With this concentration, the size distribution of particles increased 
as the flow rate increased. The size range of particles with 7 wt% concentration of PCL45000 
was broadened varying between 30 and 300 µm (Fig. 4.3b), and by increasing the concentration 
of this polymer to 10 wt%, the size distribution increased further ranging from 40 to 500 µm 
(Fig. 4.3c). As Figure 4.3c show, the 10 wt% of PCL45,000 solution could not provide stable 
cone-jet at low flow rates (less than 30 µl/min) compared with other two PCL 45,000 solutions. 
This was related to the very low electrical conductivity of this polymer solution (10 wt%) that 
could not provide enough charges on the liquid surface for formation of stable cone-jet mode. 
Therefore, it resulted in large size distribution of particles at low flow rates.  
In general, toluene is a low viscous, highly volatile and almost non-conductive solvent (ʵ = 
2.38 at 20C; ˃ = 8.0 x 10-8 µS m-1 at 20C) (Smallwood, 1996), and the combination of this 
solvent with a polymer such as PCL provided the solutions with very low conductivity that do 
not have enough capability to interact with an electric field. Therefore, high applied voltage 
was found to be necessary to achieve the stable cone-jet at different flow rates. Due to the very 
low electrical conductivity, the polymer solutions at low flow rates had difficulty to provide 
the stable cone-jet, but as the flow rate increased, the range of voltage was also elevated in 
order to compensate the low conductivity of the polymer solutions for obtaining the stable 
cone-jet for collection of the spherical particles. 
4.1.3.2 Parametric Mode Mapping of PLGA Solutions  
The findings from the electrospray of different concentrations (5, 10 and 20 wt%) of PLGA 
solutions dissolved in the two highly conductive solvents (DMF and DMAc) at different flow 
rates and the ranges of applied voltage are provided in Figure 4.4. As it shows, the size 
distribution of the spherical particles was significantly effected based on the variations of these 
two processing parameters. 
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Figure 4.4: Parametric mode mapping of particles obtained from (a) 5 wt% concentration of 
PLGA in DMAc and DMF (b) 10 wt% concentration of PLGA in DMAc and DMF and (c) 15 
wt% concentration of PLGA in DMAc and DMF                                                                                                      Chapter 4: Results and Discussion 
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PLGA Solutions with 5 wt% concentration in DMF and DMAc provided particles with size 
distribution varying from 0.3 µm up to 10 µm (Fig. 4.4a) depending on different flow rates. 
By increasing the concentration of these two polymer solutions to 10 wt%, the particle size 
distribution increased between 0.3-40 µm (Fig. 4.4b). This range of particle size was extended 
wider up to 120 µm by enhancing the concentration of the two polymer solutions to 20 wt% 
(Fig. 4.4c). The wider range in the size distribution of particles with higher flow rates as well 
as higher concentration of the polymer solution is attributed to the high values of dielectric 
constant, conductivity, surface tension (Table 4.1) and the applied voltage that provided less 
stability of the cone-jet mode in production of the spherical particles. 
In general, the two solvents of DMF (˃ = 4.0 µS m-1; ʵ = 37.8 at 20C) and DMAc (˃ = 4.6  µS 
m-1; ʵ = 36.7 at 20C) (Smallwood, 1996) are highly conductive with low volatility rate, and 
their combinations with PLGA co-polymer provided solutions with great ability to interact with 
the applied electric field. Therefore, these types of solutions required lower applied voltage to 
break the surface tension of the liquid solution for production of microspheres compared with 
the PCL solutions. However, due to high surface tension, high conductivity and high dielectric 
constant of the polymer solutions, they had difficulty to provide the stable cone-jet at high flow 
rates. Therefore, PLGA in DMF and DMAc generated small particles with a broad range of 
particle size. For the same reason (high conductivity and dielectric constant of the polymer 
solutions) no samples could be collected at flow rates above 100 µl/min and 120 µl/min, 
respectively, for 5wt% and 10 wt% concentrations of the polymer solutions. Since, the higher 
concentration of polymer led to reduction of electrical conductivity, the cone-jet was obtained 
with 20 wt% concentration of the two solutions (PLGA/DMAc and PLGA/DMF) at higher 
flow rates for production of particles, but still was not stable enough to produce monodisperse 
particles. 
Different concentrations (5, 10 and 15 wt%) of PLGA co-polymer dissolved in DMC were 
electrosprayed at different flow rates and the size distribution of the produced particles were 
arranged in Figure 4.5. At various flow rates, distinct ranges of voltage were applied in order 
to obtain the stable cone-jet, and hence various ranges of particle size were collected.  
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Figure 4.5: Parametric mode mapping of particles obtained from PLGA/DMC solutions: (a) 5 
wt% concentration, (b) 10 wt% concentration and (c) 15 wt% concentration                                                                                                       Chapter 4: Results and Discussion 
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PLGA solution with 5 wt% concentration in DMC provided a range of particles size varying 
from 100 µm up to 320 µm (Fig. 4.5a) depending on different flow rates and the ranges of 
applied  voltage.  By  increasing  the  concentration  of  PLGA  solution  to  10  wt%,  the  size 
distribution of spherical particles varied between 80-370 µm (Fig. 4.5b). This range with 15 
wt% concentration of PLGA was broadened, changing from 100-450 µm (Fig. 4.5c). As the 
three graphs in Figure 4.5 demonstrate, by increasing the concentration of polymer and the 
flow rate, the range of particle size also enhances. This increase in the size distribution is due 
to the reduced ability of the higher concentrations of polymer at higher flow rates for obtaining 
the stable cone-jet in production of near monodisperse microspheres. 
In general, DMC is a solvent with relatively low viscosity, low dielectric constant and moderate 
electrical conductivity (˃ = 2 x 10-5 Sm-1; ʵ = 3.1) (Tundo and Selva, 2002), and its combination 
with PLGA provided solutions which have less ability to interact with the applied electric field 
(potential). Therefore, electrospray of this solution at various flow rates was found to have less 
applied voltage compared with the other polymer solutions adopted in this study. This was 
attributed  to  the  inherent  physical  properties  of  the  solvent  such  moderate  electrical 
conductivity and surface tension  under ambient  temperature. The unique property of this 
solvent led to better stability of the cone-jet throughout different flow rates with various 
concentrations  of  the  polymer  solution  compared  with  the  other  PLGA  solutions 
(PLGA/DMAc and PLGA/DMF) in this study. 
4.1.4 Polydispersity Index 
Polydispersity index (ratio of standard deviation to mean size) (PDI) is another factor to assess 
the EHD cone-jet mode and the size distribution of particles. Since, the collection of particles 
in this study is carried out at the stable cone-jet mode, values of PDI for each polymer solution 
with  different  concentrations  indicates  the  stability  of  the  cone-jet  mode  as  well  as  the 
monodispersity of the generated particles at various flow rates. PDI in terms of percentage is 
calculated by taking the standard deviation divided by the average mean value of the particles’ 
size and then multiply the total value by 100. PDI was calculated for each specific flow rate 
based on measuring the diameters of randomly 70 particles collected from electrospray of each 
processing sample. 
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4.1.4.1 Polydispersity of PCL Particles 
Figure 4.6 is plotted based on the graphs provided in Figures 4.2 and 4.3. This figure shows 
the polydispersity index of particles’ size obtained from electrospray of both PCL types in 
toluene. In general, PDI of PCL45,000 for all concentrations is greater compared with the 
values calculated for PCL10,000. This is attributed to the higher range of voltage applied to 
the PCL45,000 polymer solutions to compensate the relatively low electrical conductivity 
compared with the PCL10,000 for obtaining the stable cone-jet mode in production of the 
spherical particles. At flow rates above 35 µl/min, by increasing the concentration of polymer 
solution the PDI decreases. For example, the PDI of 5 wt% PCL45000 above this specific flow 
rate is approximately 45%, whereas by increasing the concentration of polymer to 10 wt%, this 
value drops to less than 40%. Also, the PDI of PCL10000 solution with low concentration (15 
wt%) is above 22%, and this value by enhancing the polymeric concentration to 25 wt%, drops 
to less than 16%. This decrease in the PDI with respect to the higher concentration of polymer 
is attributed to the changes in the physical properties of the solution and also the lower value 
of the applied voltage that provided more stability of the cone-jet in production of the spherical 
particles. 
 
Figure 4.6:  PDI of Particles’  size obtained from PCL10000 and PCL45000 dissolved in 
toluene 
4.1.4.2 Polydispersity of PLGA Particles 
Figure 4.7, which is related to the results provided on the three graphs in Figure 4.4, shows 
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electrosprayed at different flow rates. In all concentrations of these two polymer solutions, the 
PDI  increases  with  respect  to  enhancement  of  the  flow  rates.  This  phenomenon  is  more 
noticeable by comparing the low concentrations (5 wt% and 10 wt%) of solutions with the 
highest one (20 wt%). This figure also states that by decreasing the polymeric concentration, 
more monodisperse particles were obtained. However, the polydispersity of the particle size at 
low concentrations is still incredibly high to generate near monodisperse particles as drug 
carriers. The high values of polydispersity show the instability of the cone-jet for production 
of particles due to high conductivity and dielectric constant as well as high surface tension of 
the polymer solutions. 
 
Figure 4.7: PDI of particles’ size obtained from PLGA dissolved in DMF and DMAc 
Figure 4.8 shows the polydispersity of particles’ size of PLGA solutions in DMC which is 
arranged based on the results illustrated on the three graphs in Figure 4.5. This graph shows 
that the PDI of PLGA/DMC with 10 wt% concentration never exceeded 40%. However, this 
value for the two other concentrations, 5 wt% and 15 wt%, of the polymer solution drops to 
less than 33% and 30% respectively. This graph also demonstrates an increase trend of PDI 
values as  the flow rate  increased which in  turn indicates less stability  of the cone-jet in 
production of near monodisperse particles. PDI of the polymer solutions also shows that the 
combination of PLGA/DMC provided more stable cone-jet compared with the two other PLGA 
polymer solutions for production of spherical particles with the required size (150-300 µm). 
However,  this  combination  (PLGA/DMC)  provided  poorer  stability  of  cone-jet  mode 
compared with the PCL10,000 solutions dissolved in toluene.                                                                                                      Chapter 4: Results and Discussion 
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  Figure 4.8: PDI of Particles’ size obtained from PLGA dissolved in DMC 
4.2 Optical Microscopy Analysis 
Figure 4.9 shows an overview of typical microspheres generated from EHD processing of 
various  polymer  solutions.  The  three  images  in  Figures  4.9a(i),  4.9a(ii)  and  4.9a(iii) 
demonstrate  the  small-sized  microspheres  obtained  from  the  electrospray  of  different 
concentrations  of  PLGA  solutions  in  DMAc  and  DMF.  Detailed  analysis  using  higher 
magnification (Fig. 4.9a(iii)) showed that all particles were spherical with a smooth outer 
surface and were small compared with those obtained from electrospray of the other polymer 
solutions in this study. The other three images in Figures 4.9b(i), 4.9b(ii) and 4.9b(iii) illustrate 
the relatively large size distribution of microspheres collected from the electrospray of both 
PCL types in toluene. Optical microscopy analysis using higher magnification (Figs. 4.9b(ii) 
and 4.9c(iii)) shows the porosity on the outer surface of particles, owing to quick evaporation 
of the solvent. Finally, Figures 4.9c(i), 4.9c(ii) and 4.9c(iii) demonstrate the microspheres 
collected from electrospraying of PLGA in DMC. Further analysis of these samples at higher 
magnification shows spherical particles with smooth outer surface structure (Fig. 4.9c(iii)). 
Placing the microspheres on the glass slides results in loss of their spherical shape, and the 
products appears concave (flattened) under optical microscope. This is because the polymer 
particles are not fully solidified as the melting point of the water is well above to that of the 
solvents used in this study. Therefore, the diameters recorded show a 10-15% higher value 
(depending on the viscosity of the polymer solution) compared with the actual diameter of the 
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Different polymer solutions (PLGA and/or PCL, in different solvents) have different inherent 
physical properties, which required different ranges of applied voltage and flow rate in order 
to  obtain  the  stable  cone-jet  for  generation  of  microspheres.  Solutions  with  different 
concentrations will generate different size distributions regardless of the flow rate and applied 
voltage. In general, when flow rate was increased from 20 μl min-1 to  450 μl min-1 during the 
single nozzle EHD processing, the readiness of the liquid to form the cone-jet decreased and 
the microsphere diameter distribution broadened with increasing the flow rate for all polymer 
solutions at all the concentrations tested.  
 
Figure 4.9: Size distribution of a(i) 10 wt% PLGA in DMAc at 150 μl min-1 (magnified x5), 
a(ii) 20 wt% PLGA in DMF at 200 μl min-1 (magnified x5), a(iii) 20 wt% PLGA dissolved in 
DMAc at 150 μl min-1 (magnified x50), b(i) 5 wt% PCL45000 in toluene at 25 μl min-1 
(magnified x5), b(ii) 10 wt% PCL45000 in toluene at 30 μl min-1 (magnified x50), b(iii) 20 
wt% PCL10000 in toluene at 50 μl min-1 (magnified x50), c(i) 5 wt% PLGA in DMC at 150 μl 
min-1 (magnified x5), c(ii) 10 wt% PLGA in DMC at 250 μl min-1 (magnified x5) and c(iii) 10 
wt% PLGA in DMC at 300 μl min-1 (magnified x50)                                                                                                      Chapter 4: Results and Discussion 
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For each liquid in the process of single needle EHD, a critical flow rate was observed, above 
which, the liquid showed difficulty achieving stable cone-jets, or the cone-jets remained stable 
for  less  than  5  minutes,  and  intermittent  instability  occurred.  This  critical  flow  rate  was 
observed at 60 μl min-1 for 5 wt% PLGA in DMF and DMAc, 120 μl min-1 for 10 wt% and 15 
wt% PLGA in DMF and DMAc, at 40 μl min-1 for PCL in toluene, and 400 μl min-1 for PLGA 
in DMC. This is attributed to the solvent properties, in particular, the collective influence of 
conductivity and dielectric constant (Table 4.1). Electrical conductivity showed a stronger 
influence on the stable cone-jet formation than dielectric constant of the solvents; whereas 
dielectric constant showed a greater influence on the particle diameter distribution profile than 
the electrical conductivity of the solvent. 
4.3 Particulate Scaffold 
PLGA in DMF and DMAc: Although combination of PLGA with DMF and DMAc (high ˃, 
high ʵ) is widely acceptable for clinical use at low dosage (New Jersey department health senior 
services, 2011), the polymer solutions did not generate near monodisperse microspheres with 
the required size distribution (Fig. 4.4). Therefore, this combination was discarded further in 
the development of particulate scaffold structure and encapsulation of pharmaceuticals. Failure 
was attributed to high dielectric constant of the PLGA/DMAc and PLGA/DMF solutions in 
generating the desirable size distribution of microspheres. Besides, high electrical conductivity 
and surface tension of the polymer solutions did not lead to obtaining the stable cone-jet for 
producing near monodisperse spherical particles.  
PCL10,000 and PCL45,000 in toluene: Failure of PLGA in DMF and DMAc, led to using 
the combination of PCL and toluene. Although electrospray of PCL in toluene (low ˃, low ʵ) 
provided the desirable size distribution of microspheres with surface porosity for formation of 
particulate scaffold (Figs. 4.2 and 4.3), toluene has high toxicity which makes it unsuitable for 
clinical  use.  The  side  effects  include  symptoms  such  as  tiredness,  confusion,  weakness, 
memory loss, nausea, loss of appetite, and hearing and colour vision loss (Foxall, 2007). 
Besides,  PCL  has  low  rate  of  biodegradability  which  takes  longer  time  to  hydrolytically 
biodegrade inside the human body compared with PLGA co-polymer (Chen, 2010). Therefore, 
this  combination  was  not  investigated  further  for  development  of  particulate  scaffold  for 
clinical use in treatment of chronic wounds.                                                                                                      Chapter 4: Results and Discussion 
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PLGA in DMC: PLGA solution in DMC (moderate ˃, low ʵ), a low toxicity solvent (Tundo 
and  Selva,  2002),  produced  the  appropriate  size  of  microspheres  over  a  broad  range  of 
processing parameters for all of the concentrations tested (5, 10 and 15 wt%, Fig. 4.5). This 
combination apart from producing the appropriate size of spheres, it could also overcome the 
problems  of  toluene  toxicity  and  biodegradability  of  PCL  polymer.  The  required  size  of 
microspheres for the formation of particulate scaffold was fabricated using 15 wt% PLGA in 
DMC at flow rate of 225 μl min-1 and the applied voltage ranging 6.0-7.0 kV (Figs. 4.10 and 
4.11). Collection in liquid nitrogen followed by freeze drying generated the solid spherical 
particles (Figs. 4.10a and 4.11a) with surface porosity (Figs. 4.10c and 4.11c).  
 
Figure 4.10: Particulate scaffold: a) Free flowing scaffold structure, b) SEM image of the 
microsphere and c) Surface porosity                                                                                                      Chapter 4: Results and Discussion 
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Figure 4.11: Particulate scaffold: a) Non-free flowing (rigid) structure, b) Optical microscopy 
of a microsphere and c) SEM image of surface porosity 
Collection of microspheres from PLGA/DMC solutions with different concentrations in water 
provided smooth surface (Fig. 4.9c(iii)). However, as the two images in Figures 4.10c and 
4.11c present, collection in liquid nitrogen followed by freeze drying provided production of 
solid microspheres with porosity on the outer surface. Since, liquid nitrogen has very lower 
melting  point  (-210oC)  compared  to  that  of  DMC  (between  2-4oC),  this  is  attributed  to 
thermally induced liquid-liquid phase separation of the polymer solution upon quenching in 
liquid nitrogen and subsequent sublimation of the solvent via freeze drying of the sample.  
Chronic wounds such as fistulae induce irregular shaped cavities on the epidermis and dermis 
or the tissue all the way to the fascia. Therefore, free flowing scaffold would be more suitable 
to fill in these irregular cavities, having minimal invasion of the scaffold and also allowing cell 
migration for tissue regeneration. This porous type of microspheres in the form of free flowing 
scaffold structure would be further investigated for in vitro release studies.    
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4.4 Characterizations of the Polymer and Dye Solutions Used for Encapsulation  
The electrohydrodynamic process by which the microspheres are produced is controlled by the 
physical properties such as surface tension, viscosity, density and electrical conductivity of the 
solutions  as  well  as  the  processing  parameters  (flow  rate  and  applied  voltage).  Various 
combinations  of  these  parameters  enable  the  generation  of  various  EHD  jetting  modes 
(Cloupeau and Prunet-Foch, 1990). Therefore, the first step was to characterise the properties 
of the solutions used for fabricating the dye loaded microspheres.  
Table 4.2: Physical properties of the solutions adopted for encapsulation via the single needle 
and the co-axial needle EHD/TIPS processes 
Solution  Viscosity 
(mPa s) 
Surface 
Tension   
(mN m-1) 
Electrical 
Conductivity 
(µS m-1) 
pH  Density  
(kg m-3) 
DMC  0.60 ± 0.2  30.7 ± 0.5  0.20 ± 0.1  6  1070 ± 10 
17.5% PLGA in  
DMC 
14.5 ± 0.2  34.16 ± 0.9  0.10 ± 0.1  7  1130 ± 10 
DMC with  
Reichardt’s 
0.60 ± 0.4  30.7 ± 0.8  1 ± 0.2  6  1070 ± 10 
DMC with       
erythrosin B 
0.60 ± 0.3  30.7 ± 0.6  0.20 ± 0.1  6  1070 ± 10 
DMC with        
pyronin B 
0.60 ± 0.2  30.7 ± 0.5  0.6 ± 0.2  6  1070 ± 10 
17.5% PLGA in 
DMC mixed with 
Reichardt’s 
14.5 ± 0.2  34.16 ± 0.5  0.9 ± 0.2  6.5  1130 ± 10 
17.5% PLGA in 
DMC mixed with 
erythrosin B 
14.5 ± 0.5  34.16 ± 0.7  0.1 ± 0.1  7  1130 ± 10 
17.5% PLGA in 
DMC mixed with 
pyronin B 
14.5 ± 0.4  34.16 ± 0.8  0.5 ± 0.2  7  1130 ± 10 
 
Since, the main aim of this study was to produce microspheres with size distribution of 150-
300 µm, the polymer concentration for producing dye loaded carriers was increased from 15                                                                                                      Chapter 4: Results and Discussion 
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wt% to 17.5 wt% in the solutions adopted for both the single needle and the co-axial needle 
encapsulation processes. This change in the polymer concentration was mainly related to the 
environmental variations such as higher humidity and increased ambient temperature during 
the encapsulation process. 
Table 4.2 provides the characterization results of the polymer solution mixed with the different 
dyes. Since, only one polymer solution with same concentration (17.5 wt%) was adopted 
throughout the single needle EHD/TIPS experiments, the physical properties of the polymer 
solution such as viscosity, surface tension and density were similar; however due to use of 
different dyes, the electrical conductivity of the polymer solutions varied during the process 
depending on the used dye. Therefore, the applied voltage as one of the important factors for 
controlling the stable cone-jet mode was varied more during this set of experiments. This 
change in the applied voltage interfered with the size distribution of the collected microspheres. 
The ranges of applied voltage for electrospraying the polymer solutions with erythrosin B and 
pyronin B were 6.5-7 kV and 6.8-7.3 kV, respectively. However, this range for the polymer 
solution mixed with Reichardt’s dye was increased between 7.8 and 8.5 kV, due to the higher 
electrical conductivity of the liquid (Table 4.2).    
In the case of co-axial needle EHD/TIPS process, the physical properties of the liquid in the 
inner needle changed due to the use of solutions mixed with different dyes. Since, same 
concentrated polymer solution (17.5 wt%) was adopted for all the three dyes experiments, the 
changes in the inner needle had smaller influence on the fabrication of the microspheres with 
payload compared to that of the single needle experiments. Therefore, the range of applied 
voltage was reduced between 6.8 and 7.4 kV for all the three dyes in the co-axial needle 
encapsulation experiments. 
4.5 Fabrication of Loaded Microspheres by the Single Needle and the Co-axial Needle 
EHD/TIPS Processes 
The polymeric microspheres with surface porosity were produced based on the combination of 
EHD and TIPS process at ambient temperature (~20-25oC). This technique consists of two 
stages: EHD stage for the microsphere fabrication, and TIPS stage for producing surface 
porosity.  The  main  purpose  of  process  optimization  was  to  minimize  the  waste  of  the                                                                                                      Chapter 4: Results and Discussion 
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processing materials and enhance the total dye entrapment efficiency by collecting more loaded 
particles. 
In the EHD process, the stable cone-jet mode was adopted for fabrication of the required size 
range of loaded microspheres. In the case of the single needle process, since only one liquid is 
flowing through the needle, the stable cone-jet mode could be achieved by carefully selecting 
the applied voltage in a range to satisfy the electrical conductivity and the surface tension of 
the flowing liquid. However, in the case of co-axial needle, this jetting mode can be obtained 
for liquids satisfying the conditions  i  > o   where σ is the liquid-conductivity atmosphere 
surface tension ( i   refers  to conductivity of inner needle solution, whereas  o   refers to 
conductivity of outer needle liquid) (Ku and Kim, 2002). Therefore, the key parameters should 
be selected carefully in a range to satisfy the requirements for the electrical conductivity and 
surface tension of the inner liquid which is sometimes referred to as a driving medium (López-
Herrera et al., 2003). 
4.5.1 Morphology of the Loaded Microspheres Collected from both EHD/TIPS Processes 
The surface morphology of the fabricated microspheres was studied by SEM. Figure 4.12 
shows the SEM micrographs of the control microspheres with no load produced by the single 
needle EHD/TIPS process under different magnifications. These polymeric microspheres were 
used in the in vitro release studies as control for normalization of the loaded products obtained 
from the single needle and the co-axial needle methods. The SEM micrographs in Figures 4.13 
and 4.14 are respectively related to the products collected from the single needle and the co-
axial needle EHD/TIPS processes for erythrosin B encapsulation. Figures 4.15 (the single 
needle EHD/TIPS method) and 4.16 (the co-axial needle EHD/TIPS process) exhibits the SEM 
micrographs  of  the  fabricated  microspheres  loaded  with  pyronin  B  under  various 
magnifications. Finally, the SEM micrographs of the produced microspheres with Reichardt’s 
dye encapsulation are provided in Figures 4.17 and 4.18.                                                                                                        Chapter 4: Results and Discussion 
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Figure 4.12: Unloaded microspheres collected from the single needle EHD/TIPS process                                                                                                      Chapter 4: Results and Discussion 
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Figure 4.13: Microspheres loaded with erythrosin B collected from single needle EHD/TIPS 
process 
 
Figure 4.14: Microspheres loaded with erythrosin B collected from co-axial needle EHD/TIPS 
process                                                                                                      Chapter 4: Results and Discussion 
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Figure 4.15: Microspheres loaded with pyronin B collected from single needle EHD/TIPS 
process 
 
Figure 4.16: Microspheres loaded with pyronin B collected from co-axial needle EHD/TIPS 
process                                                                                                      Chapter 4: Results and Discussion 
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Figure 4.17: Microspheres loaded with Reichardt’s collected from single needle EHD/TIPS 
process 
 
Figure 4.18: Microspheres loaded with Reichardt’s collected from co-axial needle EHD/TIPS 
process                                                                                                      Chapter 4: Results and Discussion 
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The SEM micrographs showed that the surface porosity is generated on all the fabricated 
microspheres based on using the EHD/TIPS process. However, evidence shows that the co-
axial needle EHD/TIPS processing led to higher surface porosity of the products (Figs. 4.14c, 
4.14d, 4.16c, 4.16d, 4.18c and 4.18d) compared with those produced by the single needle 
process (Figs. 4.12d, 4.12e, 4.13c, 4.13d, 4.15c, 4.15d, 4.17c and 4.17d). Surface porosity in 
the microspheres are due to the solvent extraction during the lyophilisation. Since, dimethyl 
carbonate was used in both the inner needle (polymer solution) and the outer needle (dye 
encapsulation) for the co-axial needle experiments, more sublimation of the solvent occurred 
during lyophilisation and consequently resulted in higher surface porosity in the products 
collected from the co-axial needle compared to those obtained from the single needle method. 
The Small dimple shaped cavity on the surface (Fig. 4.12) which is observed in some of the 
fabricated  microspheres  is  related  to  the  detachment  point  of  particles  from  the  cone-jet 
followed by immediate solidification in liquid nitrogen. As the SEM micrographs show, the 
size, shape and dispersals of the surface porosity are not uniformly distributed over the surface 
area of the fabricated microspheres. This is most likely to be caused by differences in the local 
concentration of the polymer and the solvent. Therefore, more solvent extraction occurred from 
one region compared to the other during lyophilisation, and consequently led to heterogeneous 
surface porosity. 
The diameter of the dye loaded microspheres and also the control products produced by the 
single needle and the co-axial needle EHD/TIPS processes were measured from the SEM 
images using Image Pro-Insight software (Media Cybernetics, UK). 100 microspheres from 
each sample were measured, and then size distribution, mean size, standard deviation and also 
polydispersity were calculated. Table 4.3 demonstrates the details of these measurements. 
The overall size distribution of the products collected from the co-axial needle products are 
slightly larger compared to those obtained from the single needle EHD/TIPS process. The 
control microspheres and the two batches of erythrosin B loaded microspheres produced by the 
two different methods had almost similar size distribution (Table 4.3). This was related to the 
similar physical properties of the solutions and the processing parameters applied in fabricating 
the products. However, the pyronin B loaded microspheres collected from the single needle 
process have slightly smaller size distribution compared to the erythrosin B loaded products 
and their counterparts collected from the co-axial needle setup. The smaller diameter of the 
single needle products with pyronin B encapsulation was due to higher electrical conductivity                                                                                                      Chapter 4: Results and Discussion 
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of the solution and consequently higher application of voltage supply in fabricating the relevant 
particles during the EHD process.  
Table  4.3:  Size  characteristics  of  the  loaded  microspheres  prepared  by  the  two  different 
EHD/TIPS processes 
Sample  Single needle EHD/TIPS 
Number of 
particles studied 
Mean size 
(µm) 
Standard deviation 
(µm) 
Polydispersity 
(%) 
Unloaded PLGA 
microspheres 
100  180  25  15 
Erythrosin B 
encapsulated 
microspheres 
100  180  30  16 
Pyronin B 
encapsulated 
microspheres 
100  165  25  14 
Reichardt’s 
encapsulated 
microspheres 
100  100  30  29 
  Co-axial needle EHD/TIPS 
Erythrosin B 
encapsulated 
microspheres 
100  185  30  16 
Pyronin B 
encapsulated 
microspheres 
100  180  33  18 
Reichardt’s 
encapsulated 
microspheres 
100  175  30  17 
 
                                                                                                      Chapter 4: Results and Discussion 
115 
 
Finally, the Reichardt’s loaded PLGA microspheres obtained from the single needle setup had 
the smallest size distribution of the produced particles (100 ± 30 µm) among all the particles 
fabricated. This was surely related to the higher applied voltage in production of the relevant 
microspheres due to the higher electrical conductivity of the single needle solution mixed with 
this dye (Table 4.2). However, in the co-axial needle setup, since, the polymer and the dye 
solutions were flowing separately through different needles, the applied voltage for fabricating 
the products were lower compared to that of the single needle. Therefore, the co-axial needle 
products with Reichardt’s dye encapsulation were quite larger compared to their counterparts 
from the single needle method (Table 4.3). 
As the calculated polydispersity in Table 4.3 shows, the cone-jet mode for producing the 
microspheres loaded with erythrosin B and pyronin B was more stable compared to that of 
producing the Reichardt’s loaded microspheres with the single needle process. This was highly 
related to the higher application of voltage with the Reichardt’s dye-polymer solution, due to 
the  higher  electrical  conductivity  of  this  solution  compared  to  that  of  the  other  polymer 
solutions.  
Further analysis of the loaded PLGA microspheres was carried out using Hitachi SEM. This 
enabled the investigation of the internal structure of the products after freeze drying. Figure 
4.19 shows the internal structure of the porous surfaced- microspheres collected from the single 
needle method, whereas Figure 4.20 exhibits the internal structure of products produced by 
the co-axial needle setup.  
The  images  in  Figure  4.19  suggest  that  the  single  needle  EHD/TIPS  process  forms 
microspheres  with  internal  and  surface  porosity.  However,  the  internal  structure  of  the 
microspheres is denser with PLGA, therefore less porosity has occurred internally compared 
to the surface area. However, comparison with the images in Figure 4.20 shows that the co-
axial  needle  EHD/TIPS  process  has  fabricated  the  required  size  distribution  of  the 
microspheres with more surface and internal porosities compared to that of the single needle 
products. Figure 4.20 also demonstrates the internal cavities of the co-axial needle EHD/TIPS 
products which can be related to the phase separation of the payload from the polymer shell 
that occurred during the EHD processing before lyophilisation. 
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Figure 4.19: Cross-section studies of the single needle EHD/TIPS microspheres with: a) 
Erythrosin B entrapment, b) Pyronin B entrapment and c) Reichardt’s dye entrapment                                                                                                          Chapter 4: Results and Discussion 
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Figure 4.20: Cross-section studies of the co-axial needle EHD/TIPS microspheres with: a) 
Erythrosin B encapsulated, b) Pyronin B encapsulated and c) Reichardt’s dye encapsulated                                                                                                      Chapter 4: Results and Discussion 
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4.6 Energy-Dispersive X-Ray (EDX) Spectroscopy Studies 
EDX spectroscopy was an additional investigation for determining the presence of dyes in the 
fabricated microspheres. Since, SEM imaging did not show evidence of the dyes entrapped in 
the fabricated microspheres, EDX studies were carried out to examine the presence of the dye 
in the produced microspheres. This semi quantitative method was used to verify the element(s) 
of  the  dye  entrapped  in  the  microspheres.  The  samples  for  EDX  studies  were  randomly 
sectioned by a surgical blade before analysis for two main reasons; 1) the EDX spectroscopy 
did not detect the elements of the encapsulated materials on the surface, and 2) the X-rays could 
not pass through the particles shell due to the solid internal structure. The results obtained from 
the EDX studies were organised in Figure 4.21. This study was only carried out on the loaded 
microspheres obtained from the single needle process. 
EDX analysis of the microspheres with entrapped erythrosin B showed that this dye was 
presented in the sample as indicated by iodine (I) in the structure of this dye (Fig. 4.21a). 
Chlorine (Cl) (Fig. 4.21b) in the structure of pyronin B was identified by EDX, indicating the 
presence of this dye in the relevant sample. The presence of nitrogen (N), in the molecular 
structure of Reichardt’s dye was also detected by EDX, indicating the existence of this dye 
loaded in the PLGA TIPS microspheres (Fig. 4.21c).  
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Figure 4.21: EDX studies of the dyes encapsulated in microspheres produced by the single 
needle EHD/TIPS process: a) Erythrosin B: a(i) Peaks of the detected elements, a(ii) Image of 
the loaded microspheres, a(iii) Semi-quantitative results of the detected elements; b) Pyronin 
B: b(i) Peaks of the detected elements, b(ii) Image of the loaded microspheres, b(iii) Semi-
quantitative results of the detected elements; c) Reichardt’s: c(i) Peaks of the detected elements, 
c(ii) Image of the loaded microspheres and c(iii) Semi-quantitative results of the detected 
elements                                                                                                      Chapter 4: Results and Discussion 
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The EDX studies showed that the dyes were entrapped in the matrix of the microspheres, as it 
could not find the elements of the dyes on the surface of the loaded microspheres. The results 
from the combination of EDX and SEM studies also indicates that the dyes were entrapped in 
the matrix of the polymer microspheres produced by the single needle rather than the phase 
separation of drug encapsulation. The potential advantage of the matrix encapsulation over the 
phase separation of drug encapsulation which was observed in the co-axial needle products 
(Fig. 4.20) is to have a more controlled release of the encapsulated agent over a longer period 
of time (Figs. 4.25-4.27).  
4.7 Fourier Transform Infrared (FTIR) Studies  
Since SEM studies could not provide any evidence to demonstrate the dyes incorporated into 
the generated microspheres and the EDX studies were only carried out on the single needle 
products, FTIR was conducted on the products obtained from both the single needle and the 
co-axial needle EHD/TIPS methods in order to investigate the structural characteristics of the 
polymeric carriers and the dyes. FTIR spectra were recorded of the individual components 
followed by the PLGA microspheres with the dye to confirm the entrapment of the active agent.  
Figure 4.22 shows a comparison of the FTIR spectra of PLGA, erythrosin B and erythrosin B-
PLGA microspheres obtained from both the single needle and the co-axial needle EHD/TIPS 
methods. The chemical structure of PLGA and erythrosin B are also shown in Figures 4.22a 
and  4.22b.  The  spectral  features  that  distinguish  the  dye  from  PLGA  is  the  presence  of 
aromaticity in erythrosin B, whilst PLGA is aliphatic in nature with the presence of a carbonyl 
ester group. As expected, the typical bands for the ester carbonyl stretching (C=O) at 1750, 
1423 (C-C stretch), 1390 (C-H stretch), C-O stretch at 1270 and 1087 cm-1 (C-O-C) group were 
observed in the FTIR spectra of PLGA. The characteristic peak due to the deformation modes 
of the substituted benzene ring appear at 962 cm-1 in the spectrum of erythrosin B. The aromatic 
ring substitution sensitive modes appear in the 1000-1350 cm-1 with prominent benzene ring 
C-C stretching vibrations in the 1440-1544 cm-1 regions. The comparison of spectra in Figure 
4.22c also clearly indicate that the PLGA microspheres obtained by either the co-axial needle 
or the single needle process contained erythrosin B and as there were no large shifts in the 
majority of the characteristic peaks of PLGA, indicated that there was no chemical interaction 
between erythrosin B and the polymer. 
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Figure 4.22: a) Structure of PLGA, b) Structure of erythrosin B and c) The FTIR spectra of 
erythrosin B and the PLGA samples contained this dye 
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The chemical structure of pyronin B along with the FTIR spectra of the samples obtained from 
encapsulation of this dye by the single needle and the co-axial needle EHD/TIPS methods are 
presented in Figure 4.23. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.23: a) Structure of pyronin B and b) The FTIR spectra of pyronin B and the PLGA 
samples contained this dye 
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Pyronin B is a water soluble dye and the chemical structure is shown in Figure 4.23a which 
indicates that the stretching frequencies of its aromatic functional group can be used to detect 
its presence. Although, there are overlapping peaks in the region 1100-1200 cm-1 and the 
intensity of the peaks of the PLGA masks the low intensity peaks arising due to the presence 
of the shoulder appearing at 1609 cm-1 in the PLGA containing pyronin B, the presence of the 
dye in the loaded microspheres can be confirmed. The strong absorption peak due to carbonyl 
group is present in all the dye loaded PLGA particles and there is no observable shift, indicating 
no intermolecular interaction between the dye and the polymer. The stretching bands due to C-
N are clearly strong in the PLGA containing the dye which further affirms the loading of this 
active agent in the microspheres (Fig. 4.23b).  
Finally, a comparison of the spectra of Reichardt’s, PLGA and Reichardt’s dye encapsulated 
PLGA microspheres is illustrated in Figure 4.24. The structure of Reichardt’s (Fig. 4.24a) 
shows that the dye is aromatic in nature and the conjugated C=N stretching vibration can be 
used to identify the presence of the dye within the loaded microspheres. The two peaks arising 
at 2988 and 2901 cm-1 are associated with aromatic C=N stretching, which is clearly observed 
in the loaded PLGA microspheres with the dye obtained by the two different  EHD/TIPS 
processes (Fig. 4.24b). 
According to the evidence provided by the FTIR spectra of the samples (Figs. 4.22c, 4.23b and 
4.24b), the single needle and the co-axial needle EHD/TIPS processes could successfully 
encapsulate the active agents into the polymeric microspheres without effecting their chemical 
structures throughout the process. Moreover, the FTIR results demonstrates the capability of 
the EHD/TIPS process to produce stable products for storage in certain period of time before 
usage for different applications.  
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Figure 4.24: a) Structure of Reichardt’s dye and b) The FTIR spectra of Reichardt’s and the 
PLGA samples contained this dye 
4.8 Yield of the EHD/TIPS Processes 
In this section, further investigations were carried out on the yield of the single needle process. 
The main aim was to improve the percentage yield of the process. For this part, the yield of the 
conventional single needle EHD/TIPS process conducted in Section 3.7.1 was discussed, and 
then it was compared to that of the modified process carried out in Section 3.7.2 for producing 
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the required size of the loaded microspheres. Since, it was demonstrated that the modified 
single needle EHD/TIPS method led to higher percentage yield of the process, the co-axial 
needle EHD/TIPS setup was also modified for the encapsulation process. This helped for better 
comparison  between  the  two  different  EHD  methods  (the  single  needle  and  the  co-axial 
needle). The details for the modifications of the co-axial needle setup is described in Section 
3.7.3. 
4.8.1 The Conventional and the Two Modified EHD/TIPS Processes  
The percentage yield of the process which is calculated according to equation 3.8 in dye 
entrapment section (3.9.2.4), was based on measuring the weight of the materials collected 
after the experimental process. The average percentage yield of the conventional single needle 
EHD/TIPS process was found to be 55% ± 2%, indicating a large portion of the starting 
materials was lost during the process. This is likely to have been caused by two main reasons. 
Firstly, liquid nitrogen vapour escaping from the collection vessel prevented the products being 
deposited in the collecting beaker. Secondly, the cone-jet mode was unstable during the mass 
production process. These issues were addressed by adopting a funnel-shaped compartment for 
directing the products into the beaker and also adding a second ground electrode for generating 
a more stable cone-jet. As a result, the average yield of the modified single needle process was 
increased to 92% ± 2% (Equation 3.8, Section 3.9.2.4). This value for the co-axial needle 
procedure based on the same modification was calculated 85% ± 3% which indicates lesser 
quantity of the products collected compared to the modified single needle process.  
4.9  In Vitro Release  Studies  of  the Loaded Microspheres  Produced by the  Modified 
EHD/TIPS Processes 
In this section, the in vitro release studies were carried out on the three dyes encapsulated 
separately in the produced PLGA/TIPS microspheres. The aims were to study the encapsulation 
efficiency and the actual  percentage of the dye  loaded in each process, to determine the 
capability of the TIPS microspheres for releasing their payload and also to measure the amount 
of dye released over an extended period of time.   
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4.9.1 Dye Entrapment of the Conventional and the Two Modified EHD/TIPS Processes 
Table 4.4: Dye entrapment for the conventional and the modified EHD/TIPS systems 
Dye entrapment  Conventional single needle 
Erythrosin B  Pyronin B  Reichardt’s 
Dye loading percentage (%)  2.86 ± 0.04  2.87 ± 0.03  2.8 ± 0.04 
Entrapment efficiency (%)  92 ± 2  93 ± 2  91.5 ± 1.5 
Actual dye loaded in the process (%)  53 ± 3  52.5 ± 2.5  52.5 ± 2.5 
  Modified single needle 
Dye loading percentage (%)  2.83 ± 0.03  2.89 ± 0.03  2.78 ± 0.02 
Entrapment efficiency (%)  92 ± 1.5  94 ± 1  91 ± 1 
Actual dye loaded in the process (%)  86 ± 2  87.5 ± 2.5  85 ± 3 
  Modified co-axial needle 
Dye loading percentage (%)  2.35 ± 0.05  2.40 ± 0.04  2.15 ± 0.05 
Entrapment efficiency (%)  73 ± 2  74 ± 2  68 ± 2 
Actual dye loaded in the process (%)  67 ± 3  66 ± 3  61 ± 3 
 
The  absorbance  signal  of  the  dyes  encapsulated  in  the  weighed  TIPS  microspheres  was 
measured using UV spectroscopy. The total amount of dye was then calculated based on the 
linear  relationship  between  the  absorbance  and  the  dye  concentration  from  the  standard 
calibration curves (Fig.  3.8). By calculating the total amount of dye in each sample, the 
entrapment efficiency was then computed according to equation 3.9. Table 4.4 shows in detail 
how much dye was loaded in the microspheres according to the UV measurements. This table 
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3.11) of the dyes loaded in the microspheres collected from the conventional and the two 
modified (the single needle and the co-axial needle) EHD/TIPS processes. 
The close values of dye entrapment and dye loading efficiencies for the conventional and the 
modified  single  needle  methods  show  the  success  of  the  EHD  process  in  encapsulation. 
However, the difference in the actual percentage of the dye loaded demonstrate the feasibility 
of the modified single needle EHD/TIPS process in preserving more dye compared to the 
conventional method by collecting more dye loaded microspheres. Table 4.4 also illustrates 
the higher loading percentage, entrapment efficiency, and actual percentage of dye loaded with 
the modified single needle EHD/TIPS process compared to that of the modified co-axial needle 
method. As it shows, the former method (single needle) is capable of producing microspheres 
with more dye encapsulated compared to the co-axial needle process. Since, the modified single 
needle method provided higher percentage yield of the process based on collecting more dye 
loaded microspheres, the in vitro release studies were conducted only on the samples collected 
from the modified single needle and the modified co-axial needle methods. 
Release  of  encapsulated  compounds  from  polymeric  carriers  can  occur  through  various 
mechanisms, including diffusion, surface and bulk erosion, disintegration and desorption. For 
PLGA carriers, the release often occurs initially by diffusion from the polymer matrix, and then 
it is mediated via drug diffusion combined with degradation of polymer matrix by hydrolysis 
(Schliecker et al., 2003). Since, PLGA degrades by means of hydrolysis (Schliecker et al., 
2003), the inward diffusion of the aqueous phase leads to degradation of the polymer chains, 
which in turn facilitates outwards diffusion of incorporated agent (Zhang et al., 2008).  
The purpose of the in vitro release studies was to investigate the release behaviour of the 
encapsulated agent from the PLGA microspheres. The clear absorbance peaks for erythrosin 
B, pyronin B and Reichardt’s dye were achieved at expected wavelengths of 351, 348 and 308 
nm respectively (Figs. 3.7-3.9), indicating that they were not damaged or affected during the 
encapsulation processes. The in vitro release of the dyes from the porous PLGA microspheres 
collected from the two modified methods (single needle and co-axial needle) occurred in a time 
dependent manner with biphasic release patterns, with an initial burst release followed by a 
period of sustained release (Figs. 4.25-4.27). The initial burst release in this work is defined as 
the quick burst release of the active dye during the first 24 hours. 
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The in vitro release profiles of erythrosin B from the microspheres produced by the modified 
single needle and the modified co-axial needle EHD/TIPS processes are presented in Figures 
4.25a and 4.25b, respectively. As Figure 4.25a shows, the initial burst release occurred within 
4 hours and it resulted in more than 40-60% of the dye release depending on the five different 
conditions. This shows that the temperature and sonication did not have any major effect on 
the duration of the initial burst release phase of erythrosin B from the single needle TIPS 
microspheres. The complete release of this dye occurred in 360 hours at ambient condition (22 
± 2oC), in 250 hours at physiological temperature (37 ± 1oC) with/without fresh media and in 
200 hours at physiological temperature with sonicator exposure. The change in the pattern of 
dye release in biological temperature which occurred with the single needle products after 200 
hours  was likely related to be caused by  the deformation of PLGA microspheres  due to 
biodegradation and/or bulk erosion of the polymer shell, and consequently releasing more 
quantity of the entrapped agent via outward diffusion.  
Figure 4.25b indicates that the burst release of erythrosin B from the co-axial needle products 
occurred  within  the  first  5  hours  and  it  resulted  in  dye  release  between  35%  and  60%, 
depending on the five different conditions. This indicates that external stimuli such as the 
temperature and the sonication exposure only had influence on the release rate of this dye, but 
not on the duration of this release phase. The complete release of erythrosin B from the 
modified  co-axial  needle  products  occurred  in  180  hours  at  the  three  conditions  of 
physiological with/without fresh media and normal (22 ± 2oC) temperatures, and in 155 hours 
with the application of sonication using various frequencies (20 kHz and 40 kHz). 
Comparison between these two graphs (Figs. 4.25a and 4.25b) shows that the release of 
erythrosin B from the single needle products occurred at higher rate, in particular in normal 
and physiological temperatures, compared to that of the co-axial needle products. The release 
of this dye from the modified single needle products also resulted in longer period of time with 
more controlled release compared to that of the co-axial needle microspheres. This advantage 
was likely related to less surface and internal porosities of the microspheres produced by the 
single needle method (Figs. 4.13c, 4.13d and 4.19a) compared to those collected from the co-
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Figure 4.25: The in vitro release profiles of erythrosin B in SBF: a) The modified single needle 
EHD/TIPS process and b) The modified co-axial needle EHD/TIPS process 
                                                                                                      Chapter 4: Results and Discussion 
130 
 
Figures 4.26a and 4.26b are related to the release profiles of pyronin B from the microspheres 
produced by the two modified EHD/TIPS systems (single needle and co-axial needle). The 
initial burst release of this dye from the single needle products occurred within 3.5 hours (Fig. 
4.26a) that led to more than 40-75% of the dye release, depending on the five different 
conditions. It suggests that temperature variations and sonication with various frequencies did 
not influence the duration of the initial burst release phase, but only affected the release rate of 
this dye from the produced microspheres. Pyronin B was completely released in 98 hours with 
more  than  94%  release  at  normal  temperature,  in  78  hours  with  60%  overall  release  at 
physiological temperature, and in 56 hours with over 82-85% dye release using sonication with 
different frequencies. 
The initial burst release of pyronin B from the microspheres produced by the modified co-axial 
needle process occurred in 5.5  hours and as the graph in Figure 4.26b shows, 40-85% of the 
dye was released during this phase, depending on the five different conditions investigated in 
this study. This shows that the changes in temperature and other external stimuli such as fresh 
media or the sonication exposure did not have any effect on the duration of the burst release of 
this dye from their carriers, but only affected the release rate. Pyronin B was fully released 
from the co-axial needle products for the period of 32 hours with overall 50% and 70% dye 
release in physiological and normal temperatures, respectively (Fig. 4.26b). The complete 
release of pyronin B with application of sonication occurred in 30 hours with approximately 
88% and 94% release using different frequencies (Fig. 4.26b).   
Comparison between two graphs in Figure 4.26 shows that the release of pyronin B from the 
single needle products occurred at higher rate, in particular in the conditions of ambient and 
physiological (with/without fresh media) temperatures, compared to that of the co-axial needle 
products. It also shows the advantage of the single needle products for releasing their payload 
(pyronin B) in longer period of time with more controllable behaviour compared to their 
counterparts obtained from the co-axial needle setup. The shorter period of dye release based 
on  the  co-axial  needle  setup  encapsulation  was  attributed  to  higher  surface  and  internal 
porosities of the prepared TIPS microspheres (Figs. 4.16c, 4.16d and 4.20b) compared to those 
collected from the single needle method (Figs. 4.15c, 4.15d and 4.19b). 
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Figure 4.26: The in vitro release profiles of pyronin B in SBF: a) The modified single needle 
EHD/TIPS process and b) The modified co-axial needle EHD/TIPS process 
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The in vitro release profiles of Reichardt’s from the polymeric microspheres collected from the 
two modified EHD/TIPS methods are provided in Figure 4.27. The initial burst release of this 
dye from the single needle products occurred in 4 hours. As Figure 4.27a shows, more than 
60-72% of the incorporated dye was released during the initial burst release depending on the 
five different conditions investigated in this study. The high value of initial burst release was 
likely  attributed  to  the  small  amount  (20%  v/v)  of  ethanol  added  to  the  SBF  media  for 
measuring the released dye. Figure 4.27a also indicates that the external stimuli such as 
temperature and/or sonication exposure did not have any influence on the duration of the initial 
burst release of the dye. The complete release of Reichardt’s occurred in 170 hours with overall 
dye release of 79% and 85% at the ambient and physiological temperatures respectively, 
whereas with application of sonication it occurred in shorter period of time (130 hours) with 
approximately 92% (20 kHz) and 95% (40 kHz) dye release in total.  
The initial burst release of Reichardt’s dye from the co-axial needle products occurred in 5 
hours that led to more than 60-85% of dye release depending on the five different conditions 
investigated in this study (Fig. 4.27b). This shows that external stimuli such as temperatures, 
fresh media and sonication did not affect the duration of this phase, but only influenced the 
release rate of this dye. As explained above, the high value of initial burst release with the co-
axial needle products was likely due to the small amount (20% v/v) of ethanol added to the 
SBF media for measuring the released dye. The complete release of Reichardt’s from the 
products  of  the  co-axial  needle  setup  occurred  in  50  hours  at  physiological  and  normal 
temperatures,  and  in  35  hours  with  applied  acoustic  pressure  (sonication).  However,  the 
complete release of the dye in physiological temperature with fresh media occurred in slightly 
longer period of time (55 hours) compared to the system without fresh media (Fig. 4.27b).  
The high release rate, which was attributed to the use of ethanol in release media, was observed 
in  the  in  vitro  release  profiles  of  Reichardt’s  from  the  microspheres  obtained  from  both 
encapsulation methods. However, comparison between Figures 4.27a and 4.27b shows that 
the single needle products were able to release the dye in a longer period with more controllable 
manner compared to those produced by the co-axial needle setup. As discussed with the other 
two dyes (erythrosin B and pyronin B), this benefit was related to the less surface porosity and 
more solid internal structure of the single needle products (Figs. 4.17c, 4.17d and 4.19c) 
compared to those obtained from the co-axial needle method (Figs. 4.18c, 4.18d and 4.20c).                                                                                                      Chapter 4: Results and Discussion 
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Figure 4.27: The in vitro release profiles of Reichardt’s dye in SBF:ethanol: a) The modified 
single needle EHD/TIPS process and b) The modified co-axial needle EHD/TIPS process                                                                                                       Chapter 4: Results and Discussion 
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Pyronin B and erythrosin B have similar chemical properties and they both are amphiphilic. 
However, pyronin B is heavier (Mw=1042.28 g/mole) and has higher water solubility (20 
g/mole) compared to erythrosin B (Mw=839.85 g/mole and 1 g/mole water solubility). These 
factors led to quicker period of release for pyronin B (Fig. 4.26) compared to erythrosine B 
(Fig. 4.25) for both the single needle and the co-axial needle methods in all the five different 
conditions. However, Reichardt’s dye (551.68 g/mole) has a different chemical structure (Fig. 
4.24a) compared to the other two dyes (Figs. 4.22b and 4.23a). Since, it was completely 
hydrophobic, ethanol was used in the SBF media, and it resulted in higher initial burst release, 
but with a longer release period compared to pyronin B. The amount of ethanol in the release 
media had a major effect on the release rate of this dye. Therefore, by varying the volume 
concentration of ethanol in the SBF media, more optimum initial burst release with associated 
different periods of sustained release can be obtained. Comparison shows that the chemical 
properties of active agents such as hydrophobicity had a much more significant effect on the 
release rate compared to the physical properties such as molecular weight. Since, drugs such 
as Cyclosporine A and Tacrolimus with high molecular weight have very low water solubility, 
it  is  predicted  that  they  would  have  a  release  profile  pattern  similar  to  erythrosin  B  or 
Reichardt’s dyes. 
The surface porosity led to high initial burst release of the loaded microspheres (single needle 
and co-axial needle) which was a required condition for the chronic wound therapy. After that 
long period of sustained release was obtained which was related to two main reasons: firstly 
decrease in inward diffusion rate of water for dye release due to the denser polymer matrix 
compared to the surface (Figs. 4.19 and 4.20) and secondly decrease in concentration gradient 
of the dye between the release media and the polymer matrix due to the high and quick initial 
burst release. However, analysis and comparison of the results collected from the experimental 
methods showed that the microspheres collected from the single needle EHD/TIPS process 
were capable of releasing the payload in a more controlled manner (longer period of sustained 
release) (Figs. 4.25a, 4.26a and 4.27a) compared to their counterparts collected from the co-
axial needle setup (Figs. 4.25b, 4.26b and 4.27b). The longer period of sustained release was 
related to the less internal and surface porosities of the microspheres collected from the single 
needle (Figs. 4.13, 4.15, 4.17 and 4.19) compared to their counterparts (Figs. 4.14, 4.16, 4.18 
and 4.20) from the co-axial needle. This suggests that surface porosity up to a certain level can 
lead to a better agent release (Enayati et al., 2010a), however further porosity will results in 
faster release with less controllable manner.                                                                                                      Chapter 4: Results and Discussion 
135 
 
4.9.2 Quantification of the In Vitro Release 
Over  the  past  few  decades,  number  of  different  mathematical  formulations  have  been 
developed, aiming to design a more and more effective controlled drug release system with 
reduction in the administration frequency and side effects connected to the dosing (Dash et al., 
2010). Quantification is very useful for prediction of the release kinetics before the release 
systems are realized. More often, it allows the measurements of some important physical 
parameters  such  as  drug  diffusion  and  co-efficient,  and  restoring  to  model  fitting  on 
experimental release data. The release patterns can be divided into those that release the drug 
at slow zero or first order rate, and those that provide an initial rapid dose followed by slow 
zero or first order release of sustained component (Dash et al., 2010). The purpose of designing 
a controlled drug release system in this study was for the biomedical application in chronic 
wound therapy. Therefore, such drug delivery systems were required to initially release part of 
the dose rapidly in order to attain the effective therapeutic concentration of the drug, followed 
by a well-defined behaviour to supply the maintenance dose enabling the attainment of the 
desired drug concentration. Although, number of different mathematical formulations exists to 
evaluate the drug release mechanism, in  this  study only  four of them  were used  for the 
assessment of the in vitro release profiles of the adopted dyes. The four applicable fundamental 
drug release equations in this study (Table 4.5) have been widely used for evaluation of the 
kinetics and the mechanism of the in vitro drug release from the polymeric drug carriers and 
they have been selected based on water solubility characteristics of the incorporated materials 
(Sharma et al., 2010). 
Table 4.5: The equations used for quantification of the in vitro dye release studies (Dash et al., 
2010) 
Release 
mechanism 
Mathematical formula  Release 
Constant (unit) 
Description of drug release 
Zero order  Qt = Qo + K0 t  K0 (1/h)  Independent  of  its  concentration 
dissolved in solution 
First order  Log Qt = Log Qo + KCt/2.303  KC   (2.303/h)  Dependent on its concentration 
Higuchi  Qt = KH  t1/2  KH  (1/h1/2)  Dependent  on  diffusion  and  also 
erosion (degradation) of drug shell 
Hixon-
Crowell 
(Q0)1/3 – (Qt)1/3 = KHC t  KHC   (1/h)  Dependent  on  the  surface  area  or 
diameter of the drug carrier 
Qt (mg) is the amount of drug released at time t (h)  
Qo (mg) is the initial amount of drug                                                                                                      Chapter 4: Results and Discussion 
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The in vitro release profiles of the dyes adopted for prediction of Cys A and Tacrolimus were 
applied on the four kinetic models (zero order, first order, Higuchi and Hixon-Crowell) in order 
to  find  out  the  best  fitted  model  for  the  in  vitro  dye  release  from  the  porous  loaded 
microspheres. The details of the four release kinetics equations which applied to the in vitro 
dye release profiles obtained from the modified single needle and the modified co-axial needle 
EHD/TIPS methods are provided in Tables 4.6 and 4.7, respectively.   
Table 4.6: The release parameters calculated from the in vitro release data of the single needle 
products 
Samples contained the dye  Zero order  First order  Higuchi  Hixon-Crowell 
  Conditions  R2  K0  R2  KC  R2  KH  R2  KHC 
Erythrosin B  22 ± 2oC   0.44  0.16  0.24  -0.01  0.76  2.28  0.45  -0.05 
37 ± 1oC  0.72  0.16  0.78  -0.01  0.88  2.60  0.80  -0.06 
37 ± 1oC (Fresh media)  0.85  0.12  0.72  -0.01  0.95  2.1  0.85  -0.04 
Sonication at 20 kHz  0.86  0.26  0.69  -0.01  0.89  3.85  0.87  -0.09 
Sonication at 40 kHz  0.87  0.25  0.69  -0.01  0.88  3.81  0.86  -0.08 
Pyronin B  22 ± 2oC   0.44  0.64  0.21  -0.02  0.77  4.44  0.45  -0.21 
37 ± 1oC  0.68  0.37  0.57  -0.01  0.83  3.91  0.68  -0.13 
37 ± 1oC (Fresh media)  0.82  0.51  0.71  -0.01  0.95  5.18  0.82  -0.17 
Sonication at 20 kHz  0.71  0.78  0.60  -0.01  0.83  6.55  0.71  -0.25 
Sonication at 40 kHz  0.68  0.65  0.61  -0.01  0.80  4.187  0.68  -0.22 
Reichardt’s  22 ± 2oC   0.35  0.18  0.19  -0.01  0.75  2.22  0.35  -0.06 
37 ± 1oC  0.43  0.23  0.25  -0.01  0.75  2.90  0.43  -0.07 
37 ± 1oC (Fresh media)  0.54  0.28  0.34  -0.01  0.80  3.66  0.54  -0.09 
Sonication at 20 kHz  0.45  0.34  0.27  -0.01  0.81  3.92  0.45  -0.11 
Sonication at 40 kHz  0.56  0.46  0.39  -0.01  0.81  4.180  0.57  -0.15 
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Table 4.7: The release parameters calculated from the in vitro release data of the co-axial 
needle products 
Samples contained the dye  Zero order  First order  Higuchi  Hixon-Crowell 
  Conditions  R2  K0  R2  KC  R2  KH  R2  KHC 
Erythrosin B  22 ± 2oC   0.82  0.22  0.81  -0.01  0.97  3.34  0.81  -0.07 
37 ± 1oC  0.86  0.13  0.77  -0.01  0.95  1.90  0.86  -0.04 
37 ± 1oC (Fresh media)  0.67  0.18  0.55  -0.01  0.87  2.58  0.67  -0.06 
Sonication at 20 kHz  0.80  0.28  0.83  -0.01  0.92  3.95  0.83  -0.09 
Sonication at 40 kHz  0.79  0.32  0.81  -0.01  0.88  4.52  0.79  -0.10 
Pyronin B  22 ± 2oC   0.60  1.13  0.48  -0.02  0.79  8.26  0.60  -0.37 
37 ± 1oC  0.67  0.77  0.55  -0.02  0.85  4.167  0.68  -0.26 
37 ± 1oC (Fresh media)  0.70  1.02  0.58  -0.03  0.87  7.75  0.71  -0.34 
Sonication at 20 kHz  0.62  1.50  0.45  -0.03  0.81  10.74  0.62  -0.50 
Sonication at 40 kHz  0.55  1.62  0.40  -0.03  0.75  11.90  0.55  -0.54 
Reichardt’s  22 ± 2oC   0.52  0.60  0.44  -0.01  0.70  4.148  0.53  -0.20 
37 ± 1oC  0.47  0.71  0.39  -0.01  0.65  6.45  0.48  -0.23 
37 ± 1oC (Fresh media)  0.70  0.85  0.59  -0.01  0.85  7.40  0.70  -0.28 
Sonication at 20 kHz  0.58  1.42  0.47  -0.02  0.72  10.67  0.58  -0.47 
Sonication at 40 kHz  0.57  1.50  0.45  -0.02  0.70  11.30  0.57  -0.50 
 
The correlation coefficient (R2) and the release constant are the two important parameters in 
each drug release mathematical equation. The former (R2) is found from the graph plotted with 
the amount of drug release (Qt for the Higuchi and Zero order, Log (Q0 - Qt) for First order and 
(Q0 – Qt)1/3 for Hixson-Crowell) versus time (t for the Zero order, First order and Hixson-
Crowell, t1/2 for Higuchi) for each controlled release mathematical formulation, whereas latter 
(release constant) is found from the slope of line equation in each graph. The R2 with highest 
value is then selected as the best fitted drug release model. Tables 4.6 and 4.7 show that the 
highest correlation coefficient for the three dyes in all the five different conditions was obtained 
with  Higuchi  compared  to  that  of  the  other  formulations  used  for  the  controlled  release 
quantification. This indicates that the amount of dye release from their polymer shell is mostly 
proportional to the square root of time. Thus, based on the description of this mathematical                                                                                                      Chapter 4: Results and Discussion 
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formulation, the release of the incorporated dyes occurred through the combination of dye 
diffusion and polymeric shell (PLGA) biodegradation (Table 4.5). The high value of release 
constant for Higuchi compared to that of the other mathematical equations that occurred with 
the three dyes in all the five different conditions is related to the high initial burst release phase. 
The release profiles of the three dyes based on the Higuchi equation are provided in Figures 
4.28-4.30 which shows the percentage of dye release with respect to the square root of time. 
 
 
Figure 4.28: Release profiles of erythrosin B in SBF based on Higuchi equation: a) Single 
needle products and b) Co-axial needle products                                                                                                       Chapter 4: Results and Discussion 
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Figure 4.29: Release profiles of pyronin B in SBF based on Higuchi equation: a) Single needle 
products and b) Co-axial needle products  
The results obtained from the EDX studies showed that the active dyes were entrapped in the 
matrix of the polymer microspheres rather than surface encapsulation. Thus, based on the 
morphological and the in vitro release studies, the high initial burst release was related to the 
surface porosity that led to quick diffusion of the dyes encapsulated close to the surface. 
Considering that the encapsulated dye is not uniformly distributed within the matrix of the 
polymeric particles, the long period of sustained release is related to two main factors: 1) 
decrease in inward diffusion rate of water for dye release due to the denser polymer matrix                                                                                                      Chapter 4: Results and Discussion 
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compared to the surface (Figs. 4.19 and 4.20), and 2) decrease in concentration gradient of the 
dye between the release media and the polymer matrix due to the high and quick initial burst 
release.  Therefore,  the  two  phases  of  the  dye  release  had  different  rates  of  diffusion. 
Quantification of the in vitro release data demonstrated that the Higuchi equation is more fitted 
model compared to the other mathematical equations, which further affirms that the release 
mechanism is based on the dye diffusion during the early stages and the combination of 
diffusion and polymer degradation through the latter stages.  
 
 
Figure 4.30: Release profiles of Reichardt’s dye in SBF:ethanol based on Higuchi equation: 
a) Single needle products and b) Co-axial needle products                                                                                                      Chapter 4: Results and Discussion 
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As Figures 4.28-4.30 show, the release mechanism of the three selected dyes, particularly for 
erythrosin B and pyronin B, was mostly based on Higuchi, which further confirmed that the 
dye  release  was  controlled  through  the  combination  of  dye  diffusion  and  polymer  shell 
biodegradation (erosion). Therefore, it can be predicted that the release mechanisms of the 
immunosuppressants such as Cys A and Tacrolimus with high molecular weight and low water 
solubility would be based on Higuchi equation, releasing the encapsulated drug with square 
root of time via the combination of diffusion and the polymer degradation.     
4.9.3 Effect of Microsphere Size and Morphology in Burst Release 
The  key  feature  in  designing  such  drug  delivery  system  in  this  study  was  to  reduce  the 
frequency of dosing and provide uniform drug release with high initial burst for treatment of 
chronic wounds such as fistulae. The total amount of dyes used in the release studies was the 
same for all formulations, and the PLGA formulations were prepared under same processing 
conditions. One factor, apart from the surface morphology, affecting the drug release kinetics 
is the microsphere dimension (Gaumet et al., 2007), as particles with different dimensions have 
different  surface areas,  and thus,  providing different  total  surface area  available for drug 
release. The initial burst release is commonly attributed to the release of encapsulated agent 
located close to the surface of the particles as well as the morphological structure of the 
products (Cohen et al., 1991; Pitt, 1990). The surface porosity led to high initial burst release 
of the loaded microspheres collected from the two different EHD/TIPS methods (Figs. 4.25-
4.27) which is related to the quick diffusion of the dyes from the polymer matrix. However, 
the initial burst release of the dyes was faster from the single needle products compared to their 
counterparts from the co-axial needle method. This was highly related to more encapsulation 
of the dyes at the layers close to the surface area of the single needle microspheres and 
consequently the quicker diffusion of the incorporated materials.  
Although the main goal in this study was to produce microspheres with the targeted size 
distribution (150-300 µm), in some cases, this required size range was not obtained due to the 
physical  properties  of  the  processing  solutions  and  the  environmental  conditions  such  as 
humidity and temperature. Thus, this could have a significant effect on the release kinetics of 
the active agents. For example, the required size distribution of the microspheres was not 
achieved for Reichardt’s loaded microspheres produced by the single needle method (Table 
4.13). Moreover, based on the SEM images, the Reichardt’s loaded microspheres had more 
surface porosity (Fig. 4.17) compared to the other loaded microspheres collected from the                                                                                                      Chapter 4: Results and Discussion 
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single needle method. Therefore, the high initial burst release (Fig. 4.27a) of this dye compared 
to the other two dyes, apart from using ethanol in the release media, could also be related to 
the more surface porosity and greater encapsulation of the agent close to the surface due to the 
smaller surface area available in the microspheres fabricated (Table 4.13).  
4.9.4 Effect of External Stimuli on Release Profile 
In this chapter, further investigation of the results obtained from the in vitro release studies was 
carried out on the loaded microspheres fabricated by the modified single needle and the co-
axial needle EHD/TIPS processes. The final objective of this study was to investigate the 
effects of external stimuli in order to tailor and control the payload release profile for producing 
more efficient drug delivery system. As mentioned in Section 3.9.2.3, the in vitro release 
studies were carried out at various temperatures, using sonication at different duty cycles and 
also fresh media to stimulate the dye release. The main reason behind this investigation was to 
have a more controlled release behaviour of the payloads from their polymeric carriers. In this 
part, the application of external stimuli on the in vitro dye release profiles of the single needle 
products was discussed in conjunction with those obtained from the co-axial needle method. 
4.9.4.1 Fresh Media  
As explained in Section 3.9.2.3, addition of the 2 ml fresh media to the release medium was 
carried out at the pre-determined times during UV measurements. The in vitro release studies 
showed that addition of fresh media (SBF for pyronin B and erythrosin B, and SBF:ethanol for 
Reichardt’s  dye)  can  in  general  lead  to  higher  percentage  release  of  the  entrapped  dyes 
compared to that of the physiological temperature without using the fresh media. This was 
observed on the release profiles of pyronin B and Reichardt’s entrapped in the microspheres 
produced by the two EHD/TIPS methods (Figs. 4.26 and 4.27) and also the erythrosin B release 
profile from the co-axial needle products (Fig. 4.25b). When the release media is constant, a 
homeostatic level occurs between the amount of dye in the media and the remaining agent 
entrapped after a certain period of time (the concentration gradient of the dye decreases to 
zero). Therefore, the release rate will decrease due to PLGA resistance to absorb more water. 
However, by adding more fresh media, the homeostasis imbalance is induced and the dye 
concentration gradient increases again. PLGA starts to absorb more water, and consequently 
more dyes will be released by diffusion (Makadia and Siegel, 2011).                                                                                                      Chapter 4: Results and Discussion 
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However, less percentage release of erythrosin B with fresh media compared to that of the 
physiological condition was recorded with the single needle products (Fig. 4.25a). Since, 
erythrosin B is less hydrophilic (lower water solubility) compared to pyronin B, this could be 
simply related to the dilution of the small amount of released dye in the new fresh media.  
Comparison of the in vitro release studies with fresh media showed no significant difference 
in the release pattern of the dyes encapsulated by means of two different methods (the single 
needle and the co-axial needle). However, more percentage release of the dyes was in general 
achieved with the single needle encapsulation method (Figs. 4.25a, 4.26a and 4.27a) compared 
to the co-axial needle setup (Figs. 4.25b, 4.26b and 4.27b) due to longer period of dye release. 
4.9.4.2 Temperature  
The release profiles of the dyes encapsulated in TIPS microspheres were effected by variations 
in  temperature.  As  discussed  earlier  in  Section  3.9.2.3,  the  release  studies  of  the  loaded 
microspheres were carried out at two distinct temperature conditions, 22 ± 2oC and 37 ± 1oC.  
The complete comparison of the in vitro dye release with the effect of temperature between the 
single needle and the co-axial needle EHD/TIPS products are given in Table 4.8. This table is 
provided based on the differences in the release rate of dyes between the ambient (22 ± 2oC) 
and the physiological (37 ± 1oC) temperatures from the point where the sustained release is 
started until the complete release of the agent. As this table shows, the higher temperature in 
general resulted in negative effect (decrease) in the release rate of the amphiphilic materials 
such as erythrosin B and pyronin B compared to the normal temperature. The lower release 
rate in physiological temperature was slightly compensated by using 2ml addition of fresh 
media in the release medium, but still lower release rate was observed compared to that of the 
normal temperature (22 ± 2oC). 
In  case  of  Reichardt’s,  positive  effect  (increase)  in  the  release  rate  was  observed  in 
physiological temperature (37 ± 1oC) compared to the normal temperature (22 ± 2oC) for both 
the single needle and co-axial needle products. Moreover, even higher release rate of the dye 
in physiological temperature was observed with the addition of fresh media compared to the 
normal condition (Table 4.8). 
The lower release rate of erythrosin B and pyronin B in physiological temperature (37 ± 1oC) 
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degradation and evaporation rate of these two dyes, in particular iodine bonding in erythrosin 
B and chloride in pyronin B, in aqueous solution of 37 ± 1oC  (Jane et al., 2010). Unlike the 
release profiles of these two dyes (erythrosin B and pyronin B), the temperature changes did 
not have any significant effect on the Reichardt’s release rate (Fig. 4.27). This can be related 
to either using ethanol in the release media to facilitate the release, or Reichardt’s dye does not 
evaporate and/or degrade with heat in aqueous solution.  
Table 4.8: The release characteristics of the loaded microspheres effected by temperature 
during the sustained release phase 
Samples of TIPS 
microspheres 
Containing 
Modified single needle EHD/TIPS 
Dye released differences 
with fresh media (%) 
Dye released difference without 
fresh media (%) 
Start  Finish  Start  Finish 
Erythrosin B  - (24 ± 2)  - (22 ± 2)  - (22 ± 2)  - (7 ± 2) 
Pyronin B  - (35 ± 2)  - (30 ± 2)  - (32 ± 2)   - (35 ± 2) 
Reichardt’s  - (3 ± 2)  + (10 ± 2)  + (2 ± 2)  + (7 ± 2) 
  Modified co-axial needle EHD/TIPS 
Erythrosin B  - (2 ± 2)  - (15 ± 2)  - (7 ± 2)  - (20 ± 2) 
Pyronin B  - (14 ± 2)  - (15 ± 2)  - (20 ± 2)  - (20 ± 2) 
Reichardt’s  + (5 ± 2)  + (16 ± 2)  + (10 ± 2)     + (10 ± 2) 
-  The positive sign shows the increase in release rate, whereas the negative sign shows the decrease in the 
release rate as the temperature increased from 22 ± 2oC to 37± 1oC 
4.9.4.3 Sonication  
A systematic investigation using sonication (Section 3.10) was carried out to determine the 
effect of various exposure parameters such as duty cycle and exposure time on the release rate 
of the dyes from the loaded microspheres.  
The comparison of the in vitro dye release studies with the influence of sonication exposure 
between the single needle and the co-axial needle products is presented in Table 4.9. Since, 
sonication was carried out on samples in physiological temperature, the difference in the 
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without fresh media. The comparison is for the period of sustained release (from the point 
where the burst release is finished until the complete period of agent release). 
Table 4.9: The release characteristics of the loaded microspheres exposed to sonication during 
the sustained release phase 
Samples of TIPS 
microspheres 
contained 
Modified single needle EHD/TIPS 
Dye released differences with 
20 kHz (%)  
Dye released difference with 
40 kHz (%) 
Start  Finish  Start   Finish 
 Erythrosin B   + (5 ± 2)  + (10 ± 2)   + (10 ± 2)  + (15± 2) 
Pyronin B   + (20 ± 2)  + (23 ± 2)  + (30 ± 2)  + (27 ± 2) 
Reichardt’s  + (3 ± 2)   + (7 ± 2)   + (4 ± 2)  + (10 ± 2) 
  Modified co-axial needle EHD/TIPS 
Erythrosin B     + (12 ± 2)    + (30 ± 2)      + (20 ± 2)    + (40 ± 2) 
Pyronin B  + (35 ± 2)  + (38 ± 2)  + (45 ± 2)   + (45 ± 2) 
Reichardt’s  + (7 ± 2)  + (8 ± 2)     + (10 ± 2)  + (15 ± 2) 
-  The positive sign shows the increase in release rate, whereas the negative sign shows the decrease in the 
release rate with application of sonication compared to the dye release rate in physiological temperature 
The release profiles were noticeably affected by having the prepared loaded PLGA/TIPS 
microspheres exposed to sonication. The sonicator has been adopted for various drug delivery 
applications in order to increase the release rate of pharmaceuticals in target tissues (Mitragotri, 
2005). The formation of gas or vapour filled bubbles in the medium exposed to sonicator is the 
main mechanism for increasing the release rate of the incorporated dyes (Larina et al., 2005). 
Such bubbles can violently collapse and deform the structure of microspheres due to high shear 
stresses in the region of collapse and/or the shock waves produced by the collapse of the 
bubbles towards the microsphere surface (Nyborg, 2001). In this study, an increase in the 
release rate was observed for all the samples exposed to sonicator in physiological temperature 
(Figs. 4.25-4.27). The results also showed that sonicator with higher frequency led to more 
increase of dye release compared to that at lower frequency with longer period of application 
(Table 4.9). This is due to more intensive bubbles produced by higher frequency which in turn 
damaged the microsphere surface and its structure, leading to more dye release.                                                                                                      Chapter 4: Results and Discussion 
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As  Table  4.9  shows,  sonication  provided  higher  rate  of  dye  release  from  all  the  loaded 
microspheres produced by the two different EHD/TIPS methods. This table also indicates that 
the sonication had a greater effect on the co-axial needle products in releasing their payload 
compared to that of the single needle system. This was highly related to higher surface and 
internal porosities of the products produced by the co-axial needle system compared to that of 
the single needle method.   
4.10 Biodegradation Studies of PLGA 
PLGA co-polymer is insoluble in water. However, it is hydrolytically unstable and degrades 
by hydrolysis of its ester bond. Thus, random chain scission occurs through this hydrolysis, 
leading to degradation into two different monomers of lactic and glycolic acids. 
The interesting feature for this part of the investigation was to observe the variations in the 
surface morphology and internal structure of the loaded microspheres during the degradative 
hydrolysis as a function of time. The SEM studies for this part were only carried out for the 
packs of loaded microspheres in the release media kept at two different conditions of ambient 
and physiological temperatures.  
The microspheres produced by the two different EHD/TIPS methods had the required surface 
and internal porosities for the particular biomedical application in chronic wound therapy (Figs. 
4.13-4.20). However, as the SEM images show, these loaded microspheres lost their surface 
integrity and became less porous during the initial degradative hydrolysis of the polymer 
(within 2 days) when placed in the release media (Figs. 4.31a, 4.31c, 4.32a, 4.32c, 4.33a and 
4.33c). These products were spongy and flexible to form into any shape. 
The packs of loaded microspheres in their release media started to aggregate after a certain 
period of time and formed into a relatively large lump shape. They became quite brittle and 
rough on the surface (Figs. 4.31b(i), 4.31d(i), 4.32b(i), 4.32d(i) and 4.33d(i)). The SEM of the 
loaded microspheres also show that the surface pores of the products is considerably decreased 
by 12 days in the release media (Figs. 4.31b(ii), 4.31d(ii), 4.32b(ii), 4.32d(ii) and 4.33d(ii)), 
whereas,  their  internal  structure  has  obtained  more  porosity  (Figs.  4.31b(iii),  4.31d(iii), 
4.32b(iii), 4.32d(iii) and 4.33d(iii)) compared to the start point of the release studies.                                                                                                          Chapter 4: Results and Discussion 
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Figure 4.31: Surface morphology of the erythrosin B loaded microspheres in SBF: a) Single 
needle after 2 days, b) Single needle after 12 days, c) Co-axial needle after 2 days and d) Co-
axial needle after 12 days                                                                                                      Chapter 4: Results and Discussion 
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Figure 4.32: Surface morphology of the pyronin B loaded microspheres in SBF: a) Single 
needle after 2 days, b) Single needle after 12 days, c) Co-axial needle after 2 days and d) Co-
axial needle after 12 days 
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Figure 4.33: Surface morphology of the Reichardt’s loaded microspheres in SBF/Ethanol 
(80:20 v/v): a) Single needle after 2 days, b) Single needle after 12 days, c) Co-axial needle 
after 2 days and d) Co-axial needle after 12 days 
As the SEM images of the loaded microspheres in the release media showed, the variations in 
the temperature up to 12 days did not have any significant difference on the morphology of the 
drug carriers. Therefore, based on the in vitro release studies, the changes in the release rate at 
various temperatures were mainly attributed to chemical properties such as the evaporation and 
degradation rate of the active agents in aqueous solutions.                                                                                                       Chapter 4: Results and Discussion 
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Summary 
This chapter of the thesis demonstrated the successful preparation of micro-scale polymeric 
particles as drug carriers using the single needle EHD method. This method overcame some of 
the disadvantages of other conventional methods such as the need for elevated temperature, 
multiple processing and the use of surfactants and other additives for producing the required 
polymeric drug carriers. 
In Section 4.1, the key processing parameters (flow rate and applied voltage) and the physical 
properties of the processing solutions were modified to obtain a stable cone jet mode. The cone-
jet mode was of particular interest, as it could result in near-monodisperse particles upon jet 
break-up. The flow rate and the applied voltage were varied in a wide range depending on the 
physical  properties  of  the  processing  solutions  for  production  of  the  near  monodisperse 
required size (150-300 µm) of the microspheres. It was illustrated that the particle sizes were 
reduced  at  higher  applied  voltages  which  was  more  noticeable  at  higher  flow  rates.  The 
polydispersity index (PDI) of the particles was found to increase by enhancing the flow rates. 
This showed the instability of the cone-jet mode which was directly related to combination of 
the processing parameters as well as the physical properties of the solutions. This phenomenon 
was  more  noticeable  with  the  processing  solutions  (PLGA/DMF  and  PLGA/DMC)  that 
obtained high electrical conductivity, high dielectric constant and high surface tension.  
Section 4.3 showed that the PLGA/DMC solution at specific processing parameters (the flow 
rate of 225 µl/min, and the applied voltage 6.0-7.0 kV) successfully fabricated the required size 
range (150-300 µm) of the polymeric microspheres using the single needle EHD method 
combined with TIPS. This combination not only led to the required size distribution, it also 
provided surface porosity in the microspheres. The key factor in producing surface porosity 
was related to thermally induced liquid-liquid phase separation of the polymer solution in liquid 
nitrogen, followed by sublimation of the solvent via lyophilisation of the sample.
This chapter also demonstrated that the dye loaded polymeric microspheres fabricated by the 
two different EHD/TIPS methods are able to release their payload in a controllable manner 
with high initial burst release for the purpose of targeted delivery and chronic wound therapy. 
The in vitro release studies of the produced spherical particles were conducted at five different 
conditions: normal and physiological temperatures, physiological temperature with fresh media 
and with sonication exposure using two various duty cycles (20 kHz and 40 kHz). The purpose 
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burst release followed by a more regulated and sustained release profile. This chapter also 
showed that the percentage yield of the process was improved in order to minimise the waste 
of the initial materials for more accurate calculation of the entrapment efficiencies. 
Section  4.5  of  this  chapter  demonstrated  that  different  morphological  structures  can  be 
obtained using two different EHD/TIPS processes. The SEM images exhibited more surface 
porosity of the co-axial needle microspheres with hollow internal structure compared to the 
single needle products. This was attributed to use of DMC in the inner and the outer needles of 
the  co-axial  EHD/TIPS  system,  and  consequently  more  extraction  of  the  solvent  during 
lyophilisation. The EHD/TIPS process does not have any control over the size and shape of the 
pores on the surface or internally. However, comparison of the results between the two different 
EHD/TIPS process (single needle and Co-axial needle) concludes that the changes in the 
concentration of polymer solution can result in different size and shape of surface pores (more 
concentrated polymer solution provides less surface porosity and vice versa). 
The results obtained from the EDX studies (Section 4.6) showed that the active dyes were 
entrapped in the matrix of the polymer microspheres rather than surface encapsulation. Thus, 
based on the morphological and in vitro release studies, the high initial burst release was related 
to the surface porosity that led to quick diffusion of the dyes encapsulated close to the surface. 
Considering that the encapsulated dye is not uniformly distributed within the matrix of the 
polymeric particles, the long period of sustained release is related to two factors: 1) decrease 
in the inward diffusion rate of water for dye release due to the denser polymer matrix compared 
to the surface area (Figs. 4.19 and 4.20), and 2) decrease in the concentration gradient after a 
high initial burst release. Therefore, each phase (burst and sustained) of the dye release had 
different rates of diffusion. 
In Section 4.7, the FTIR results demonstrated the feasibility of the both EHD/TIPS methods 
(single needle and co-axial needle) in encapsulating the active agents and their success in not 
affecting biofunctionality of the materials throughout the process. 
Section 4.9 of this chapter shows that the release of the encapsulated dyes from the two 
different fabricated products had profiles which began with a burst release phase followed by 
a sustained release. However, the sustained release of materials from the single needle products 
occurred in longer period of time compared to that of the co-axial needle products. In this 
section, it was found that the size distribution of particles and morphological structure (surface 
porosity) are the two key factors in controlling the release of the encapsulated agent. Moreover,                                                                                                      Chapter 4: Results and Discussion 
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it was also provided that the chemical structure of the encapsulated agents play more crucial 
role in the release rate compared to the physical properties. Therefore, it was predicted that 
immunosuppressive drugs such as Cyclosporine A and Tacrolimus with high molecular weight 
would have release pattern similar to that of erythrosin B and/or Reichardt’s due to their high 
resistance to absorb water. The quantification of the release studies as a part of this section 
provided  the  evidence  to  show  that  the  release  mechanisms  of  the  three  selected  dyes, 
particularly for erythrosin B and pyronin B, were mostly based on Higuchi model. Therefore, 
it can be further predicted that the release mechanisms of Cys A and Tacrolimus with high 
molecular weight and very low water solubility would be based on Higuchi equation, releasing 
the encapsulated drug from the porous PLGA microspheres with square root of time via the 
combination of diffusion and the polymer degradation. 
Section 4.9 also showed that the temperature can have a negative effect on the release rate of 
amphiphilic materials such as erythrosin B and pyronin B, and positive effect on the release 
rate of Reichardt’s dye. Furthermore, this section demonstrated that sonication can lead to an 
increase  in  release  rate  of  all  the  incorporated  agents  regardless  of  the  method  used  for 
encapsulation process. The evidence provided in this section also indicated that the addition of 
fresh media can in general have positive affect on the release rate, leading to more dye release. 
Although, the application of external stimuli led to different release rates of the dyes through 
the course of release, it did not change the duration of the initial burst release phase. 
The final part of this chapter (Section 4.10) indicated that the loaded microspheres lost their 
surface integrity and became less porous during the degradative hydrolysis of the polymer shell 
in their release media. However, the internal pores start to grow through the course of release 
studies by means of hydrolysis due to more SBF absorption of PLGA carrier.  
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Chapter 5 
Conclusions and Future Work  
5.1 Conclusions 
The main objective of the research described in this thesis was to demonstrate the feasibility of 
the electrohydrodynamic processing as an alternative and viable technique for preparing the 
microspheres with the required size distribution of 150-300 µm for biomedical application, in 
particular, in chronic wound therapy. The next objective was to stimulate the in vitro release 
profiles of the encapsulated agents from the prepared microspheres in order to predict the 
release profile of toxic immunosuppressive agents such as Cyclosporine A and Tacrolimus. To 
fulfil this objective, three different dyes (erythrosin B, pyronin B and Reichardt’s) with various 
chemical and physical properties were selected in order to cover the high molecular weight and 
low water solubility of the drugs. The in vitro release studies were carried out at various 
conditions using external stimuli such as temperature and sonication to provide an optimum 
release profile for this particular biomedical application. The following conclusions are drawn 
from the extensive investigations carried out to achieve these objectives. 
5.1.1 Mode Mapping of PCL and PLGA Particles Using Single Needle EHD Processing   
Biodegradable PCL and PLGA polymeric microspheres with various size distributions were 
produced using single needle EHD technique. A method of microsphere fabrication providing 
systematic variation of size and size distribution has been demonstrated at ambient temperature 
and pressure, with adjusting applied voltage, flow rate and polymeric concentrations serving 
as the process control parameters. The range of operating parameters in terms of flow rate (for 
PCL/toluene varied from 20 to 50 µl/min, for PLGA/DMF and PLGA/DMAc varied from 30 
to 200 µl/min and for PLGA/DMC changed from 75 to 450 µl/min) and the applied voltage 
(7.5-18 kV for the PCL solutions, 8.5-14 kV for PLGA/DMAc, and PLGA/DMF, and 5-7.5 kV 
for PLGA/DMC) along with the inherent properties of the solutions such as viscosity, surface 
tension and electrical conductivity were identified for the ideal processing window in obtaining 
the stable cone-jet. As it was stated earlier, in general, reduction in polymeric concentration of 
solution leads to high electrical conductivity and lower value of surface tension; therefore, less 
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obtain  the  more  stable  cone-jet  for  production  of  near  monodisperse  polymeric  spheres. 
However,  for  fabrication  of  the  required  size  distribution  of  the  microspheres,  more 
concentrated polymer solutions with higher flow rates and applied voltage were needed which 
in some cases led to high polydispersity of the produced particles. 
Polydispersity index (PDI) was another parameter for validation of the EHD jetting modes. 
This  parameter  determines  the  capability  of  the  polymer  solutions  in  generation  of  near 
monodisperse  microspheres  at  the  stable  cone-jet  mode.  High  PDI  of  PLGA/DMF  and 
PLGA/DMAc solutions demonstrate poor ability of the flowing liquids in obtaining the stable 
cone-jet for productions of near monodisperse particles. The high value of PDI also shows the 
large range of particles’ size. This index with the other processed polymer solutions drops to 
less than 50% which in turn determines the great capability of those solutions (PLGA/DMC 
and PCL/toluene) for achieving the stable cone-jet mode in generating the near monodisperse 
microspheres.  The  noticeable  reduction  in  the  PDI  of  PLGA/DMC  and  PCL/toluene  is 
attributed to the lower electrical conductivity, lower dielectric constant, moderate surface 
tension and viscosity of DMC and toluene compared with those of DMAc and DMF. This 
shows the significant impact of the physical properties on providing the stable EHD cone-jet 
mode for production of near monodisperse particles.   
This investigation also demonstrated that the single-axial EHD technique combined with TIPS 
process  was  successful  for  the  production  of  near  monodisperse,  porous  polymeric 
microspheres and also developing them into particulate scaffold as drug carriers under ambient 
conditions (Figs. 4.10 and 4.11). Out of the five different types of polymer solutions (PLGA in 
DMF, PLGA in DMAc, PLGA in DMC, PCL10000 in toluene and PCL45000 in toluene), the 
combination of PLGA and DMC finally produced the required size of microspheres ranging 
150-300 µm for the formation of scaffold in clinical use. Owing to the inherent properties of 
the solvent, the PLGA/DMC solution also overcame the undesired effects of toluene toxicity 
and slow biodegradation of PCL in PCL/toluene blends. The appropriate size distribution of 
particles with 15 wt% PLGA in DMC solution was obtained at flow rate 225 μl min-1 with 
range of voltage 6.0-7.0 kV (Fig. 4.5c). Electrospray of this polymer solution in liquid nitrogen 
generated the desirable size distribution (150-300 µm) of microspheres for formation of the 
particulate scaffold, and by freeze drying the sample porous surface of the products was yielded 
for the purpose of better drug release. These products in the form of particulate scaffold were 
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5.1.2 Preparing Loaded Polymeric Carriers with the Required Size Distribution 
Simple manipulation of the voltage, flow rate, collecting distance and  varying polymeric 
concentrations during electrohydrodynamic jetting were demonstrated to provide a means of 
producing biodegradable PLGA drug carriers with size distribution of 150-300 µm and porous 
surface morphology. As it was shown, in addition to the solution properties and the processing 
parameters (applied voltage and flow rate), the environmental conditions such as humidity and 
temperature have significant impact on the size of the generated microspheres. Previously in 
Sections 4.1 and 4.3, the required size distribution of microspheres were collected with 15 wt% 
PLGA/DMC solution. However, due to environmental changes, the required size range of the 
products could not be obtained for further investigation. Increasing the viscosity of the polymer 
solution was found to be essential in order to obtain the required size range of the microspheres. 
Therefore, in Section 4.4, the same single needle EHD setup combined with TIPS was carried 
out on 17.5 wt% PLGA/DMC solutions with different processing parameters (flow rate of 400 
µl/min and applied voltage of 6.5-8.5 kV) to produce the required size range of products.   
5.1.3 Modification of the EHD/TIPS Processes 
Based on the percentage yield of the process which was calculated 55% ± 2%, the conventional 
single  needle  EHD  method  combined  with  TIPS  led  to  waste  of  approximately  half  the 
processing materials adopted during the encapsulation process. Therefore, modification was 
conducted in order to minimize the waste of the initial material and also enhance the accuracy 
in  calculation  of  the  entrapment  efficiency.  The  percentage  yield  of  the  process  after 
modifications was increased to 92% ± 2%, indicating small amount of initial materials loss. 
The co-axial needle EHD/TIPS process, which was also modified according to the single 
needle method, had the average percentage yield of 85% ± 3%.  
Actual percentage of the dye loaded parameter was defined in Section 3.9.2.4 in order to show 
the effect of modification on preserving the encapsulated materials based on the total collection 
of the loaded microspheres. The actual percentage of the dye loaded before optimization was 
found to be 53% ± 3% in average, indicating large amount of drug lost throughout the process; 
however, this value after modifications of the single needle and the co-axial needle EHD/TIPS 
processes was averaged to be 86% ± 4% and 65% ± 5%, respectively. This modification as 
described earlier is found to be really important in mass production for preserving the initial 
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5.1.4 Production of the Loaded Microspheres by the Modified EHD/TIPS Processes  
The modified single needle and the modified co-axial needle EHD/TIPS methods were carried 
out for production of the encapsulated polymeric microspheres. The aim was to encapsulate a 
second material in the polymeric carrier and stimulate the in vitro release profile. For the 
modified single needle encapsulation process, the three different polymer solutions that mixed 
separately with erythrosin B, pyronin B and Reichardt’s were electrosprayed for production of 
the required size distribution of microspheres.  It was  found that the  erythrosin  B loaded 
microspheres had size distribution of 180 ± 30 µm, whereas the size distribution of the pyronin 
B loaded particles and Reichardt’s loaded microspheres were 165  ± 25 µm and 100 ± 30 µm 
respectively. The size distribution of the produced microspheres were directly related to the 
physical properties of the solutions and the processing parameters. 
For the modified co-axial needle process, a second solution (DMC) mixed with each dye and 
the polymer solution (PLGA/DMC) with same concentration as used in the modified single 
needle process (17.5 wt%) were adopted for encapsulation of the active agents. The average 
size distribution of the loaded products from the modified co-axial needle was found to be 180 
± 35 µm, which shows that the produced microspheres were slightly larger compared to their 
counterparts obtained from the modified single needle method. 
The SEM images showed that the single needle and the co-axial needle EHD/TIPS methods 
produced microspheres with internal and surface porosities. As the SEM images showed, the 
internal structure of the single needle products was denser with the PLGA polymer compared 
to their surface. Comparison of the morphological structure between the products of the two 
methods showed that the co-axial needle EHD/TIPS process resulted in higher surface and 
internal porosities compared to their counterparts collected from the single needle method. 
Stability of the produced microspheres loaded with various materials was carried out using 
FTIR. Based on the evidence provided by the FTIR spectra of the samples (Figs. 4.22c, 4.23b 
and 4.24b), the single needle and the co-axial needle EHD/TIPS methods could successfully 
encapsulate the active agents (erythrosin B, pyronin B and Reichardt’s) into the polymeric 
microspheres without affecting their chemical structures throughout the process. Moreover, the 
FTIR  results  demonstrated  the  capability  of  the  EHD/TIPS  process  in  producing  stable 
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Encapsulation is a method of enclosing the therapeutic agent in protective polymeric carriers. 
This study confirmed the successful encapsulation of the three different model drugs in the 
required size distribution of the polymeric microspheres. The successful encapsulation was 
shown in the products obtained from both the single needle and the co-axial needle EHD/TIPS 
methods. In number of studies, encapsulation of various therapeutic agents were reported in 
PLGA particles, and in most of the cases the solvent evaporation method has been adopted as 
the fabrication technique. This method has some definitive disadvantages such as relatively 
low encapsulation efficiency, particularly in preparation of drug loaded particles in nano scale, 
defunctionalisation of drug under extreme processing conditions and multistep processing 
(Section 2.7.1). However, these disadvantages were minimised and bio-safe products with 
complete extraction of solvent were obtained with using the EHD method combined with TIPS. 
5.1.5 In Vitro Release Studies of the Loaded Microspheres Produced by the Modified 
EHD/TIPS Methods 
The in vitro release profiles of the three model drugs (erythrosin B, pyronin B and Reichardt’s) 
loaded in the TIPS microspheres were studied. It was observed that the release of the model 
drugs was time-dependant and all the release profiles started with an initial burst release 
followed by a period of sustained release. During the sustained release, the release rate for all 
the samples increased as biodegradation of the polymer particles took place via hydrolysis and 
the internal structure would be expected to contain higher concentration of the incorporated 
materials. Release of the encapsulated materials from the PLGA matrix occurs with diffusion 
of dye during the early phases, and then it is mediated through both diffusion of the therapeutic 
agents and degradation of the polymer carrier at the later stages.  
The results from the EDX studies showed that the active dyes were entrapped in the matrix of 
the polymer microspheres rather than surface encapsulation. Thus, the high initial burst release 
was related to the surface porosity that led to quick diffusion of the dyes encapsulated close to 
the surface. Since, the encapsulated dye is not uniformly distributed within the matrix of the 
polymeric particles, the long period of sustained release is related to two main factors: 1) 
decrease in the inward diffusion rate of water for dye release due to the denser polymer matrix 
compared to the surface area (Figs. 4.19 and 4.20), and 2) decrease in the concentration 
gradient after a high initial burst release. Therefore, each phase (burst and sustained) of the dye 
release had different rates of diffusion. The in vitro release studies showed that the loaded 
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release compared to that of their counterparts obtained from the modified co-axial needle setup. 
According to the SEM images, this was attributed to the less surface and internal porosity of 
the produced microspheres from the modified single needle EHD/TIPS method compared to 
their counterparts collected from the modified co-axial EHD/TIPS setup. Moreover, the SEM 
combined with EDX studies provided the evidence that incorporation of the dyes by the single 
needle  process  occurred  in  the  polymer  matrix  and  the  layers  near  the  surface  of  the 
microspheres  (Fig.  4.19),  whereas  with  the  co-axial  needle  method,  internal  cavity  was 
obtained that indicates the phase separation of the agent encapsulation from the polymer matrix 
(Fig. 4.20). 
Use of three different model drugs was to predict the stimulation release of immunosuppressive 
agents such as Cyclosporine A and Tacrolimus. The selection of these three dyes was based on 
the chemical property of their water solubility and physical properties such as molecular weight 
similar to the actual drugs. Comparison of the in vitro release studies showed that chemical 
properties of active agents such as water solubility (hydrophobicity) have much greater effect 
on the release profile compared to the physical properties such as molecular weight. Therefore, 
it was predicted that the release profile of the actual drugs would be similar to that of the 
erythrosin  B  or  Reichardt’s  dyes.  The  quantification  of  the  release  studies  provided  the 
evidence to show that the release mechanisms of the three selected dyes, particularly for 
erythrosin B and pyronin B, were mostly based on Higuchi equation. Therefore, it can be 
further predicted that the release mechanisms of the immunosuppressants such as Cys A and 
Tacrolimus with high molecular weight and low water solubility would be based on Higuchi 
equation, releasing the encapsulated drug  from such porous polymeric microspheres with 
square root of time via the combination of diffusion and the polymer degradation. 
5.1.6 Studying the Effect of Particles Size and Morphology on the Burst Release 
The particle size and the surface morphology are the two key factors in initial burst release 
phase. Particles with different dimensions will have different surface areas and thus have 
different total surface available for drug release. Moreover, this phase of release is also related 
to the surface porosity, as the initial burst release is commonly attributed to the release of the 
drug loaded close to the surface of particles. The initial burst release of the dyes was faster 
from the single needle products compared to the co-axial needle products. This was highly 
related to the quicker diffusion of the dyes incorporated in the layers close to the surface area 
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In case of Reichardt’s, the required size distribution of the microspheres was not achieved for 
the dye loaded microspheres obtained from the single needle method. Moreover based on the 
SEM images, the Reichardt’s loaded microspheres had greater surface porosity compared to 
the other loaded microspheres from the single needle products. Therefore, the high initial burst 
release of this dye compared to that of the other two dyes, apart from using ethanol in the 
release  media,  could  also  be  related  to  the  higher  surface  porosity  and  greater  surface 
encapsulation  of  Reichardt’s  due  to  the  smaller  surface  area  available  in  the  produced 
microspheres. 
5.1.7 Studying the Effect of Fresh Media on Release Profile 
Based  on  the  in  vitro  release  studies  conducted,  the  release  profiles  of  pyronin  B  and 
Reichardt’s entrapped in the microspheres produced by the single needle and the co-axial 
needle methods and also the erythrosin B release profile from the modified co-axial needle 
products showed higher release rate with fresh media at physiological temperature. This was 
due to the increase in concentration gradient that occurred between the amount of dye in the 
media and the remaining agent entrapped by addition of fresh media, and consequently led to 
more release of the dye via diffusion. However, less percentage release of erythrosin B from 
the single needle product with addition of fresh media was recorded compared to that of the 
physiological temperature without fresh media. Since, erythrosin B has lower water solubility 
compared to other hydrophilic materials such as pyronin B, this could be simply related to the 
dilution of the small amount of released dye with the new fresh media.  
Comparison  of the  in vitro  release studies  at  physiological  temperature  with  fresh  media 
showed no significant difference in the release pattern of the dyes encapsulated by means of 
two different methods (the single needle and the co-axial needle). However, more percentage 
release of the dyes was in general achieved with the single needle encapsulation method 
compared to the co-axial needle setup due to longer period of release. 
5.1.8 Studying the Effect of Temperature on Release Profile 
Effect of temperature was investigated on the release profiles of the encapsulated agents in 
order to stimulate an optimum profile with more controlled release. It was shown that increase 
in temperature in general resulted in lower release rate of the amphiphilic materials (erythrosin 
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of factors such as  quicker degradation and/or  higher evaporation of the dyes  in aqueous 
solutions at physiological temperature (37 ± 1oC) over the course of release studies. However, 
the lower release rate in biological temperature was slightly compensated by using 2ml addition 
of fresh media in the release media, but still lower release rate was observed compared to that 
of the normal temperature. In case of Reichardt’s dye, since it is hydrophobic, it could not be 
degraded in aqueous solution (release media) and/or evaporated by heat as observed throughout 
the in vitro release studies. Therefore, the positive effect of release rate was observed in 
physiological temperature (37 ± 1oC) compared to the normal condition (22 ± 2oC) in both the 
single  needle  and  co-axial  needle  products.  Moreover,  the  higher  release  rate  was  even 
observed with addition of fresh media in physiological temperature. 
5.1.9 Studying the Effect of Sonication on Release Profile 
This  further  investigation  was  carried  out  to  study  the  effect  of  the  different  sonication 
parameters such as duty cycle and exposure time with the purpose of obtaining more efficient 
release  profile.  The  sonication  systematic  exposure  was  conducted  on  the  loaded  PLGA 
microspheres at two different frequencies of 20 kHz for 30 s and 40 kHz for 20 s. The release 
profiles were noticeably affected by having the loaded microspheres exposed to the sonicator. 
It was related to the formation of the gas or vapour filled bubbles in the medium exposed to the 
sonication as the main mechanism for increasing the release rate of the incorporated dyes. This 
increase was observed for all the samples exposed to sonication in physiological temperature. 
The effect of sonication on release rate of the dyes from the co-axial needle microspheres was 
greater compared to that of the single needle products. The in vitro release studies also showed 
that exposure of samples to sonication did not influence the duration of the initial burst release 
but it led to higher release rate with shorter period of sustained release (Figs. 4.25-4.27). 
Moreover, the results demonstrated that the sonication with higher frequency led to more 
increase of dye release compared to less frequency with longer period. This is due to more 
intensive bubbles produced by higher frequency which in turn damage the microsphere surface 
and its structure, inducing more dye release (Enayati et al., 2010a; Nyborg, 2001).  
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5.2 Future Work 
The synthesised polymeric particles should ideally have the following features: high loading 
efficiency, controlling drug distribution and release characteristics, uniform size and shape. 
The applied processing technique should be able to produce these features, and also be efficient 
in  terms  of  time  and  material  usage,  convenient  and  easily  scalable.  The  EHD  forming 
techniques have demonstrated great promise in terms of these criteria offering a versatile 
capability for the generation of nearly uniform loaded microspheres. In this thesis, it was 
demonstrated that the EHD methods can achieve near uniform dispersion of drug within a 
polymer matrix of the products with high loading capacity and minimal drug loss. However, 
there are several aspects of future work recommended as follows:  
5.2.1 Effect of Needle Geometry on the EHD Processing 
The geometry of a needle is one of the important factors for the applied electric field in the 
EHD processing. However, to the best of the author’s knowledge, there are only few documents 
to systematically demonstrate the influence of needle geometry within the research work of 
EHD spraying as a vital factor for the applied electric field which is a driving force for the 
liquid to form the cone-jet mode. Most of the previously discussed investigations were based 
on the regular geometry of the capillary with brief explanation of its influence on the cone-jet 
domain (Chen et al., 1999). Therefore, further investigations are required to be conducted to 
assess the effects of irregular needle geometry such as tip angle, length and shape on the stable 
cone-jet domain, in which the cone-jet mode can be achieved and maintained for long period 
of mass production.  
5.2.2 Encapsulation of Different Therapeutic Agents 
Effective drug delivery strategies for different biomedical applications are becoming more 
significant as more specific drugs become available with growing knowledge about diseases 
from human and genome project. All therapeutic agents would require tailored drug delivery 
system  and  targeting  mechanisms  to  deliver  them  to  their  specific  target  tissue  without 
influencing their therapeutic efficacy. In this research, it was demonstrated that biodegradable 
spherical particles could be prepared with high encapsulation efficiency for chronic wound 
therapy. The encapsulation process was conducted on various model drugs with different 
physical and chemical properties, aiming to predict the in vitro release profile of actual drugs. 
Since, working with immunosuppressive drugs can be hazardous, this investigation should be                                                                                            Chapter 5: Conclusion and Future Work 
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conducted  in  a  wider  range  of  model  drugs  to  cover  the  variety  of  the  existing 
immunosuppressive agents for different biomedical applications.   
5.2.3 Cell Study for the Prepared Microspheres 
Spheres are a potential useful drug delivery system with ability of delivering the therapeutic 
agent in a sustained release profile. These particles can be used for different applications in 
biomedicine  depending  on  their  dimensions.  For  example,  nano  size  particles  are  very 
important for their great efficiency of arterial uptake (Song et al., 1998) and cellular entry 
(Desai et al., 1997), whereas micro size particles are useful for targeted delivery (Monsky et 
al., 1999) and wound therapy within tissue (Keshaw et al., 2010). In this study, loaded PLGA 
microspheres with size distribution of 150-300 µm were successfully produced and the in vitro 
release  studies  showed  an  efficient  drug  release  profile  for  this  particular  biomedical 
application. However, the mechanism of enhanced therapeutic efficacy of the drug loaded 
microspheres  should  be  conducted  at  tissue  level.  For  instance,  further  research  can  be 
conducted on the behaviour of the packs of microspheres and their reactions at tissue level, 
their trafficking and sorting into different intracellular compartment.    
5.2.4 Effect of Morphology on Various In Vitro Parameters 
Recently, there has been growing recognitions that particles with surface porosity play an 
important role in various applications such as chronic wound therapy. The surface morphology 
influence the effectiveness of drug delivery system. In this thesis, it was shown that the drug 
carriers of this particular morphology could be obtained through different combinations of 
processing parameters and physical properties of the solutions. This specific morphological 
structure was different between the two types of produced microspheres obtained from the 
various EHD/TIPS methods (the single needle and the co-axial needle). Also, it was shown that 
this morphological structure (surface porosity) influenced the in vitro release profiles of the 
encapsulated  dyes.  A  more  systematic  investigation  should  be  carried  out  assessing  the 
effectiveness of the surface porosity on the release profile of the incorporated materials and 
discover an optimum surface porosity on the required size distribution of particles for an 
optimum drug delivery with more sustained release phase. Apart from the in vitro release 
studies, other in vitro investigations such as biocompatibility, clearance and targeting of these 
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particles. For instance, the dependence of phagocytosis by macrophages on shape and aspect 
ratio, the internalisation of spherical particles and their bio distribution should be studied. 
5.2.5 Effect of Dimensions in Tissue Engineering 
Tissue engineering has emerged as a viable alternative to the problem of organ and tissue 
shortage. The use of the fabricated PLGA microspheres in this study within the required size 
distribution  and  surface  porosity  as  scaffold  materials  for  the  growth  of  cells  for  tissue 
engineering is an emerging area for applications in medial engineering (Botchwey et al., 2004). 
As the in situ deposition study (Section 3.11) showed, the produced microspheres had tendency 
of settling down at the bottom of the created irregular shaped cavity within tissue. Further 
research is required to investigate the in situ deposition of the microspheres similar to the in 
vitro and in vivo cases for the chronic wound therapy. 
5.2.6 Preparation of Multilayer Microspheres 
The potential capability of EHD processing has attracted the researchers in this field for 
preparation  of  multi-layered  micro-  and  nano-particles  for  various  applications  in  food 
engineering, drug delivery and biomedicine research. The multi-layered structure can enhance 
the  capability  of  the  products  for  successful  penetrating  the  body’s  immune  system  and 
efficiently  carrying  the  therapeutic  agents  to  their  intended  sites.  Each  layer  can  be 
systematically designed for a specific reason, which can meet and overcome the physiological 
barriers encountered as it moves through the body. 
The produced microspheres in this study can be prepared in multi-layered structure with each 
layer loaded for a particular purpose. The four layered structure which was carried out for the 
first time by Labbaf et al. (2014) can be further improved based on more appropriate selection 
of materials for better encapsulation of the active agents with more controlled release. The 
further work can be related to preparation of multi-layered porous surface micro- and/or nano-
spheres for a wider range of biomedical applications.  
5.2.7 Targeted Drug Delivery via Bioconjugation 
The EHD processing can be employed to produce bioconjugated polymeric carriers for targeted 
drug delivery. One of the more important applications of such targeted drug delivery system is 
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technologies such as nanotechnology and advanced polymer chemistry are required to bring 
together new ways of developing such drug delivery system. Using monoclonal antibodies 
(MAbs) is one of the methods which can be applied for development of such drug delivery. 
PLGA polymeric particles can be used for site-specific drug delivery by incorporation of 
appropriate targeting groups of antitumor monoclonal antibodies. Therefore, further research 
can  be  conducted  for  delivering  the  anticancer  such  as  radionucleotides,  toxins  and 
chemotherapeutic agents to the tumour and also preventing damage to the normal surrounding 
tissue. 
5.2.8 Sonicator Safety 
In this study, sonication was used in combination with the model drugs release. It was shown 
that the acoustic pressures with different applied frequencies (20 and 40 kHz) enhanced the 
drug release. However, understanding the safety of therapeutic sonication and the development 
of generalised rules that account for sonication health and safety is a crucial topic for future 
research activities (Madersbacher and Marberger, 2003; Nyborg, 2001). 
The problem of biological response in the use of sonication for stimulating drug release should 
be addressed. It is likely that sonication frequencies which optimize membrane permeability 
are different to the frequencies that optimize drug release. Therefore, the response of cells and 
their membranes to sonication must be carefully considered in order to minimize or avoid the 
damages to the target or adjacent tissues. 
Ultrasound  frequencies  ranged  from  19.5  kHz  to  10  MHz  is  used  for  various  medical 
applications. Some applications of ultrasound with low frequencies are in angioplasty at 19.5 
kHz, ocular drug delivery at 20 kHz, lipoplasty at 20-50 kHz and transdermal delivery of 
insulin,  low-molecular  weight  heparin  and  vaccines  at  20-100  kHz  (Mitragotri,  2005). 
However, the significant clustering of applications is found in frequencies ranging from 1 to 3 
MHz. This range frequencies are mostly used for medical imaging. At this range of frequencies, 
focusing and targeting treatments are better. Therefore, it is beneficial to develop a research 
area to investigate the exposure of drug carriers at higher frequencies and study their release 
characteristics. 
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5.2.9 Quantifying the In Vitro Release 
In this study, quantification of the release studies was conducted to find and predict the release 
mechanism of the incorporated materials from the PLGA particles. As it was shown, the 
mechanism of dye release from the porous polymeric particles was based on Higuchi equation. 
However, the correlation coefficient for this modelling equation was not high enough to satisfy 
the in vitro release data, due to different diffusional rates for the two release phases. Therefore, 
more accurate mathematical modelling equations are required to consider the significant effect 
of surface porosity of such microspheres on the release rate, particularly on the initial burst 
release phase, and dissolution of the encapsulated materials into the release media. 
5.2.10 Commercial Viability 
A full assessment of commercial and clinical viability of the utilised techniques in this study is 
a crucial problem which should be considered in future work. The EHD processing has some 
definitive advantages compared to other existing particle fabrication techniques in terms of 
simplicity, efficiency, cleanliness and ambient conditions. Although in this study, it was tried 
to electrospray for mass production, there is still the issue of scaling up and associated cost to 
address, where it should be noted that EHD with single needle is a low-volume throughput 
process  and  it  is  not  suitable  or  efficient  for  traditional  industrial  spraying  processes. 
Approaches  that  address  this  problem  are  to  use  multi-nozzle  or  slit-nozzle  systems 
(Almekinders and Jones, 1999; Regele et al., 2002; Snarski and Dunn, 1991). Therefore, further 
research can be conducted on scaling up and commercialisation via two methods: 1) scaling up 
the production through multiplexed microfabricated sources of spraying and 2) fabrication of 
miniaturised portable devices for encapsulation and delivery of drug for patient-specific needs. 
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Martínez-Pérez,  C.A.,  Olivas-Armendariz,  I.,  Castro-Carmona,  J.S.,  García-Casillas,  P.E., 
2011. Advances in Regenerative Medicine. InTech, mesico, Shanghai, 275-290. 
Mathiowitz, E., Jacob, J.S., Jong, Y.S., Carino, G.P., Chickering, D.E., Chaturvedi, P., Santos, 
C.A., Vijayaraghavan, K., Montgomery, S., Bassett, M., Morrell, C., 1997. Biologically 
erodable microspheres as potential oral drug delivery systems. Nature 386, 410–414.  
Mei, F., Chen, D.-R., 2007. Investigation of compound jet electrospray: Particle encapsulation. 
Phys. Fluids 19, 103303–103313.  
Mitragotri, S., 2005. Healing sound: the use of ultrasound in drug delivery and other therapeutic 
applications. Nat. Rev. Drug Discov. 4, 255–260.  
Mitragotri, S., Blankschtein, D., Langer, R., 1995. Ultrasound-mediated transdermal protein 
delivery. Science 269, 850–853. 
Mitragotri, S., Lahann, J., 2009. Physical approaches to biomaterial design. Nat. Mater. 8, 15–
23.  
Mitschele, J., 1996. Beer-Lambert Law. J. Chem. Educ. 73, A260–261.  
Miyazaki, S., Yokouchi, C., Takada, M., 1988. External control of drug release: controlled 
release of insulin from a hydrophilic polymer implant by ultrasound irradiation in diabetic 
rats. J. Pharm. Pharmacol. 40, 716–717. 
Mizushige,  K.,  Kondo,  I.,  Ohmori,  K.,  Hirao,  K.,  Matsuo,  H.,  1999.  Enhancement  of 
ultrasound-accelerated thrombolysis by echo contrast agents: dependence on microbubble 
structure. Ultrasound Med. Biol. 25, 1431–1437.                                                                                                                                                 References                                                                                                              
180 
 
Modi,  S.,  Jain,  J.P.,  Kumar,  N.,  2005.  Synthesis,  characterization,  and  degradation  of 
poly(ester-anhydride) for particulate delivery. Isr. J. Chem. 45, 401–409.  
Monsky, W.L., Fukumura, D., Gohongi, T., Ancukiewcz, M., Weich, H.A., Torchilin, V.P., 
Yuan, F., Jain, R.K., 1999. Augmentation of transvascular transport of macromolecules 
and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res. 59, 
4129–4135. 
Moon, G.D., Jeong, U., 2008. Decoration of the Interior Surface of Hollow Spherical Silica 
Colloids with Pt Nanoparticles. Chem. Mater. 20, 3003–3007.  
Moore, C., Promes, S.B., 2004. Ultrasound in pregnancy. Emerg. Med. Clin. North Am. 22, 
697–722.  
Murillo, M., Gamazo, C., Goñi, M., Irache, J., Blanco-Príeto, M., 2002. Development of 
microparticles prepared by spray-drying as a vaccine delivery system against brucellosis. 
Int. J. Pharm. 242, 341–344. 
Murthy, R.S.R., 1997. Biodegradable polymers, in: Biodegradable Polymers. CBS Publisher, 
New Dehli, India, pp. 27–51. 
Mustoe, T., 2005. Tissue repair and ulcer/wound healing: molecular mechanisms, therapeutic 
targets  and  future  directions,  Dermal  ulcer  healing:  Advances  in  understanding. 
EUROCONFERENCES, Paris, France. 
New Jersey department health senior services, 2011. Right to know hazerdious substance fact 
sheet.  Available  at:  http://nj.gov/health/eoh/rtkweb/documents/fs/0759.pdf  (accessed 
3.26.14). 
Nicholls, G., Heaton, N.D., Lewis, A.M., 1990. Use of bacteriology in anorectal sepsis as an 
indicator of anal fistula: experience in a distinct general hospital. J. R. Soc. Med. 83, 625–
626. 
Nihant, N., Grandfils, C., Jérôme, R., Teyssié, P., 1995. Microencapsulation by coacervation 
of poly(lactide-co-glycolide) IV. Effect of the processing parameters on coacervation and 
encapsulation. J. Control. Release 35, 117–125.  
Nishiyama, N., Kataoka, K., 2003. Polymeric micelle drug carrier systems: PEG-PAsp(Dox) 
and second generation of micellar drugs. Adv. Exp. Med. Biol. 519, 155–177.  
Nyborg, W.L., 2001. Biological effects of ultrasound: development of safety guidelines. Part 
II: general review. Ultrasound Med. Biol. 27, 301–333.                                                                                                                                                 References                                                                                                              
181 
 
O’Donnell,  P.B.,  McGinity,  J.W.,  1997.  Preparation  of  microspheres  by  the  solvent 
evaporation technique. Adv. Drug Deliv. Rev. 28, 25–42.  
Ohtsuki, C., Aoki, Y., Kokubo, T., BANDO, Y., Neo, M., Nakamura, T., 1995. Transmission 
and Apatite Electron Layer Microscopic Formed Observation of Glass-Ceramic Body 
Fluid on Its Surface in a Simulated bonds to living bone through an apatite layer which is 
formed on the surface of the glass-ceramic in the body . J. Ceram. Soc. Japan 103, 449–
454. 
Okada, H., Toguchi, H., 1995. Biodegradable microspheres in drug delivery. Crit. Rev. Ther. 
Drug Carrier Syst. 12, 1–99. 
Okochi, H., Nakano, M., 2000. Preparation and evaluation of w/o/w type emulsions containing 
vancomycin. Adv. Drug Deliv. Rev. 45, 5–26. 
Okubo,  M.,  Konishi,  Y.,  Minami,  H.,  1998.  Production  of  hollow  polymer  particles  by 
suspension polymerization. Colloid Polym. Sci. 276, 638–642.  
Oyane, A., Kim, H.-M., Furuya, T., Kokubo, T., Miyazaki, T., Nakamura, T., 2003. Preparation 
and assessment of revised simulated body fluids. J. Biomed. Mater. Res. A 65, 188–195.  
Paik, N.-J., Cho, S.-H., Han, T.R., 2002. Ultrasound therapy facilitates the recovery of acute 
pressure-induced conduction block of the median nerve in rabbits. Muscle Nerve 26, 356–
361.  
Paine, M.D., Alexander, M.S., Stark, J.P.W., 2007. Nozzle and liquid effects on the spray 
modes in nanoelectrospray. J. Colloid Interface Sci. 305, 111–123.  
Pancholi, K.P., Farook, U., Moaleji, R., Stride, E., Edirisinghe, M.J., 2008. Novel methods for 
preparing phospholipid coated microbubbles. Eur. Biophys. J. 37, 515–520.  
Panyam, J., Labhasetwar, V., 2003. Biodegradable nanoparticles for drug and gene delivery to 
cells and tissue. Adv. Drug Deliv. Rev. 55, 329–347. 
Pareta,  R.,  Brindley,  A.,  Edirisinghe,  M.J.,  Jayasinghe,  S.N.,  Luklinska,  Z.B.,  2005. 
Electrohydrodynamic  atomization  of  protein  (bovine  serum  albumin).  J.  Mater.  Sci. 
Mater. Med. 16, 919–925.  
Pareta, R., Edirisinghe, M.J., 2006. A novel method for the preparation of biodegradable 
microspheres for protein drug delivery. J. R. Soc. Interface 3, 573–582.  
Park, T.G., Yong Lee, H., Sung Nam, Y., 1998. A new preparation method for protein loaded 
poly(D, L-lactic-co-glycolic acid) microspheres and protein release mechanism study. J. 
Control. Release 55, 181–191.                                                                                                                                                 References                                                                                                              
182 
 
Parks, A.G., 1961. Pathogenesis and treatment of fistuila-in-ano. Br. Med. J. 1, 463–469. 
Peng, X., Zhang, L., 2005. Surface fabrication of hollow microspheres from N-methylated 
chitosan cross-linked with glutaraldehyde. Langmuir 21, 1091–1095.  
Pitt, C., 1990. The controlled parenteral delivery of polypeptides and proteins. Int. J. Pharm. 
59, 173–196.  
Pitt, W.G., Husseini, G.A., Staples, B.J., 2004. Ultrasonic drug delivery--a general review. 
Expert Opin. Drug Deliv. 1, 37–56.  
Poliachik, S.L., Chandler, W.L., Mourad, P.D., Bailey, M.R., Bloch, S., Cleveland, R.O., 
Kaczkowski,  P., Keilman, G., Porter, T., Crum,  L.A., 1999. Effect  of  high-intensity 
focused  ultrasound  on  whole  blood  with  and  without  microbubble  contrast  agent. 
Ultrasound Med. Biol. 25, 991–998. 
Prausnitz,  M.R.,  Mitragotri,  S.,  Langer,  R.,  2004.  Current  status  and  future  potential  of 
transdermal drug delivery. Nat. Rev. Drug Discov. 3, 115–124.  
Ptachcinski, R.J., Venkataramanan, R., Burckart, G.J., 1986. Clinical pharmacokinetics of 
cyclosporin. Clin. Pharmacokinet. 11, 107–132.  
Pushkar, S., Philip, A., Pathak, K., Pathak, D., 2006. Dendrimers : Nanotechnology Derived 
Novel Polymers in Drug Delivery. Indian J. Pharm. Educ. Res. 40, 153–158. 
Rajput, M., Sharma, R., Kumar, S., Jamil, F., Sissodia, N., 2012. Pulsatile Drug Delivery 
System : A Review 3, 118–124. 
Rangkupan, R., Reneker, D.H., 2003. Electrospinning Process of Molten Polypropylene in 
Vacuum. J. Met. Mater. Miner. 12, 81–87. 
Rasiel, A., Sheskin, T., Bergelson, L., Domb, A.J., 2002. Phospholipid coated poly(lactic acid) 
microspheres for the delivery of LHRH analogues. Polym. Adv. Technol. 13, 127–136.  
Rasve, G., Borade, G., Deshmukh, S., Tagalpallwar, A., 2011. Pulsatile drug delivery system: 
current scenario. Int. J. Pharma Bio Sci. 2, 332–343. 
Ravivarapu, H.B., Lee, H., DeLuca, P.P., 2000. Enhancing initial release of peptide from 
poly(d,l-lactide-co-glycolide)  (PLGA)  microspheres  by  addition  of  a  porosigen  and 
increasing drug load. Pharm. Dev. Technol. 5, 287–296.  
Rayleigh,  J.W.S.,  1882.  On  the  equilibrium  of  liquid  conducting  masses  charged  with 
electricity. Philos. Mag. Ser. 5 14, 184–186.                                                                                                                                                  References                                                                                                              
183 
 
Reddy, M., Gill, S.S., Wu, W., Kalkar, S.R., Rochon, P.A., 2012. Does this patient have an 
infection of a chronic wound? JAMA 307, 605–611.  
Regele, J., Papac, M., Rickard, M.J., Dunn-Rankin, D., 2002. Effects of capillary spacing on 
EHD spraying from an array of cone jets. J. Aerosol Sci. 33, 1471–1479.  
Reichardt, C., 1994. Solvatochromic Dyes as Solvent Polarity Indicators. Chem. Rev. 94, 
2319–2358.  
Roh, K.-H., Martin, D.C., Lahann, J., 2006. Triphasic nanocolloids. J. Am. Chem. Soc. 128, 
6796–6797.  
Rooney, J.A., 1970. Hemolysis Near an Ultrasonically Pulsating Gas Bubble. Science. 169, 
869–871.  
Salamone, J.C., 1996. Controlled Drug delivery system, in: Claypool, J. (Ed.), Polymeric 
Materials Encyclopedia, Twelve Volume Set. CRC Press, Florida, USA, pp. 1510–1512. 
Samarasinghe, S.R., Balasubramanian, K., Edirisinghe, M.J., 2007. Encapsulation of silver 
particles using co-axial jetting. J. Mater. Sci. Mater. Electron. 19, 33–38.  
Savic, R., Luo, L., Eisenberg, A., Maysinger, D., 2003. Micellar nanocontainers distribute to 
defined cytoplasmic organelles. Science 300, 615–618.  
Schliecker,  G.,  Schmidt,  C.,  Fuchs,  S.,  Wombacher,  R.,  Kissel,  T.,  2003.  Hydrolytic 
degradation of poly(lactide-co-glycolide) films: effect of oligomers on degradation rate 
and crystallinity. Int. J. Pharm. 266, 39–49. 
Schmidt,  W.,  Roessling,  G.,  2006.  Novel  manufacturing  process  of  hollow  polymer 
microspheres. Chem. Eng. Sci. 61, 4973–4981.  
Schreier, H., Gonzalez-Rothi, R.J., Stecenko, A.A., 1993. Pulmonary delivery of liposomes. J. 
Control. Release 24, 209–223.  
Schuppan, D., Freitag, T., 2004. Fistulising Crohn’s disease: MMPs gone awry. Gut 53, 622–
624. 
Schwartz, D.A., Herdman, C.R., 2004. Review article: The medical treatment of  Crohn’s 
perianal fistulas. Aliment. Pharmacol. Ther. 19, 953–967.  
Seow-Choen, F., Hay, A.J., Heard, S., Phillips, R.K., 1992. Bacteriology of anal fistulae. Br. 
J. Surg. 79, 27–28.                                                                                                                                                 References                                                                                                              
184 
 
Setterstrom, J.A., Tice, T.R., Myers, W.E., 1984. Development of Encapsulated Antibiotics for 
Topical Administration to Wounds. Recent Adv. Drug Deliv. Syst. 185–198.  
Sharma, R., Walker, R.B., Pathak, K., 2010. Evaluation of the Kinetics and Mechanism of 
Drug Release from Econazole nitrate Nanosponge Loaded Carbapol Hydrogel. Indian J. 
Pharm. Educ. Res. 45, 25–31. 
Sheng-Tanner,  X.,  McKerlie,  C.,  Spaner,  D.,  2000.  Characterization  of  graft-versus-host 
disease in SCID mice and prevention by physicochemical stressors. Transplantation 70, 
1683–1693. 
Shi, J., Alves, N.M., Mano, J.F., 2006. Drug release of pH/temperature-responsive calcium 
alginate/poly(N-isopropylacrylamide) semi-IPN beads. Macromol. Biosci. 6, 358–363.  
Singh, J., Roberts, M.S., 1989. Transdermal delivery of drugs by iontophoresis: a review. Drug 
Des. Deliv. 4, 1–12. 
Sinha,  R.,  Kim,  G.J.,  Nie,  S.,  Shin,  D.M.,  2006.  Nanotechnology  in  cancer  therapeutics: 
bioconjugated nanoparticles for drug delivery. Mol. Cancer Ther. 5, 1909–1917.  
Sinha, V.R., Trehan, A., 2003. Biodegradable microspheres for protein delivery. J. Control. 
Release 90, 261–280. 
Sinha, V.R., Trehan, A., 2005. Biodegradable microspheres for parenteral delivery. Crit. Rev. 
Ther. Drug Carrier Syst. 22, 535–602. 
Smallwood, I.M., 1996. Handbook of Organic Solvent Properties. John Wiley & Sons Inc; 
Spiral edition, New York, pp. 245-251. 
Smith, D.P.H., 1986. The Electrohydrodynamic Atomization of Liquids. IEEE Trans. Ind. 
Appl. IA-22, 527–535.  
Snarski, S.R., Dunn, P.F., 1991. Experiments characterizing the interaction between two sprays 
of electrically charged liquid droplets. Exp. Fluids 11, 268–278.  
Song, C., Labhasetwar, V., Cui, X., Underwood, T., Levy, R.J., 1998. Arterial uptake of 
biodegradable nanoparticles for intravascular local drug delivery: results with an acute 
dog model. J. Control. Release 54, 201–211. 
Suzuki, R., Takizawa, T., Negishi, Y., Utoguchi, N., Maruyama, K., 2007. Effective gene 
delivery with liposomal bubbles and ultrasound as novel non-viral system. J. Drug Target. 
15, 531–537.                                                                                                                                                  References                                                                                                              
185 
 
Swain, B.P., Pattanayak, D.K., 2008. Simulated body fluid (SBF) adsorption onto a-SiC:H thin 
films deposited by hot wire chemical vapor deposition (HWCVD). Mater. Lett. 62, 3484–
3486.  
Tamada, J.A., Langer, R., 1993. Erosion kinetics of hydrolytically degradable polymers. Proc. 
Natl. Acad. Sci. U. S. A. 90, 552–556. 
Tang, K., Gomez, A., 1994. On the structure of an electrostatic spray of monodisperse droplets. 
Phys. Fluids 6, 2317-2332.  
Tang, K., Gomez, A., 1995. Generation of Monodisperse Water Droplets from Electrosprays 
in a Corona-Assisted Cone-Jet Mode. J. Colloid Interface Sci. 175, 326–332.  
Tang, K., Gomez, A., 1996. Monodisperse Electrosprays of Low Electric Conductivity Liquids 
in the Cone-Jet Mode. J. Colloid Interface Sci. 184, 500–511.  
Taylor, G., 1964. Disintegration of Water Drops in an Electric Field. Proc. R. Soc. A Math. 
Phys. Eng. Sci. 280, 383–397.  
Taylor, G., 1969. Electrically Driven Jets. Proc. R. Soc. A Math. Phys. Eng. Sci. 313, 453–475. 
Thompson,  D.R.,  Kougoulos,  E.,  Jones,  A.G.,  Wood-Kaczmar,  M.W.,  2005.  Solute 
concentration  measurement  of  an  important  organic  compound  using  ATR-UV 
spectroscopy. J. Cryst. Growth 276, 230–236.  
Tundo, P., Selva, M., 2002. The chemistry of dimethyl carbonate. Acc. Chem. Res. 35, 706–
716. 
Uhrich, K.E., Cannizzaro, S.M., Langer, R.S., Shakesheff, K.M., 1999. Polymeric systems for 
controlled drug release. Chem. Rev. 99, 3181–3198. 
Umamaheswara Reddy, C., Arun, A., Amalraj, A., Reddy, B.S.R., 2007. Polymeric drug based 
on  sulfanilamide:  synthesis,  antimicrobial  and  drug  releasing  studies.  J.  Pharm. 
Pharmacol. 59, 1207–1213.  
Unger, E.C., Hersh, E., Vannan, M., Matsunaga, T.O., McCreery, T., 2001. Local drug and 
gene delivery through microbubbles. Prog. Cardiovasc. Dis. 44, 45–54.  
Valo,  H.,  Peltonen,  L.,  Vehviläinen,  S.,  Karjalainen,  M.,  Kostiainen,  R.,  Laaksonen,  T., 
Hirvonen, J., 2009. Electrospray encapsulation of hydrophilic and hydrophobic drugs in 
poly(L-lactic acid) nanoparticles. Small 5, 1791–1798.  
Vandervoort, J., Ludwig, A., 2002. Biocompatible stabilizers in the preparation of PLGA 
nanoparticles: a factorial design study. Int. J. Pharm. 238, 77–92.                                                                                                                                                 References                                                                                                              
186 
 
Vert, M., Feijen, J., Albertson, A., Scott, G., Chiellini, E., 1992. Degradable Polymers and 
Plastics. Melksham Redwood Press Ltd. 73-92.  
Vonarbourg, A., Passirani, C., Desigaux, L., Allard, E., Saulnier, P., Lambert, O., Benoit, J.-
P.,  Pitard,  B.,  2009.  The  encapsulation  of  DNA  molecules  within  biomimetic  lipid 
nanocapsules. Biomaterials 30, 3197–3204.  
Wang, J., Wang, B.M., Schwendeman, S.P., 2002. Characterization of the initial burst release 
of a model peptide from poly(D,L-lactide-co-glycolide) microspheres. J. Control. Release 
82, 289–307. 
Warden, S.J., 2003. A new direction for ultrasound therapy in sports medicine. Sports Med. 
33, 95–107. 
Weber, C., 1931. On the breakdown of a fluid jet. J. Mech. Appl. Math. 11, 136–159. 
West, R.L., Van der Woude, C.J., Endtz, H.P., Hansen, B.E., Ouwedijk, M., Boelens, H.A.M., 
Kusters, J.G., Kuipers, E.J., 2005. Perianal fistulas in Crohn’s disease are predominantly 
colonized by skin flora: implications for antibiotic treatment? Dig. Dis. Sci. 50, 1260–
1263. 
Williams, D., 2008. The relationship between biomaterials and nanotechnology. Biomaterials 
29, 1737–1738.  
Witschi,  C.,  Doelker,  E.,  1998.  Influence  of  the  microencapsulation  method  and  peptide 
loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro 
testing. J. Control. Release 51, 327–341.  
Wu, J., Nyborg, W.L., 2008. Ultrasound, cavitation bubbles and their interaction with cells. 
Adv. Drug Deliv. Rev. 60, 1103–1116.  
Wu, Y., Clark, R.L., 2007. Controllable porous polymer particles generated by electrospraying. 
J. Colloid Interface Sci. 310, 529–535.  
Wu, Y., MacKay, J.A., McDaniel, J.R., Chilkoti, A., Clark, R.L., 2009. Fabrication of elastin-
like polypeptide nanoparticles for drug delivery by electrospraying. Biomacromolecules 
10, 19–24.  
Wu,  Y.,  Yu,  B.,  Jackson,  A.,  Zha,  W.,  Lee,  L.J.,  Wyslouzil,  B.E.,  2009.  Coaxial 
electrohydrodynamic  spraying:  a  novel  one-step  technique  to  prepare 
oligodeoxynucleotide encapsulated lipoplex nanoparticles. Mol. Pharm. 6, 1371–1379.  
Xie, J., Lim, L.K., Phua, Y., Hua, J., Wang, C.-H., 2006a. Electrohydrodynamic atomization 
for biodegradable polymeric particle production. J. Colloid Interface Sci. 302, 103–112.                                                                                                                                                  References                                                                                                              
187 
 
Xie,  J.,  Marijnissen,  J.C.M.,  Wang,  C.-H.,  2006b.  Microparticles  developed  by 
electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 
glioma in vitro. Biomaterials 27, 3321–3332.  
Xie,  J.,  Ng,  W.J.,  Lee,  L.Y.,  Wang,  C.-H.,  2008.  Encapsulation  of  protein  drugs  in 
biodegradable microparticles by co-axial electrospray. J. Colloid Interface Sci. 317, 469–
476.  
Xu, Y., Hanna, M.A., 2007. Electrosprayed bovine serum albumin-loaded tripolyphosphate 
cross-linked chitosan capsules: synthesis and characterization. J. Microencapsul. 24, 143–
151.  
Xu, Y., Skotak, M., Hanna, M., 2006. Electrospray encapsulation of water-soluble protein with 
polylactide. I. Effects of formulations and process on morphology and particle size. J. 
Microencapsul. 23, 69–78.  
Yamaguchi, Y., Takenaga, M., Kitagawa, A., Ogawa, Y., Mizushima, Y., Igarashi, R., 2002. 
Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by 
hydrophilic additives. J. Control. Release 81, 235–249.  
Yang, Y.Y., Chung, T.S., Ng, N.P., 2001. Morphology, drug distribution, and in vitro release 
profiles  of  biodegradable  polymeric  microspheres  containing  protein  fabricated  by 
double-emulsion solvent extraction/evaporation method. Biomaterials 22, 231–241. 
Yao, J., Kuang Lim, L., Xie, J., Hua, J., Wang, C.-H., 2008. Characterization of electrospraying 
process for polymeric particle fabrication. J. Aerosol Sci. 39, 987–1002.  
Yeo,  L.Y.,  Gagnon,  Z.,  Chang,  H.-C.,  2005.  AC  electrospray  biomaterials  synthesis. 
Biomaterials 26, 6122–6128. 
Yin, W., Yates, M.Z., 2008. Effect of interfacial free energy on the formation of polymer 
microcapsules by emulsification/freeze-drying. Langmuir 24, 701–708.  
Yoshida,  M.,  Roh,  K.-H.,  Lahann,  J.,  2007.  Short-term  biocompatibility  of  biphasic 
nanocolloids with potential use as anisotropic imaging probes. Biomaterials 28, 2446–
2456.  
Yoshii, H., Soottitantawat, A., Liu, X.-D., Atarashi, T., Furuta, T., Aishima, S., Ohgawara, M., 
Linko, P., 2001. Flavor release from spray-dried maltodextrin/gum arabic or soy matrices 
as a function of storage relative humidity. Innov. Food Sci. Emerg. Technol. 2, 55–61.  
Yow, H.N., Routh, A.F., 2008. Colloidal buckets formed via internal phase separation. Soft 
Matter 4, 2080-2085.                                                                                                                                                  References                                                                                                              
188 
 
Zbicinski, I., Smucerowicz, I., Strumillo, C., Crowe, C., 2000. Application of pulse combustion 
technology in spray drying process. Brazilian J. Chem. Eng. 17, 441–450.  
Zeleny, J., 1917. Instability of Electrified Liquid Surfaces. Phys. Rev. 10, 1–6.  
Zhang,  H.,  Lu,  Y.,  Zhang,  G.,  Gao,  S.,  Sun,  D.,  Zhong,  Y.,  2008.  Bupivacaine-loaded 
biodegradable  poly(lactic-co-glycolic)  acid  microspheres  I.  Optimization  of  the  drug 
incorporation into the polymer matrix and modelling of drug release. Int. J. Pharm. 351, 
244–249.  
Zhang,  H.,  Zhang,  J.,  Streisand,  J.B.,  2002.  Oral  mucosal  drug  delivery:  clinical 
pharmacokinetics and therapeutic applications. Clin. Pharmacokinet. 41, 661–680.  
Zhang, H.B., Jayasinghe, S.N., Edirisinghe, M.J., 2006. Electrically forced microthreading of 
highly viscous dielectric liquids. J. Electrostat. 64, 355–360.  
Zhang, J.X., Chen, D., Wang, S.J., Zhu, K.J., 2005. Optimizing double emulsion process to 
decrease  the  burst  release  of  protein  from  biodegradable  polymer  microspheres.  J. 
Microencapsul. 22, 413–422.  
Zhang, L., Eisenberg, A., 1996. Multiple Morphologies and Characteristics of “Crew-Cut” 
Micelle-like Aggregates of Polystyrene- b -poly(acrylic acid) Diblock Copolymers in 
Aqueous Solutions. J. Am. Chem. Soc. 118, 3168–3181.  
Zhang, Y., Guan, Y., Yang, S., Xu, J., Han, C.C., 2003. Fabrication of Hollow Capsules Based 
on Hydrogen Bonding. Adv. Mater. 15, 832–835.  
Zhu, G., Mallery, S.R., Schwendeman, S.P., 2000. Stabilization of proteins encapsulated in 
injectable poly (lactide- co-glycolide). Nat. Biotechnol. 18, 52–57.  
Zimlich, W.C., Ding, J.Y., Busick, D.R., Moutvic, R.R., Placke, M.E., Hirst, P.H., Pitcairn, 
G.R., Malik, S., Newman, S.P., Macintyre, F., Miller, P.R., Shepherd, M., Lukas, T.M., 
2000.  The  Development  Of  a  Novel  Electrohydrodynamic  (EHD)  Pulmonary  Drug 
Delivery Device. Respir. Drug Deliv. VII 1, 241–246. 
 
 